var title_f13_41_13968="Model for rapid response systems";
var content_f13_41_13968=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F58952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F58952&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 552px\">",
"   <div class=\"ttl\">",
"    Model for rapid response systems",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 532px; height: 534px; background-image: url(data:image/gif;base64,R0lGODlhFAIWAvcAAP///29tbREREXt5elBQUF9eXmBgYGhlZtDQ0H98fTMzMxkYGVRSUw0NDRwcHICAgEBAQGZmZldWVnVzczAwMHJwcHR0dF1bXMDAwCopKWJfYGloaUdGR8vKyo+NjklISK6uri4uLoOCg2VjYz4+PiUlJTk5OUxMTLCwsDo6OnBwcGxpan9+f1hYWEtKSj47PBYWFmNiYgAAAMnIyGRkZIJ/gHJycpSSk0VDQ6akpWZlZre2t87Ozjs4OFtaWsLCwn18fCwsLJiXmJCQkMXExVFOT6ampiwrK6moqVdUVYOBgjY2NrKysoB/fyAgIJeWllZVViQgITMwMS8vL4aEhUI+P0ZFRYiIiDczNERERN3d3bu7uyIiIpmZmeDg4MTDw8bFxsjHx8LBwcrJyczLy6inp87NzaWkpKGfn+Lh4qOhop6cnOPj4+Xk5JuZmubm5o2LjJmXl728vOjn55aUlOrq6uno6JORkpGPj4qIib++vuvr6+3s7IeFhu7t7e/u7oWDg9/f39PS0+7u7tnY2LCur9XU1Le1trKwsczMzNLR0dfW1rWztNDPz9rZ2q6srbm3uNzb26upqru6uxsaGlVVVQYGBnd3d6qqqvDw8KCgoPb29vHx8fLy8vv7+3l2d/Pz8/T09PX09fz8/P7+/vf390hHSPj4+P39/fn5+aKgofr5+kVERRgXGK2rrPr6+ltYWTg3Ny4tLUZFRra1tc3MzJeVlqCfoE1KS728vVRUVEpJSrq5uSMiIkpGRzIxMaCen3BvcJ2bnHBvb5qZmYmHiIuJioiGh6KhoomIiZKRkYSDhKCfn7m4uGxrbLSzs0VFRZ6dnsfGxpaVlby7u5GPkGJhYVVUVJybm4SDg6GhoSMjI52dnbCvr6Sio6mnqHd2dq6trYyLi6yrq2VlZXZ2dhcXF4aGhqalpZubm56enoqKiuHh4RQTE7W0tHl3eNra2omIiO/v70tLSysqKu3t7QkICIaFhaKionJxcb+/v76+vr++vwMDA9LS0pmYmCH5BAAAAAAALAAAAAAUAhYCAAj/AAEIHEiwoMGDCBMqXMiwocOHECNKnEixosWLGDNq3Mixo8ePIEOKHEmypMmTKFOqXMmypcuXMGPKnEmzps2bOHPq3Mmzp8+fQIMKHUq0qNGjSJMqXcq0qdOnUKNKnUq1qtWrWLNq3cq1q9evYMOKHUu2rNmzaNOqXcu2rdu3cOPKnUu3rt27ePPq3cu3b14ZgAMLHky4sOHDiBMrXjzYb0LGkCNLnhzZsVMZXjFbNqiZa+fNST9rFQ2aNFbToImitrrab2uqr1P/jC2Vtl7bUHHL1qn78m6BvZsG/11zOMYsV2Ian7s8NHGjoq9wGcglecQrWQAgR7j94RbN3xuG/1/YPG75o+eft4w+XWD1it0Nxhffe7zC9G7xq1a/n6B06sldAZgCiQBwSWCJSCeADAoMgl0XgXURQYTaWSeQggwOokVgDXIBGBfhaaEAYBEAIJ2HHX6YyIgyVFKQfmzBKJSM/JkU3WBXJCJDgRFkJwMmA0k3yCDVYVdhQREocGSQXAz5nkAbYjJeeJWUqIUACXKhxSACdDHeFUoeRGNaY85W44wF/efeFV20t8V00skQgYPZaReBkd1dsaAM081npJ2JZBHhlJh5GOGfXHipmRaVMNjFi8SV6ZOkZ4LEHoA6FlhJnQJ1aeSVXeB5CQBRGtinhSZmB2qSAAwig6KDAP9AZYlB1pnod7EyCelvuP1p0XzemWafRJRW6tGla5o4YCJcDuhgYC4aCeGrgvJ5qn/Qyrqgh10MMiKImIkYmBaIdvutgIA9SlCxWXmRyWMJtTngFniiOhCwB+E70LAE8SvDFuHV+xC7xm50nq8UIXwSwVchIIMBCIiJECavCnSnwhPpKxC/+wr7mcYSF9zTwZwmXPLCfUEAGASa7GpQJaP6l912DKZ7JLo7TmjzfF3sGSefGzr73bcF/htwFtO+KkCsYCLEsMgXPX2T1FVpIpgAD3gBHHfq1nqkDAGequMWBrE6XxYxyypalN9p6qLRmAkMQKJzd+0y1DlRXRxlfPf/7fffgAuGAQCoVZnmzMn9C0CbFTIe5J7X7jtiFomMF+igmv0Hd6pLYodJeyHjnTdJGCNUekh6T2V1YFhrTfjEYFt8hcCKM47c2FD+aOqSBVWJKwCsuqqoQAqUuLmoAnGpgL3ris5bRYrLh+rpF9ZJ/YuAabG4oQrQyyndoeulsgws353mnll4/zXZtgeIYLVcRC4Q/Mx+u8W2r343oPbHZzfto5dYGrych5PlRG8h1/vT9V5ENoqp62Lfs1vz9uIwiIXPKSB7HQGnlpBqZWEQELJYBHS2o2oJ4GaByc6bbJY7Ep0oQ8riU4HWRTaYHY46EhxI6qLirgE+hWK5ctoG/zl4ECF5i02aGSHhyPa7+eVIcUbqEgAwcUKvmUhLXOpCIrBkIBfRUDsS9BX4OBOpzAzRJqhRookiEELgGY9sBpKBAJKDHMdhJ2jjsmK5ksYnBgLAcDIbiACAdMHSmPGMNEGNEavzHS2IyHiEFIiOtHC7Hf0xO1I0SNM4V7ctzpAzDYwd8K5AMfbJQHuF3MwOZbJKRKZyfoD5oHbkWDzgpSswJdqOzhSgQkOBDgBblFO5YiindWXPROgj24HkmEMdlrErrXSl+bISzdMcUpowqaZLtMmaa2Jzm95MDTdZMk5XllMl56xNOL+5knSixJ25WSc7UwJPGz3TM/MEJzTvuf+VejrPnyQBKFMEKhKCiixwCE3oZCKl0IY61DD53GdEJ0pRclb0ohgNaEY3ylGDdfSjICVWSEdKUh+W9KQkNShKVwoXlbL0pWtxKUxnahaZ0vSmYbEpTneKT576FJE6/alQpxLUoRrVN0dNaqWKqtSmFoWpTo0qUKAq1aruhKpWzSoatcrV23T1q3bBKljHSk+ymjU/Z02rWsSq1rZyhK1ujWvU5EpXedb1rkTFq167ude+RgWufg3s1gRLWOcU9rBPRaxi0bTYxo7MsZB9XmQnWxzKWpaVl82sPln60M569rOK+SpgyXSm0aoSpqZ9bFdTW9PSiha1rl0tbGvEWtf/zDaRcIxIBisr25eSBmeVQCVBdlu9iRyQdwrR13G5wzzywHG5DKltX6Q7FtFcggsFomRu79VcTZ7MIdBtiHK3azDyQoS6e0FvTgsySCRFKGkSotAyd4RL7AiIkrEcxNBkSDgWPWo7OPvkHwPjPhmSkFwqIlybelRgAimYCxHwZSIOrDgP6rdmXJxgVb0QMQ0iwHUlFc0pEWI2e7FKd8W9ItmMuLy2/fFtYasQ7tKkJRlz8RJvI5snu0g4L1aSRz7yInVGFb1/sfgK3yFbFmjlTKtmgnxW04TK3nVS0WTycR/qHOSuKCc6pViNV4jAl6ZTu1M5Dkm0qqNgyGzKwLDZ/4mOe9MSW0XCNwJnC2AWcxKZPFirGmAwBlipdUFEKqTp7rraGVWpEC3IUIVJgU0iEpI1U8syyxi6i8xRhoEDpB3rEI4/vuScIRSrShPSyJFm5J6n6VSHCabDVS4bLvFrrcWlC35N2lODgnknTllYfwziH/uuFeCBeEuO78FZiXSGYBLNGYUMKhrZxMWnZWevwvkdjxqbnNXxkY+zL+FYVdR7l9XJoGWCDje5NZzVBVUx3bTt6gNk8ADfxlarXpABiFG6yvDylauDs3dJ5OZvhIgbIwVHnWbxRrXuJNwgBx/KukMD2or37TkycpWAB/mgCNWsYtQeVY/cI68+Js+Sgv/EBAn/ix1wjYiLcHt5gXD2XYRHdOJ93g2NlqeFRG2Rcw6PcSVctEU822p4BeG5z98NPCVlQQHaS7Kdlij1JesISAs07s37iXGP4DgCn7tCtBB35+3VbX4SOjrHvh72aG25O9p+Y9ztWPO55hPnGuSVR7Y4nUrMEegxs/TQgYlqbcGqIHz/4xwXHbm4U33PmRJ1R/AOHa7zcyN/p5j2pHXLYZOKRYpGUZeO/UsAZH7EuF6S4zfnRlvyqe4WoXxiR1OTarUIqWoB5Fu3HpOsM4S4eZfJkknV3oGmpVpQPxbvGzIi4Sok4qYju/R+311Wu2T4kZfwg8VsqGZuNd53d8j//ZZHn+vA/iHAP6cJ7cUFIntRilRULX9k3x+GRKAScTZUmI/uywHDcF/6Rzv+BW05QyHpV3tzogCjMgh1Nmd4dExXdW/sRBtcgglcQjZ/ZzFqlzkNAgDkJ0gWQjsxVknmVWINoX5W0iWk5oF2ZnreV0AS+E20wUcRsCHCNXJ1o22CwWQ26DU043l19Et6kmUHSBPDpzZdwCIQ9mwrZHIRCH7zRBtoszEywCUhOB33c3hgEkQEkYFAlzhA+ERwxHjIZVKyYVC+R4XRs1tyMxL0J3EMsSGfxEg+03MMMnrf4n8Vsy8+QzthSEyXU2tFuBc9JEQTQUW5IofRZV7ElYYe/xgg0gdxcROJX/Rssbd81sQXFQRr7BYRmbRJzmUyDyEA28WGlPhpuxd+tJcyK4Nu3JYQx3Yyl2ArydEoGbJfWEJhCwZgCPIeNmgkK1chWQA6OlMdM8MiJWJfrzKJRyJhFKZk2YZhAmaIUWh5fGFucpQ1OWc6gRFJhKdfS7OFj1h1LXh7l5ZbvnhKCGM2yfdFeEJ0OyIdTMSM89F+z4ZqQ9JiFcZn1DiB/WRxABmQfDM4sYEz3viISkRCcrJ6zwVqbPJL6Ugu2TGEfYQvUCR9r/InR1MhDIhL94hntBJmjkcemNgvrPWGH4GNrbONBxGLmsQFpGgiHUiFIkQ4p+aQM/82dfd1R4cmP6goMJqnkfSIRKUGSXeWaSN5HyXZMTrhcOZFkqwIZdbnEK4COraYP6vGbGtYYDuiP82HJx/ik2UHloABiTRZL9S2hFoJjTLwQUlphtiEGtAHE8DXj3mxia90hiXZhOGCjJ8HGC7ya3wiR7Y4KhjSgbbYILjILCbkeq8CX9jWlrHycRKEkh1RiHkpTiX5d7NCfImwKUySj5NGNlzgP3GTarPTgfqoZHrGhRbjdNaBj0dEODHWiZoJhf44ED0YHoaSLmOUZ+OxHRtpJwqpZzV5IH9HkZHzL3k2aqVnmSiDmzLIXu7zR3wGmheCmsGZHBsJKuJIk60nSaf/1JOJdpSo6ZxT6RjQiU4lOS0j8pfZQ22BGY1OpDbE5EVXiXQjBGy5FJa2toxsKUuWZpuGJJ1xaRKOqFGXNxRzSUTVOHDnV1YLChFVKX69QVwN+n0PSk1dVxFgEpMMkaHDVX1MGRTrOSnWqHMM4ZIFUR1q1IT7R3L9l5hcOF840wXIMYwhZ5+JUB3Uxo+JtJTj1qEKYZAmCY6x4oU4eCscWGqogmJL8nTaM3hF1zaEZjhXMo0zcaLyl4l6h0DdSBAK2QU9qIEkp4MeySRd1h3dAT5I8x0CEDO9uYcampscOqEFwaLJU3xN44X/kYW/850I0SVTuCRUCjf3U4tAWqfT/7mKXyoRPaObXVmHomcufZSfxqZrIHRr1rGj4bFFNcgiI+agEyiQppoYRKoeXLpWt6WqryVw8/eq4GagVbWq8USrUmWrT6GrCspVvCocMWhVv2p8FCEoqGSsukWiFzGXChShkyer8JYxMqBoEPgTCZqKvtqqCKGn85MFSzOLp4RHu8YilTAIjVlHVdQ0NCqm8oUgh3lhqSIgSVOD9aVC7vZffulRvTWrRRqm99IjPQMhwhUloNhEHClFnqKazXVikYSUp7ldpNasppccPWOuKjSqGTGsZKGxSlGQ/jo/bNQijRSIr8IojhJHfwdgWfA5jllMWNZHcTInf7Jkw5mE4//SrGV6SttRphkLrfy2opNTEMNHio0UPHSqJoRHScmxIck2kwRBho32KV0ynPYYlI+GSQGyNDuLsTa3r9EqEUeoNlpwP4MZKpjjbN0RAQKkh3aDa82SIcBlnwr0IafEa0ZCtlK0tc5nd9kKq0hxrZulVRxrWEkBuOvhs7GGq1E1uEjBuM/qtT+ruE7luJUnuU1FubMXq5CbuJrbt5x1qqAbuqG1uQtXugVluqjbq6m7uo/Luq6rEZj7uhUVu7I7UbRbu6qIu7p7Xrvbu+Dlu8CrlME7vOlJvLp7u8ZLQJQnKM6avHZKoc2UmNk1gDbylASBiBBBKOXnvHopEeb6JAL/QUXaU0uDB0TVi0DNa5IRIaLcG1YV8ZlPsiF0lBzFd1yUKSvdJ4xaQq7+p5jSeGC6CXp41DXvKq5E8iEh4pcvlCIyxL/tm14XsSF1MnQKkHxFZjexoycuOEUnJKWSJ5NOSo6WKBBUSooKk2mSKiXggRlYiiXSsSVTy4EPbFsUAb/WsUl9epNf1EiDobQkNxDFyZAtqi5Ic8J1YnW2h3S8KRihsoFQ0igK8IIzbB4T8b3TIwDawyrlW4VfhGhXZqicIqird5CHqj6BtCpKIjy/05lWxKRciLRT7L7e20zIN70spEMIjL9E2Kn8m5+Ox2wBDBiGeTJxS7bcQnoJfLNH/0d6NxrHeLFDD5cShuvInUtP1ssSk0zJqarJrIu8nLzJn4y6ojvKpHxxodzJp4zKqZy6nrzKBerKpdvKsKyesxzLtbxwsnzLEKzLl5XLvPzIv2xZvhzMdTHMxMwcxxxZxpzMLcXMjrXMztwW0BzNMUXNhMVhg/Vh1rxXT8Yy5zZl27xXfyYYgRbOeuVqgcGJ5lxX3gYB67xX5uaK73xX7jbPezVv9WbPeJVv+6bPdBVw/hzQAm0ppVzQBn3QhTHQAyO4Cv27WTXNk8vQDR1dEj3RwiusFg2VVMG8CcG+93HJJyFuHs2SGd2J5OcqyaFxEJHJnKQR2NvRujFeJ3jJWf93cP4CMENJ0SVtlzjGwS4Sf0axQCPtNCDNETbtMSOq0ztNRtd7QpegwThmwElGLQp8jM5Gbcc1XwnSS4FxRSgyCCsCmE8rwBSSnQvivzJXsSB8rg0mbbMkmXoIhv7HdHjilz1Tlr4k1TWDXY+XKvAlQKBI0ktNGlhCIIZtIWwjSllwsRKpHYxdCWFivw2LSaMSMFiUsAdRwmYcmpImwnTjxtwVeSMnm8ujJ9rzgy/sXY4ttoVqn0/7Iy42eP2zJJ9dmUtdSJUA1QIC1klsH3orMDYIPscVs3Sym8xYNyYbxQThpk18Q3bieJ7THsg5v/m3RHmmRj+4bYGkt1swOZX/oxkki3Sag9NfWD0sW7wW/VsC8NMCoCRGi3RH8otkZ4NlfBCegrXKwkljBMdlbMTEp58lojyoMkmhBpqyWSTniWp7W9486ztc/N7jUWnkjTyt0t7MA9GXaxA6ktLTqi1l69tLq47zXbce4iG59bYNwnmDqd9me8fwOchpki0jGUCxwp/Q5mCR+UHHxidy3Zg+GOK0hl2IjD+Ksj99reIAtLYEOtgrMUkPAccZkXV1SZVjVHvNheFKJTXApqwXAhgguhELZL4ZG0s4IeboPdFYTri3/Yq5uuZnLlRpflRxjh5uvuRZXudsvrh4DhwI3ed+Psp7fhZzHuh0TugPbeiH/47otaroi87oeu7oEQ3pGS7pqPPnln7pmJ7pms43GKWxlDvoTD27MULFwZq7pNXMpb6hp/4WoP7mZ+TppG650gTrqC7rG4TNHtbPX4HrmqHNaMHrAuHrqQHsACDs0tTNUQbOY4Hs3ywDVHYWzC5lzr4b0a7s3zTOgVHOZIHtgKHtaMHtD0Mc4O7t2ITOgKHOYWHuMoDuZaHu7G4Z7h5R7YwW884W9U4c9z5P8YwW+84W/U4c/55P9ZwWA98WBf8cB59P+KwWC+8WDa8eDx9R/KwWE+8WFa8eFz9RAJ0WG98WHf8cH0/pCr3pDQVeJA+QBnPyiKEaKn8YsOGlGg0W+v9BVUFF8y9/FbaxnjPfuPWXuX8F8xct8/pauYxF9D+P8w69XrDL83BY6OqE9CdYXUPv81PF9E9PEZEcpFEPH1xuJksPtl3fQWG/9UU/EkOd9EcPxEwcio9R1Pky9mIf6jH/n86WXHBPEjI995dIEEkDvkJ7938/XDYT1jwuRrbd9BR6lWmzEMM59bcKxItK1B8N9sdx4Whvdg4x5dvk9jvP9+2hJ82l+dOX1FcSkrkdQa7OWxBRwTUeJiFaJtQlGtqt198BIUY3P2mjixDWhI+ycvA1jLHkIVgcQ3xNmfBl5+ZzZqTCIRdW+8iBg6293Al2v0/nbMpIa26510Wzi8n/4Yw3m2DIHxGicWZNw/vNqCJqra7OEteBH9gtXeXBV/UQoSOuqX2vsvu9yTnBCKPiDxAABA4kWNDgQYQJFS5kaFBGwQgyJMroMlCLDExbZFwRKGPLRS0gCXrsWEmggIqYBBCMoABAFo4vswDoQpLLlUQCEgG4ZHIjgCtcXsYc2RDAQ4I1J0awiFFjTJggRSbkcukoxysrs5hMJCNR0C1AuQwapOCKxp2VfJocSrDq0bA5d/YsiNToQrsCuwgVqBEASgAq2w58y6Wi4SsKBgEwG1TL4IEwgTIleGWmQMN1727m3Lkj5y18D76VwVYAR7+WWbo87fmoa9ixYecFEIGy/8BEWSZ28dsxLMxLt30PvzhRhpasEoVKbtsbplLlcGkuJzqQdkLaewnm3t27LXDhAwdFlMiUpEYtzCmqrk35SoTeQaUPHb9UOnQZoj/Ltl5Qu8DEipsovSvqKw+oLDARirzybBOIuciw0g/BgQTARDP+MuzsuoW6ekw8Bs0LS6TUZkouv6k21HBFFvtjSbiWABiEIu/O40Knui6cDzCBLrrwkuWsag4pmOQaKSztshCyqIay0y/GGXmzS7LQcKzkMr1kWEwBEXmiLrDj2AuKrJt643K+57RkzLwLjTyIQ9ecBBAwHh+8oqYtmRpEALOAUmygMQe5qSDJtBCArSsqwf+EpJo+dLFFSN/sTAEFHttCATzX3BGrhyzz0cu/qtsMzkhLbRIi43gTID8a7SKJMSwHIu+isAAILTrd8hNKqS6oJJLTAxndVaKKHsXLP+PgW5WLViMUSIHLBKi1RwWUM0+53ybCCstcsxhEI4kqRfMKLarNj6lZr7CPyQyzmygzW5nNb6hyrRXoEgEWA6CS3cqSQYBBIyPWVnP7vESiOo01NVJSE0oP4UvqPXc+paqlMFcuhNpi1Z9GXfjjuxq+a89pQZ7NKJGNIjmwWBF61U6jvGsx5ZBbhNDk13CeWWdTaeaZ4Qwvcelnz3z2eSGhRy35ZoVkZvFohqBmaFF9dZb/mmjssN5Za6u5xtpor8N2aMWrxR7bbBXRPlntUstmmzOw3+babUnlhtvuU/GuWW8N6TbIabnj5vsgLZgVVTa/MfxZ3cQVHpzdx7OOPLbGBwL8bcE3y7WiRMwt0y4HAW3Zs0tG56/y/UIu2bMZV6d88rO5vtxj2ONccXa1M9ecI0Pdq8S70AE0nbNKDj+dbLhd56yrp2uHHGvcUXa+aIbk5WInGcyt6FaJ6toLPnm3l5dcc60adM+Mwh8qi4w5Qv/YvDuTLLGCgL9NwAgsU1dAxTSqVqdB5AolA+JX9r7lEYqkrV2bYdBFvme9nWTBXEzpAseCUh7uVQQm7KPd9PwG/8GjfG+DXJAYBS1ovbVNr4PVs8pP5NMap5XmJClZSWsEohYA5GQL8nkhDV8iLu38RyG6u8v8wmO/ylwGLATxkUZ+Ax81wSwxWzpLxxR4PKWVpCBvycJM0KMkyyEFMIKRoKOkp8LKkYYtZdwXUwyVmyVFL34qPGNCDCSDLu2FRLQhiYAkkiJ4ZaELJMOUH4/DHEIWa4h15Mz8JuSdSiyJQpPkDrF646CDtUYyDMKjHBfZt+QN545MKdRxLiWDLCTCL4Yk0BVrR7dRjgszqTplKj0JPzoy8iCZOpOwQgUUPtYqYTbcF1dIEoEbLSZhEErMSqKmyyLy7lAAqsSMOJITRf/6SXgCgVKz2jMQD83vT32hG+pyFjIdMUpNZyqloyoBxRkShGlzfCVseNmlwbzzIO/USNWol0toFkRiXMjjsLIXzL6gcGMSIZ9EhHSRmHDvSwKxJj0l18iBnTJ7HKmgQwuSEzyyZ6HMkhI3oXgg5hTQm/9cIAP/2EfPkZJ3h1SOKpEiUcjszYOwGSg+mSMxmuYnEf6a0AoB+kmAbsyfF8XlUVv61Fya82dS1RpV7WZVoilAkkhtqlMRh7yjYtVkYuUZWXPnVZ12Fa22A2VY6WhWnMHVbHJlGxHX6srXuRWNTqVr2PqKNrve1ah5Behft1ZYwdYtsS4L6GItmsKovpX/r459HmVTp1bLYpatiN2rXi1rWLEFNrOMbStnd+pZyhpHtatlbWtd+1rYxla2qkXZbG17W9zmVrfm3G1vfQvbt/5WuMMF7WiNe1zkJle5y2Vuc537XOhGV7rTpW51rXtd7ALgAQ8A6Hbp6N1cgje74x2vJggAUAJogo7mRa96yfve6yLACQB1AgLoKF/62he++6WuAPQ7PQQ4k47+va+A+Xvg56rAAHQ0gAoAqmAGOxjBE26uF2TwX9ghQAZeAKiFMTw5DXOYwiNW7gMokInaZYIC3D2qiVEMOxWzmMQzPq4B6gtiCizYqzb+sN4QkGMaB/m4DxCAAVAgYrl5AQUG/xCAjL1KZCMj+W1KZrKThXxlx2ZiCBDgmG4hoAIpE8QLKoBAbwUAgSG8+K5a5nJvvxzmgYy5zLs9c5qxfOfxZmLJRVYzADKhgiKjoM9Y1jOTDdDnPwd60Hhm9J0zQYATC0TFBFh0ox8daT9TgNKN5nSnAWAACAgEAjr2dEFALWpSl1rVQs6EEzShCSdU2tOtfnWsV31rIWuCAhRwL64Fomte+1rYJBaAgYVd7GEne8IQCLWyma1saO9XvMOedrStbV0vwBnX2b52t739bXCHW9zjJne5zX1udKdb3etmd7KVsgXyVEopZmy3stnzNsZF+2UK6UJ4AkbCentaXqWh9/827yLHeXKmdV5LxE4Eai5vAdOAOLu3bBIOlxIhpN8EEZTDAR5wTmcmPWMxSMUzdPG7MI/hlCpZ0gzVha7sRKsUH578jDefSRpk47hRwLQ+DnJGw+svmCghhRjUBVrZKopKFwuzxkmT3Yzw6D88UOckUgl5gW9gIzRZFyhVrL0MUif0y7nSq3U9iV/PieuZiCrVJ8Hy4G8kWQ/XgyTirbVDZy81xfhxlnI+C+08QG4pONCFLHSY6PONFY+Rg4LHdMfsKZvMYaOsXNJFpSNnaEz/iw8rj7Oa8I5L0xSTftBSTCP15Ck5fNkYteLFMI3uJ8gMiUcCZZbV5xQApNlCxqf/8/udD/wyPzc8loVuoYGvx0Qc05gAUgT54U8eKjE50Zekwi9MrVK1rQT9128oJCWRveLxMYxxuNAbIbKynSaXDns8Err3eEcysfSI7xNJk/AQvvh4FjkH9Sm6TwGSB1EAtgijSRK6lwC/mfoR6zsOQDk/MZI+k+mcniOISnCJsriEmGMMSTKTCHATzuuKaVmmmdI8hwgL99uhsRCUKooMq7invtMmAFEAZ3o3ZHHA/TO+iagmAAAq5JgJjOGLRVkd30NAXqE85WhA5OiOm0IhlGORhjMIiYk4xnk6pQuXx2CcTrILLXQ7XClBkBIOkkjBl7i7AxoIXompGAxDGbGi/xxUN/Y7sFtSIaV6w3UzFB0ZsTmcnpmzQz/8Q0AMREEcREK0mycsRETMrH2rnYuTjPorrkSMRARrRKLYQ0m8ROd5xP/ZiS4coaKDDhNiqE+0IHmSF/b5lywMF+zZu92YOkeUqAi4DDDCRFpEo94jiSz4wJdhI8XDkSwJoCXpRTg6CMyribC4iQ2MxaNYI1GJkVfsDanAwVqcxsl5RJMSosFIvi7wugGppUTQRm+UJ9T4lf8IDVkCCuZrC2u0k+CgRneMnHW0DRF0ljZyC6tYFHeKgP8riH0cEjvZwCtBE6sIwC95RH2pEofjtHV8xwmLR6boxJjwQcZhlocRKh/EmP+E9Me2qELsqZUjTEJ13AKiepaaiw1tLEM80pk4XIhDFB2YOUFLZEhqXBlT8ZAxwUOaszmjWEnruEWZ/EmFSJqFycV9UcDKuJGJK6D+QaAu6MIMOgrtkTvr0B6JU4BE0LunPCiKwB/JACFrBLw8BEqxLBWVeAzKE45AuYkpYowquqbW8yEXEgr2cyGd8IraAMKYcL2rEItJuhne84sgKqqxHEwNCZhIekmDy0VOgqff65Ht86W5DAuNKMcGNI6k0w72gAn688n7I0z4isnpygp9uUkLSaIeRIm1JCfceMsj+T2ya00gAUggFJKEgcyhSZM8iUE/MTbPzC7QJAhwQaX/vliWjFyY34SNPamOXAkPLWQLlSopAGk7nPIlNrQObKnKneCV6UQSoQjDqFDDdayo3nyv4xSo0mwNoQSZ8vwYnmQY5cGZOhxP8vIfoaqgxXhNu4sWR/GQrlgMmaFPtJvIVSQo7mmolAwKpxOU6MC3koSUReSZPpTP8To9HMoMBAyNDNwYwviJ3kCPMEqLSki9tTgJohDGyEOJ9ZRQFb0dpOChBJmQ9+hBkuI4w+hPzlNNscAPoegjadRG9jCMFL2r4rgThPmIgVnRZPNAGeGTm4MIaeII9Nw8zuMSENyUgejHH5WSpUqsGHKdwoGIy4iAbEJSXAtOceGJfGkIVmSL/5HKSDNNxWCplYXaCImMvpE8qtnpUimckOLhpjElU2hryc4I0tHKU4QSKNEIIKIQU0C9NqqBFEI1G7g7UJg4DqUcjzWKmAlqOgOyHv45oLPryH0Jl0H4UoIpGUZtVFXlma1gva84Pz+hIvTwEBMlIclzmiaySxyyvT8xC1PlJD9dVWE1GfVoyjBNlqFoRx+Nvt6oJG+Sj/dLFlM9iFQdVlx7uTd5z4NoT6eSDHwUEyusIGmpR5fcPS2tDQz0pl7aoacbUoE6Umu9tQjYqp68izjk1lAimlxxISx5Tsy4jDrFjEE6u5FqFSyUDn+NV2+7iC0djp00HXzNIn1tUoX9Sf+v21ChgsqBORiJSASJsQrVGBSQWIqiOwj6xBGObKCfEdSKpcYY3aIWwoqVwIgr5QppCdkSZA9hNFlc1MWdUMYHbVmhdY2X3czMu6AIEJRiESSc7cHYm6Xd4Nlr5AtzDNqhvdq7uFioy02SEMAK6QIcEkHVIMr9Ibt+/CUDbA/ZPIqwxFq3NQqG7UHwxJY9IdWPpRBwqRYtCEMfzAl/uqSHVMXa+KO3LdyGmFetuQSKFbLLiVjDzS5s9TTdmClt3dYGTYjGvdzH3dyEOMXaq1wWyVzOpUV3ZYwRgVeQ+UY3fJBYzAJaqQmTCiGC4livGNtNBaqS4Z6HKDrVOLqk66f/0X2uSOUasjPV4piWagUZlVqqXHwKj4Ddb5IhtnVJzEOPC3RYEmU6E42VxkOX/Ave5BLdsmMIx12RQtEPWA1WnFleQmGKAtoC6HWQV0HaQRjbEoSXl9mj3UsV1ag+W3E+aQTf5RLfyFEQGXUL5P3TmjQcgyDK40WPcsGnr7Vfp9WCsN231lAXchUeghzAAhRgx9IfSyVVwCTZpfAUu+wnATXNSXUjc/kdplxhCAoghImXI50Rj0XfBJZUyoiIbOGTLqlbA6JgkFBdZimZitldc3naIBSIIQRhy1qitcS9vMATMQFC9/1AHKEL6oU9C8aS1RNRewTeeBIMzPgIvpDK/+R1LA/RkPKFYhVij8UEzCX+wW3aGJDQURa+X0VCP/OLpUwil+0742k1iDW+q+Bc3LvASTgOYSV6Or94i28dmh/lgpmoUuotwYDEURCEwdWMXPHwitJtigRqZKC8t+dMDeU4jjBkD2OMzgPJ5AqWGBgGFJKNqeBkCpwKDME0ZV/2Gpb9ZWFeGPwcZmO+MqvVkOE95kZlkArMVomNGaiZp2BmZqAMnYgoTuyNlGW25rFU3cMJnsNcYY/4VLA8kpPNyKBYlaXcRPuMVQHayLbrSr7TymzKOwGl4X+hupS8WwQ1IKuToRX2Zl9j3xcRHTHOX4wIzLq4xSc6SjKpooe20P9z/cddrA7SkBDg/AkRJeOXMKZECNubtVXU3DwxJmhcM2hZuY1I0mOPcFaxu5QxdUjTfAnGdBDLMGCe+BeOeA790MwQuQ/TQwo9DuTBoIhAMlaBteDs2UbzQ2lcA2dD7mFW9kXf6KaKaCaYRIrHU42XA9wl7RNwOiScuGgY9KW0xWTWayV8vOAdir4HVGuohjZndjgtFJGCrQjxRGeuRssd5LzQwRf/tI/5mWcDJSih3mhbxiDC1ha59ags1cKsXpe5Brn43Ax8reahVOTKRsQIxewGfVRJ5ezOLm3TPm3UTm3VXm3WhmPNTi7d0Fzk6rHW1pl9XUQKjhPQXYjhfeP/qUlT6tIESKxtm2aI165X2OhmFvHtzCKy4e5sqW5fNLQP+71M6mCfkuWmAeHIpLAPWkYhy1kVwGjhgqDdr/CigeNnpgjoD/5YAVHg5TKAKWiE565slba7u5vu+sVL6/6hx9jZek1G08GTTb7RCuGofKneAKbZbRIAq/ALBTdBgxDpt5YuFZsCeTgn4oaU+y5uvajj6vYl5jjJeqXMpKhjocNVHCTrCj5KPNpv/W0npsYUt1hapYauHysAx9lwDYlueboNSWZijkggDkqp753etSWMe7RUMF667BXNdjoI1JyJDH6IKAcQ/XBr5hasAGsCUvhyUqhv1iZKWKZICq7C/4nyQZb4I+5ebIqk5Tsdzn/RoBIUD45RDNVQCmZpC5CQbCYqn/FVLuFWBzD/cjHn8eWSDxIjMjModENH9FtjnHEdMfnmAUd/dEiH6guvB1TodE/v9EPP9PHM8U8vdVQI9dreckK5uWRetwBjgVGIdVmf9VFA9dbO7VU3blZ3HU+KyQ61dYASbm6gdWKvdVEnGlUXR5fhdaxS7uciMjLwBGmfdmqfdmA37QKlYHuW5451xerA3VHtVOXg3UqF3bvNu4lQDOtZJUD/Zyu8LvmO9mqfd2m/9tImJm3X6CJ5UGesjk3mVVlFilqVzIeg8NxzzIy4qYK3WRXUAsnLLhULgf86eAWKr3iLv3h7r+wU0XbuHAps9F+/LJZoXYreWFbVTOpm3VfojGQbz1LsyvFViHmZn3maj/mMr2x8x8vE3vda6eCb0XJIVhMsvQy/cOtLStdzLXpjqnBzjS8BAIJUiHqpn3qql/qbn+s5vQKO/73C7tgmvhnVrZaweE6iClimO/ebWhaKICp2h2y4ri7hTodTmHu6r3u7r/urP/ZEJLIZKAW//3vAD/zAz3u9J0QDCIEZ2ATFX3zGb3zHJ/zCB8SIfwPHr3zL3wTIj3w7/DEfEAXP/3zQD33R//zM1/z9C7ABCAXVX33Wb33XZ/3SN32gE24hAAXbv33cz33dz/3/2Jf9eiOyL+gE4R9+4i9+4zf+3vf9dTMAWfgCTnh+6I9+6Z9+6k9+5T83FZMFdsgE7u9+7/9+8A//TCAu8i9/8z9/9E9/9V9/9m9/939/4sKbH2uBP6h/+79//M9//d9//geIPwIHEixo8CDChAoXMmzo8CHEiBInUqxo8SLGjBo3cqwoAwDIkCJHkixp8iRKBALA+Wnp8iXMmDJn0qxp8ybOnDp38uzp8yfQoEKHEi1q9CjSpDM/omzq9GlJTTJu8Klq9SrWrFq3cu3q9SvYsGLHki1r9izatGrXsm3r9i3cuFyZQq1rl+SDBvr28O3r9y/gwIIHEy5s+DDixIoX/zNu7Pgx5MiSJ1OubPkyZsJ073KGauDIvjqiR5Mubfo06tSqV7Nu7fo17NiyZ9Oubfs27ty6d/Pu7Xv15s7CS2aicASeneTKlzNv7vw59OjSp1Ovbv069uzat3Pv7v07+PDix5MvPz348PQAEFCQMOc9/Pjy59Ovb/8+/vz69/Pv7/8/gAEKOCCBBRp4IIIJKrjgfuip15lKFrwxIYUVWnghhhlquCGHHXr4IYghijgiiSWaeCKKKaq4IostuvgiiA4+aJdUHrRxI4456rgjjz36+COQQQo5JJFFGnkkkkkquSSTTTr5JJRRSjllkTLO+FRezbCxJZddevklmGGKOf8mmWWaeSaaaaq5JpttuvkmnHHKOSedddp5p5pWXomSAfTskAaggQo6KKGFGnooookquiijjTr6KKSRSjoppZVaeimmmWq6KaeQ6rknScXR448XpZp6Kqqpqroqq626+iqssco6a6w/yHCOrIrIIoMMl9D6qxeXyPADsMUaeyyyySq7LLPNOrvqp6CGxB4DgVh7LbbZarstt916+y244Yo7rrYItMArry0wQa61Yshwz7gtCCAGu+C6C4624MhAb739+vtvvecCPDDBBRt8sMHRSqtSAFo4/DDEEUs8McUVW3wxxhlrvLHEiAhwBD4Ol+OADBw7jMG7GweRgsktQ1z/jgwYuDwzzTVvfK7NOeu8M889z6zwnlIlEwnRRRt9NNJJK7000007/TTUUSdtggC1GF1LEER3EwSvQXRDtCYCoBsB0XrIkE3S2ZAswy5Wn4vu0WZbkIIMDujBNa8pWB2JAynQLYPekchNtDZrk6wH0i04YIHYaDPOdtG17IJuC4LL0ALeZBOtNq9tE+3ALpPLEMTeFqCbAuKRPL6L0pJTHkkKDkQugwWRcD66Nqa/rgfdDmhTtAQCvB2ENqKTTrTugKcuNfPNO/889NEjDfSMeSHiCPbZa7899917/z344Ys/Pvnldw+CDDp4T0YDKThCxhENkOGIBR/Mb7oIjuQi/0P+299CuyNA0DfsDZB7+3PALbB3iyOAIIAykAABG2CBADagBfoDIPog6IgPyCAX3JOADD6QPQs0IIEgOEL+JOAAD4rgCBc8QgJFwD9H/G+CAnSfI0hmw/Q5QoYmTEECSWhCFH5whT10oQwbSL8O7m+CZJDABEGYPTIUUAIpmB8IRZiLBjzwgurzYQCBaL4xkrGMZjwjGr1HPfUYIAPdIAQc4yjHOdKxjna8Ix7zqMc98rGPdpShCOw4ARlQA47hkMEE6PhAQlCDf3T8gAPiOMhwEKJvdWxkIOsYOzg6QAJx/EADGIlIQoBSkoSkowrl2IBEwpEcoTzCEeaIyTg24P8DpIwkHCdZSU/C8QgpIAQ5ZNCBOa4yjq6kIyzn2IEGkAOOfiPEEGQwhDmCUJINGCYhOjDKVDoTl4TwJTCF6cdxkrOc5jwnOvW4RuEUJwMzWAQ84ynPedKznva8Jz7zqc998rOf93yADB4AT4CiaxESaIA8H7iIGagQXRJYBC8CSk8HmCKe3JCoA0xQz4gKNJ42OAK6HADPTnpUBryIqA0WQdGS8oKeKoxnRNFVUBvwSgI0gCdH42kCka4UnhcVKEnhaQKNjoNXppBAS2MqUxnQk6YPvCk8aYDQiA5hoSQ7ggS4AU8QxhOES03pS4UqUqES1ahI9Sda06rWtbK1rff/XCdn2EMAQ9C1rna9K17zqte98rWvfv0rYAPbV0zIIAZ3rYQMDFGJBthVBpUwhAMckA+6OtYQzZBBE/BK0bpiA7OQNUFeL5tZuiK2EtIwxE7p6oDH0jUfMpDGZSe72dbKoBl4rYQD6hrbvGKiEqaQQQNg61m6moAekDUFZz272roOla7SqARiZYCN3Q7Wt8A9LWGxkY/c1jUfuJXBZBFb18XmFbfM5S5qQWuI50YXG4J9L3zjK9/50levcLWLSjYgiP3yt7/+/S+AAyzgARO4wAY+MIIN7IAG7KC/upCBICoggwYLAgkyqMAOLsxfGehCEBlmwX854AD+ShgJgnBA/ywA/GH+OoAD/I3FiE/c4f2K2MMa5gA9SDzh/+oixvttgIsFDAcZsGDFP+5wjfdbYhm/OMX9JQKHBQFkBA8ZxIKIhS7oUQEA02PED9axif3b4xf7OBZO5i+UZ5zgNbO5zW5+M5z/e1+oSEUEirgznvOs5z3zuc9+/jOgAy3oQRN60GVogAMScGda0EMGivhCA+jxhS/QowGTboAV7swAGTBAEbSQgaL1TAxOK6IMKL7zqff86VArAsZfUMQwEI1qSSsiAaD2tAyGUetbE6PRtNgzAxyQ52HIwBp3HkYsWq1rRVhDBrT4dKcVselfj7rTpk62IhwQ7VYnmwEMeLU4bv9NbGPDGtt5jsWym/3rXTv7zgmwQhk83YBOE5sYd/6CA+gRb1pYQdHBxjOMAd7tbysi3KwuNMITrvCFM7zhep6zU/KChEZQvOIWvzjGM67xjXO84x7/OMhDLvJnbBpdDAACxY2QAV5lwAgUBwIXZRAATjfiGTJAOcaBsDZoiIHiKM64zXHeCJXzChoZcIDPV86rAFDc5kxvRLNlkIFYyOAZGA/2xQNgOKYHIOYOQLnNle6Af1Rc50XveSO0XXEzNwIISpd5xbXOKwc83eJdn7vQ3QWNihuB6mdvhBj8zoCaQwNd0HA51ikO47XHou1vr7vIIy/5yVO+8pbHOMT5VAL/I5ih857/POhDL/rRk770pj896lOv+tWzvvWuVz0lGPD62X+eCTenPe5H/wQZxCP3vv898IMvfOBnnjgUKAE/yKD85TO/+c5/PvSjL/3pU7/61r8+9rOv/e1jnxIE4D74mY8CGQwg/OaH/hIocf71s7/97n+/+4s/EvbMYwz2vz/+86///fO///7/PwAGoAAOIAEWoAEeoAF6HwIuIP6hzwAwIATuH/o4QwRWoAVeIAZmIAbK37QIQAyEAQiGoAiOIAmWoAmeIAqmoAquIAu2oAu+IAzGoAzOIA3WoA3eIA7moA7uIA/24AhyIAB4AduAAREWoREeIRImoRIuIRM2/6ETPiEURqEUTiEVVqEVXiEWZqEWbiEXdqEXfiEYhiESAuF6CIA1TBoapqEariEbtqEbviEcxqEcziEd1qEd3iEe5qEe7iEf9qEf/iEgBqIgDiIhriEZrgcFfIAYLCIjNqIjPiIkRqIkTiIlVqIlXiImZqImUuIJUAIlukMJ8EoEbCIplqIpnqIkUsIJoKIjysAqsiIsxqIsziItauIhAkBxbAMT6AEv9qIv/iIwBqMwDiMxFqMxHiMyJuMCKAAynoAMJOMwnsACBKMz8uIJNAA68OIyQiM3dqM3IuM2IiNNiUMvLsAJBGM4cqMr6gE6pM839mI18mI76sA71qM93v8jPuaj2UgLSBjANnSBHASkQA4kQRakQR4kQiakQi4kQzakQzrkPMjAQx7kPCyAQpbALwjkAmTkRHakR34kSBKkhK2DRs5DSBakDJjkSQpkRK6kS74kTMZkR95iSOTFE0wCTuakTu4kT/akT/4kUAalUA4lUQ7lRuJkMCwAr5RAMuzkCMiUC0zCNISiDJTANPRkUi5lU7rAAjylDCzAVU6CC8iAWMrUL8hUMOxkMMhAMIRiVCZDKJYAMuSkV8rAL8zlRp6lXYIATk7lUoYlV3olWCKlUlZlU04CXFblXOJkXd4lTx4lMjwQVUblTiaDTC3AJCwACZDAUvJlZv4CY6L/i2PyJGd+pQxEZWSOwCSsZVueJmLG5WLi5FjyigvU5WmmJmHyCgl4pmaWZgl4ZlEGp3AOJ3EW53DSZEhIxQRAAnM2p3M+J3RGp3ROJ3VWp3VeJ3Za50ZCAjMUFiS4wi7EAHROTnO6QgP8wneWQAO4wnN2p3iCp3hODgm4gissQAkwJ3lCwnYy535C58yVADMw5w14pyuUABRAwswdAyTcwC8o6AI0gHjeQAPswneeZ3quJyTIJ33aJ3cSaHguKIEaKILKgIIyqII+53Z25wIEACTEAPn5J4k2p1JGqAwcqH6iZ4IuaINCJwkswA2AKIW654gCqICGqI2SQAP86DHc/2d+dqh4HoN33sB+ziiI2mh2XimWZqmWbmmWImcH+sAhhKmYjimZlqmZnimapqmarimbtqmaLgAFHMIAkF+acpCYGoAMREOYKoMMGACZzukAkOkHLICYXoMMhKmdHgKciumimqkz5KmYvkCchumcKoOhSgKZLsAHRGoDHAKe6ukh8KmfDmqhHiqgkqmkimmlXmqaLmo0yIAzhKkk9GmZPioVMOqmhmkJTOqisuqZiqqYhtAhvKqfPiqoHkKqUqoMKAOwjmmiDiutvgChhimeKoOi5uoh7Kqbbiu3dqu3fuu3eum0UAAOMIK5niu6pqu6riu7tqu7viu8xqu8uusCTP8BI3yDUpaAKSzDuv7WuZpCA6CrDJhCuuJrVe6ruZrCApwrniasDJhrvZ5rxK7rowqDxC6VDCxDNfDKC5iCxTLCAhCsueKpMACswBKswjLswxqsvvIryGKsxnKsx65rxAoDrJ5rn6rro7osyIosI0yBvYKsvW6sDHTsx6Lro1YDzhKszRoAI1TsxS7VMiRtuvqruTYtI5jDC5zrMtxsyJ4r0M6r2I4t2Zat2ZqtuIZEcTgBOiCC274t3Mat3M4t3dat3d4t3uat3tJtK0zB2xYAB7SCDBSA3HKADLwtBzQA3MoAB8wt4Aou4Qbu3x4uIhiu2/bt22Lu3K6ADBBD5qb/wNzmAAcYrgwoASK0QuO6bQHIgOgq7tsybuW2wuT+beAO7umCrtyKLumabtxi7qitwOsSbtxyLu+ebuoiAtBert8igu7ySvG6Led6wOs27qgRLud67uXiLtxGb9xarttW7+2+rRLIAPCi7tsm796mr/quL/u2L/umrUgYgBN4QCHUr/3eL/7mr/7uL//2r//+LwAHsP6aQwjk7zaYQ/7OggzY7wXIgBDU75BdQP8ecCHMAgLXbwPXrwLXLwHbbwfr7wY4sP2mQAP0rzfIwCwUgjmkcP2mAAI38AMXQgRX8AUXQgbjLwWTsAmjcP52sBDIwAbYrwxIMP6GcA14MAsX/0IIFLAKM7H9nnASQzDtCHEK/7AEh3AMF4IO4+8M3+8G168Va3ENNzAcqHASL7EAp7EarzEbt3Ebw69IPIA9wMEj1LEd3zEe57Ee7zEf97Ef/zEgB3IeE/AjbIAJGMMj2EID4EAeNzAL1LEqNEAvqIIq9EIDoAEeGzIiKzIjs4I52HED1zEryEAdE3Idm8Al63EI24IdG4MMhIAqPAIL9IItsAIrxPIgbcAjmMMkFzIQP0IkT3Ilp7IngzIpa3IiL/IjuDIsyzIt2zIu/zIeE7ItSPMjDHEeu/IF2LE5sIIdL3Eph8AjQPMj5PIg9/Ioe3M1b/Mqt/Irx/Iss3IvmP8DIs/yIzhyHa+zLMuANxuDKXfzN4uzIA80QRe0QR+0QcOxSEjFCkiCQz80REe0RE80RVe0RV80Rme0Rke0OciCJBTDrvCKCQCDRANDSGfBR3MBr3BBMUg0SKPLSEtCFpjDQ/uADDh0Fty0JHT0QxeDSsvAAUT0AUwFRAPBT8tAFgDDARy1Dzi0OTB1T/80S+M0TTu0TX90SMtATEuCUaNLUi81ujS1RPP0gAa1Q8uAWEc0AfAKTZsDSju0LHj0Tns0WPNKWkO0T/NKTqP0gDb1UN9AUR91UksCMJiAVxP2Sfe1Qx+AOYg0Se/0W0tCXG80ZVe2ZV82ZmO2QouESjD/QBl8NmiHtmiPNmmXtmmfNmqntmqvNmu3tmu/NmyjNgzgQGzXtm3fNm7ntm7vNm/3tm+b9mZzNgWQwBkUt3EfN3Int3IvN3M3t3M/N3RHt3RPN3VXt3U392xft3ZvN3d3t3d/N3iHt3iPN3MHt0gUx9ipgXqvN3u3t3u/N3zHt3zPN33Xt33fN37nt37vN3zDAATwN4AHuIAPOIEXuIEfOIIneHyb90gYgAMoARpEuIRPOIVXuIVfOIZnuIZvOId3uId/OIiHuIiPOImXuImfOIqnuIqvOIu3eIgz+EjIcROsAY3XuI3fOI7nuI7vOI/3uI//OJAHuZAPOZEXuZEf/zmSJ7mSLzmTN7mTPzmUDzmMj4RUGIAbXDmWZ7mWbzmXd7mXfzmYh7mYjzmZl7mZnzmap7marzmbt7mbvzmcx7mcz3mZT/n8CcA8xIGe7zmf97mf/zmgB7qgDzqhF7qhHzqiJ7qiLzqjN7qjPzqkR7qkTzqlV7qlH7qdzx8FxAIddLqnfzqoh7qojzqpl7qpnzqqp7qqrzqrt7qrvzqsx7qszzqt17qt3zqu53qqZ/pIFAcl5MEdBLuwDzuxF7uxHzuyJ7uyLzuzN7uzPzu0R7u0Tzu1V7u1Xzu2Z7u2bzu3d/uy8zpJGAAlWAAelLu5nzu6p7u6rzu7t7u7vzu8x/+7vM87vde7vd87vue7vu87v/e7v/87wAe8u4M7XthDPsABwie8wi88wze8wz88xEe8xE88xVe8xV88xme8xm88x3e8x388yIe8yI88yUM8wZOEVEBBHqw8y7e8y788zMe8zM88zde8zd88zue8zu88z/e8z/880Ae90A890Re90R+9zJ88SagEDvSB0z891Ee91E891Ve91V891me91m8913e913892Ie92I892Ze92Z892qe92lO90i89BfwCIMS93M893de93d893ue93u893/e93/894Ae+4A8+4Re+4R8+4ie+4i8+4ze+3bd9qFDAArxDDVS+5V8+5me+5tf/AMZ2vud/PuiHvuiPPumXvumfPuqnvuqvPuu3vuu/PuzHvuzPPuvzo7QYQCscQALsPu/3vu//PvBDvu0PP/EXv/EfP/Inv/IvP/M3f1M8gCXEwABMP/VXv/Vf//ULv/NvP/d3v/d/P/iHv/hfiVS4wCecP/qnv/qvv/pr//i/P/zHv/zPP/3X/52bwATkv/7vP/8DxASBAwnKAHAQYUKFCxk2dPgQYkSJEylWtHgRY0aNGzl29PgRZEiRI0k2RECBXgWVK1m2dLnSYEmZM2nWtHkTZ06dO3n2fJiJQrsDAYgWNXoUaYCYPpk2dfoUalSpU6k+NNAOygqtW7l29bq0/2pYsWPJljV71uYDSwwOtHX7Fi5csGjp1rV7F29enppkkBjxF3BgwYHn6jV8GHFixXoRCKCgAXJkyZMjF158GXNmzZtnnux1AXRo0aNBW+Z8GnVq1amBCmAAC3Zs2bNNr7Z9G3duswYEWEnyG3jw4LV1Fzd+HHlNtTgYNHf+3Dnx5NOpV7cOke+vItu5d98u/Xp48eN1Ny6BC3169bjAk3f/Hv7ik5R81bd/v318/fv5lwXaoAocBBxQwPz6OxDBBH0yoAEsqngQwioMVJDCCi0U6YF+pHiBww4nvBDEEEWUiK9tejjxxA9HXJHFERujBIsYsVCxxRptTPCkdqTYkWfGG3388T2g7KHniB6BPBLJ6gywJwojk3wSytwydDLKKq3kjK8rtdwSOQS4/BLMMMUck8wyzTwTzTTVXJPNNt18E8445ZyTzjrtvBPPPPXck88+/fwT0EAFHZTQQg09FNFEFV30vYAAADs=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Rapid response systems seek to identify warning signs of clinical decompensation and prevent cardiac arrest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Sprung CL, et al. Evaluation of triage decisions for intensive care admission. Critical Care Medicine 1999; 27:1073.",
"       </li>",
"       <li>",
"        Hodgetts TJ, et al. Incidence, location and reasons for avoidable in-hospital cardiac arrest in a district general hospital. Resuscitation 2002; 54:115.",
"       </li>",
"      </ol>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13968=[""].join("\n");
var outline_f13_41_13968=null;
var title_f13_41_13969="Dermatomyositis - upper back";
var content_f13_41_13969=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatomyositis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Confluent violaceous erythema is present on the posterior neck, upper back, and shoulders. This presentation is often referred to as the \"shawl sign\" of dermatomyositis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13969=[""].join("\n");
var outline_f13_41_13969=null;
var title_f13_41_13970="Cross-clamping the thoracic aorta";
var content_f13_41_13970=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F86032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F86032&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cross-clamping the thoracic aorta",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Access to the thoracic aorta is best achieved by incising the parietal pleura overlying the aorta and retracting the lung anteriorly. Blunt dissection is used to develop a space between the&nbsp;esophagus and aorta to permit&nbsp;aortic cross-clamping above the diagphragm without damaging the intercostal vessels. When the aorta is collapsed, as in the hypotensive patient, palpation of&nbsp;the naso- or orogastric&nbsp;tube can aid in differentiating the esophagus from the&nbsp;aorta.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13970=[""].join("\n");
var outline_f13_41_13970=null;
var title_f13_41_13971="Ultrasound gallbladder sludge";
var content_f13_41_13971=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F86996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F86996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Ultrasound of gallbladder sludge",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ultrasound of the gallbladder in sagittal (A) and transverse (B) projections in an 80-year-old male with right upper quadrant pain reveals a normal sized gallbladder with layering sludge (white arrow). Some brighter non shadowing foci are appreciated in the sludge (yellow arrowhead). One month after the ultrasound, the patient had a cholecystectomy. Noted within the sludge were small stones, the largest of which was 0.5 mm. The gallbladder was not inflamed at that time.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13971=[""].join("\n");
var outline_f13_41_13971=null;
var title_f13_41_13972="Ocular cicatricial pemphigoid histopathology";
var content_f13_41_13972=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F55683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F55683&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 496px\">",
"   <div class=\"ttl\">",
"    Ocular cicatricial pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 476px; height: 356px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFkAdwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwCzFcrdiRblEkBGRlaoQaxHaymMQIqKcDC0WpEc8Yj+Zs8Cp72ytQT57BZW5x6V7TSQG5a3MUw3E5DDkVk3niCKC7S2ihG0HrjpT9LjEM8eHJjzg1l+INLebVJHQbUH3QKXugdLo2qrqWUbGV5x6VzfjXTJ474PGWZW54qfwjp08GpgtnyuldJey27QyJIQWXpmosTY4bStFupnV0STjvXXxXkWmW6pK53+9Y8GuSQ3flxr8g44rQ1jTBqixXlv1H319Kbt1KF/4SuEybAvy1qabqaXse9DgA4Nc1F4fkkkDbQPSt7T9LFnAEDd8tU6AX9Svks7QTOeKrWfijTpgRKTGw4BPQ1NfWcOoWyQ7sd8evrWUnhS33HzJOD2pWiJq509nqMMp32z5A61PNcSBvNiOB3ArCsNPg0xSkbOE75rQt722XI85Dn+9UuKFYvreo671RRIOhNVWkZ5lZ+gGOKX9zOCYX3fSkKjGGOMUNBYw/GEssSxzxFgo9Kg0vXmYRrMQc4HvXQXUUc1v5Ug3Rms2Lw7ZLKs4dgBztPSrXKNKxPqWhWepsLgphm5rQsLSCw0lobdcOOfrTmIjKKp+Wq97M8ETyRgsw7DvQ/ITVy1b3WbmK3mRiSuc4zW4FVIw2Qu0ZriIPHNtFkT2rLMODxVm38QrrE4WJZFT9BUOLJcbG9POCSdxz6iix1j7PKqxsTJ3XPWqsUMxUlF3LjrUE1qJlI+5OOhHUVDigsj0G1liuIFlhYc9R6VI+McnmuE0+9ubDyyCdo4cetdpbyx3ccc0cnUfdrKUbaGDptakqgZAIzTggBOOKUClrNqxncO3A5pqrhecZ+lOo75oATHT2pSKKQ9KAFAz160FVyOOQc59aXOAKXHFADRxTXJ6Z4pwpBz1oAjPQ4APsBSRtvTcYyuezDmndDRQAfgPypPy/KlooATA9B+VLRRQADI6dPpTXGfQfhTipVeabk0AN289R+VKQCOigfSlHPWkPykk9KAEKg+n5Un3eFwB7UKTmhutADeeMEAAcfKPzpe3PJoHJp2B6UAM57HFMYAjhQPpxUxA9KYKAI0XA5z+dQ30uyDGetWtpPSs3V/vAdhSexdJe9YyX3FyckUoBxz+dOK5pQ2OKyPQ0tYrsYlcEoSfWr9hcvFMuT8h7VWf1p1sAbhKqG5nNJq50g46U0r05Jp20jk09enXFbM4DwUWJtZ5LgZAUZWuSu9SlluXeTJfdge9d3ZWc5gBuc7AMnNYfmaZ9rLbPuvzkDHFeje6udydyfRnkitt8rbS3QHtV2a4Z3j3njoDUlwY3/exqDF2xToYVnQPKpUA8Uhl2OUw27vHyWG3iueQXT3h3K3zHFb4eMKEQ9OxpJf3QErIODmgChcaQkE+6VgqqMlielXtP1i0yLWCQk9Oa5rWbbVdXuneFt0AGAgOMVtaJplpo1kk2oTKsw5OTzSauBuXF3HaKWPJUVSPiCNxloyAe9VE1TTNTuTB5pDk5UEdamurGISiNdvsKVgNWwuo7iNnXpjhqxrzW5Yrl4YhuOeSK11iW1svLQAZ6mqqR6bFkzuDJ60lbqAumakuowyW1zGVZhgE1y2qaRd2k58iTKlsV1tulpKxltG5XnHep5ZbeQospQPnoad10QGN4QiuoPPknJ8vBwDVV/EUkF4wKEoD6da7C3jWJCBsKHuKqy2ds5IMKY65xUgU9E15dRujCUwoFXNSsJ5VL2j7cc4pLCxtYyz2wAkzzV8ByQvQClsBysMmrQXarLkqPaulSQwQmWY5QDOPWq2oarbWRXzwNwPYVXt/EFldM0JVVVuKauBFLqWgXEm6SDdJnnFbehy6XdTCKwUIpPzVz+oeDzI5nspsI5zgVpeHdKk0UsxOXJySabs1uTK/Q7AsY3CdFHQVW1uFGijlxiQd6adQjk5b74HaoTJJcMQwOztmsdepHKV8iRSc1YsLmWxuFmhPy45HqKgDFZPLZQKyH1822ova3CgJ0BpuHMM9L0+8hv4RIhAcdVzVngjOelcJBL5SrNFIdh5yvSuk03WY7mILJww4471jKDMZwtqjYB3D61XUS72DfdHQ+tSxENGCh3fSn1mZEAzuzU69qYFPtUirgUALkU00p4pKAGrnNOoooAZg0gFPIyKReDj1oAQAg5NKSG6c0496auO1ADW+7RSt96koAKQ9KWigBuDRg06igBm3bwOlFObpTTz8tABSNntS0UAIPu01CCcg8U+kCgHjpQAjdazr6KTywWO4j0rQbrTXUPwelJlQlyyuczg4x3p2cD3q9e2rLlkXNUBG/dTmocex3xlGSG7ieoq1psXm3Sk9E5pkVq8rAYNa9nai3Q/3jVRVtTOrNJWRaqSMgLye9R05SAOa0Zws4NRFe2E0aBVYAgD1rzeDw+82qSRFeMk4rsYJvKngbJGOGraS2tEmW8QBpwCA3oD1rtu0jsvYwv7GeCCGPYNg6j1NMuLV4onDrt9K6R7pSMMNzdRVCXVtKunMN64ilB5+tCbDmZy9pExuiSpziud8U6xI121vA+AvBxXps9hC0Cy2Mm5XGCRXCt4MupdaYypmFznNVzKxSmjnNHvrqG8ixI7b2wy+ta3jC6j821gSGR7iT7xHNdV/wAIdFpzrc2xErLzg9qxtUMi3asYwzn7px0oTuVdPYoWPh+8juoyQI0UBtzelbVtqkQ1L7O8RLrxvPSpLIXd1Mv20SD6UmseEbi4xNp7sGPJz1NMDVv33W7t0+XtXAtMWlfO92zwDXb6TpV1Y6WsV0TI/P3u1RtpcUR+0NC3HPHShaAVPCEbxpIzpjce9YniSS4GolwrIBwCKtX+qS/vI48qOwHFSaZK98wivk+QDgmh6gaPh65ludNO5ySnXNTyalHGQjkhs8ihVs9NtGkVtob0rGuL/Tp5v3smG7GlZAdVHMq7ZoVGGGcCr0EokOWJ5rkLLXYYJPs7fLztB9q17/WU05IsDfv5B9KTjfYCzPbae+43oLFTnms+2g0c3BMaYOeDVhp4dWiPl8SEciuauba4tJH8tcjNUtrFW0O9+ZURkfMXoD0qzJIfLZ2IKbc81zHhLUJGuWiuQdpXjNbFycW1zGDyBkGsmtSSOG5jlLMmNwOAK01nY2uQfmHpXA6VeNDfMHkAjDZIPeuz06eOWVmTKxt3NEkrhY0kZLiJW480Vh6/o4v0LxriZVq+QLeXrtq554fBZfm9aE7akHNeGDcoktjchti8qTVlI7uxv8nc0Z6Adq2ZmG0hQAT6ClMjKFdzkkY5FK6Y0roNO8QJpl1iWdZAeqE8iukj121kCmNgc+teOeKNBvJL0XtuWPcAGtLwjPeSrJFeRf6sD5j2qHS0uS6cbbHr1texzEDNXfpXCQXDW5Vlc4rs7C6jurVXQ/P3HpWEo8phOHKTkZpNtLSE81JmJRSgc0HrQAlHaiikwExxigDFDcYpaYCEZpoGTT6QAUAJtFN5UkN36YqSkPQ0AMooooAaGBO3ndQ/3SB97tTh0x2oPIx+NADFzgZ696dig4HNICcE5+lACHrRQORRQAMBjJNMHNOK7qMCgBh+YYx0pnlJ3UVNtHpRgelADFAX7oAoPPWn4HpRgelADKkjUlePX0pi9asRcKcZ69qoTPE5rieC9MTqcdBxVrcfOT966+wrZ1TTg90kqMFwOfWs8QiF2llkUv8Awr3ruep2E0nmQJLIG4IyTXKzaZFqrTStcxo68jJxV7xDNJGiiWdgrj7grk9b0+4uNMVrQSkE/KVPJq47FIktNW1LR70pb3JYA4weQa67SPGN/fqyyRIHVeWFYHgTw3qbZfU7Yi36qX611v8AZREpFvEqIOvvUvlYluc3ovi+707WZW1JWms3Jyp6iu2+0aNdW8OoEKFPKjPSvN/Ghs7C5MLwnziN1WdDuw/hkGHMyhjkHtU8iG4o9Ctde0q4uNkYXdTrrXIbXLSuioDgAnrXD+GvtDXHmpb7Yx1JHer3iPTRqNrueQwsXyoJxmnyIOQ2db8ZWumrFI9uJYZhkkf0rT0K4std04vbMOvCuelcVN4bl1Dw1seSNzGflbd2q94XtDo+lBPN+ZTksG4qXFdBssaz4ac3ha1B25+fitKDQYI4Y2c/vMYxVV/HOn2bBJGWVicMMVu294mr2zS2ibMLkZ4GKfNJLUmzKOq6DBqVmLfGzyxnFcQ3gC6a9DJLmENmrF9rup2mvRqxZFDctj5SK6DUvGdvFcp9kjSQbRub3p2lHRBZla48GwPcwzyAsygZx3rB12wuVvCQrPAvCgD9K9J0DWINWsluJCiv90KOlRapaOlxvRV8thknFCqWdmUtDiNBj/saB729O7d91D1om8UQtdbJLdfJz1FWfEWnTXsY2FgB7YrCsvDtxI4E8bBQeWquW+pV1Y69EhAS8th8rDtV61nTZcEAGRxjms6O5tLGBbZZA3I49KsNcvE24IuzsaiwjmLrw9eG7aWGRFDNkgeldbo9kYkVZ5lOBVB9ZsXYCSXYwPNXIpoLxP8ARZw2PQ8mgdjZNsuwo5Bx0as57eaKbcWyO1Zh1k2U/kvGQv8AerYju98KzQEOuOc9jU2Yhy3AyBtOfWnTwmSMMGxiqi6xbtKUJTd3xV+KcTptHAPSiwGaZZlcRFSUz97tU0+qWmlTBbkHa/Uir0gXHQY96qX1nBfwFJgPY96SavYGO1Ai90x5tGnBcLu298elYfhfxdcWV08N2DFcDjnoapSaXf6NexPZSGSFzgjJxXSTaZbXyxvcQjz153KMGiSjbUjlvudvpOuQakQkihbjA4PetVhhiteaTPDYxrK7mJo/48811XhvU4dQtTIbkSOe/rXO4LoY1KZ0PfFBB61Su757OEyJbtPt52jqawbbxPq0sjmTTVEeeFwd2KzM0jqj3HcUg461DBfQXECSNmOQ9VbjFWGQ7Q3UHpigUhpFJTwOMkEU0nNJhYj2qZVZlPy0+igg44pCCkPSgZ70dQaaARO9I/T3pyjFIRk5pgNPFICGOFOTQSAOelCgDkdaAFNFFFABRRSA5oAWkJ4oz19hmmFgGA9aAFooooADTGI3YzTmGRTYwD834UWAVAevangqPvMQfamAEN7U8IrcmqYmfPcniCdbmP7XI7J35q/BqkVqxnvFYxNyjnkCuPnuWkRkmGQDXR6TJFeWi2twQUYYwa9JpI9BpdDU1Ky/tpY7uxmWWMDle+K6vw3DarZRxOqBlGdrdq5ZHj8NKwtkkaM849aih8RW92WlniMAPJ7VnNtqyJsdtNq9vBdiKRgIzwCOgPrUxuLeJl/fKWbkc8GuCtb2LVprhrZHaC3UfOemao2lpe3N4dk7li2F5qVBLW4WO/1bS9K1GCR9ThRiRhXHasXSbfSrKEW2nyhgx3NwKvXUbx+F7tboEMiZz715dpWsTwWE8gT7zFQ/cCqQROzl1Zjqq2toB5asd+BxWB4p1V9U1yCxiO2IjA2nvXV+GdNsf7FNzJNm7mA+c/w5rIXwgJfEiSW14jLGc4FUO5x2oS6lBD9l82ZIEcgKpOa6vwZpF59nka9EjwEcBmroPEOk2WmRrfaqWMZIG4DjPvUzwz/2SbiyJkgYZTZ/WjRrQE7nPnwQ8upieGUPb/f2cflWndeIZbIJYixliSM4JA6isTRL7Xl1JikbCIH5jTTrWpy+JAtxBugLbSCO3rStd6jOm8UyHXdGgWygCyJHtJA5PeuR8M+DtRuI5JpUaOFQck16GXjhhICBWYfIoq1o97bL4fuXu5yk6kjb7Uua2wHGXV1N4UjtYIx5idS2K37LxdLfGDckb25+UjnNX7610vVtPhDzgyS9BjpXn7yNonij7FGri1LD5j0ppKS8ydz1eC8067byFKI+M/NVPXNNcWxe0BAA52nNctrenPIBPbSNGcA5WqfhfxHf2+oC0vAzw55ZuwrNRfxBY5++SRLg53b92eetdZpBlubDY4JOPyrc1bwzbapfi6tHAiYZbHrWlY6ZDZw+UuCSOvrVc6Q+ex5RqulXVnLK4QshOc1FYXslowdNyEdRXsVzo8dzbOYsE45T1rk5fCySTMGRgfQdKanF7jU0Mgjj1fT1nCgOR0NTeHY2ikmtpBwwxWlBodzBEnlphQOgqNdkNzlzhh1pOSewHNatoE8Vy8kL7eSevWrHhm6uUufJuQTjgVLrKXtzqCGGYC3z1HWtW0jWPYWAHHX1p9AJNevVsrXePmqvYXbT26S7cBhnmrd1ZrdjawDx9cGpFhCxrGoAReAB2qNAJVm2ou8ZXris7WLm5hRZrYbl9K03XEOB25NRxsrjkAr6UadQMW1vbfWrWW1vFCSHjnuaxxa6x4dYm2ffb/wgeldYthb+aZAiqRyMd6rTaxb2kvk3attboe1F7bCaOi8NazK9vbT3ZwpGGWuwt7+CYlrVo+Dk4Fee/urm2BtG+QjtUGjvd6Vfbt7GJuorCUObVGc4aXPR5ra3uJA8qDf/AHhxXO315qWnXzwoWaHICnFbumXUV3Csgb61ZOJD8yggdMisHoYczRix6hqcIia7hLRO20kDoK2GwVU+ozUnUAHt0pr9KBN3IjwGJ6Bc07qKbL/qX+mKFDEg5+WkyReAeTxSNjIx0pxAIwai3DO0fQU7gPopDkEA96UjBwaLgQvjHOaSRjFFvKM65A+X3qVgMUIAAaYCHg80lB60UAFIOhPcHFK3ABFJxnnuaAGtkkY7UzJz6mpEz82T3oZeDt4NAEYZu4p45xilIyoPY0i8YAoAT7wPscUAYFPxgcU000wCpI03DINR9OD1qaHO049aoGfOEGjrdyEIjZ7GtfT/AA3d2U6OSWB6CtBtThs7PNkElJPLDtVKPx/AkptmiV2HDMRXfJvodzv0KmuaskGoR2t/GQAcKx6VzWoRG51Cd2/1Cj5fQ16Pf+H7HW4EvpMEMNy81DfLpU2nxaZPGsLfdDr1Y00xXfUxvhJJCs17bzgbG5Gen0rvNSEGmIZrdE3nkbT1rlpdGh0CzgW2Od2S5Hf0qNmlljUSkqGyOtRy3ehKWpbn8Q2k9lLY3UuXn5Kg1yl/qmhpYfZI4ipiY52dDWQbR7HWLi4uEL26nCvmoLfSFlYXBYmKRsDNWo2LSsbv9oSX2jpHar5SIcD396Zot1fw3ySRZcqRnFbfh3TYrnUILdceUAN3vXosXhrTogQg257gc1E5KISmloZuvmPWvC0kMiHeUBA9x1rzzwfq11aySacGzE2QB6V6Ld6bNYzkNIXgIwPavJ/Fk8tjqZ+wwtFkks4HJoi00Ct0PVfCoj8qX7QOd3NX7u10+GZXkh3Z5DDtXG+DNXFzpivdP5YHBJ71panq0QTZbSGRAepqZJ30E43LviHSHnMN1bvsjzwD2qvBo5mL+cCzEdq0bTUV1rQlhiP79DhhVzwxaTW6OkwLEHqwpc1txN6HMw6J5V9AqTCIo2cN2qTx5o9ulqLt5Fe4VRjHeux1DT1uUB27JQeDXlN9Pqei+IZTqcck1iSRk8gD8aum3J3CLXU07HVpmtbKGYhQ3Ck9qt3/AIRlvka5jvY4pP7obiuIjknm1Ka4jDvpy5cDsta2i3A1CznRJXDKMhS3NXbXQvc6CznvNLsBDDdo7g8gHJxT4PGOL5bKaNlHdq5OK2u3cfZUk3A8kmu3tdHtL7Q/9PUJPtOZOh6VMo33ElYv2etosv8AotwJc9VzW39uhS1F02A/JxmvIvC2msmu3K28jPCoI3Amtu681GAMrhf7prJ09Qsdlomvm6kl8xdi9ias6/p0F/p0jW4/e7cgiuR0u5SFnE0uVwflPHNdH4Y1WG4uJIAVUhejHg1MoqD0JtbY4+wtb62bkllB5GK1JJVW1eX7zKOnpW/fahY2krJOUXPWo7a307U0kNg4kJHKiqVS71Q7vqcro2vK8xjmGxW7mugEzRnIYNFjORXN+I9IMEwMalSPStPQN82jypPncBxVblGwl1HIAQtc9rGvJazCARkDPWoIr97J9rk5BxzVjUdPj1iJZl2+cB0BosBsabepeW6MMBsdKZqumxahbMh/1nZvSuSsrDVIL0BVZY1PBzxXc2KuEHmYLYpS90DmdEjvdLvVhZHaLOM44ror+8SDJcZDdR6VIbyNJ0jlVAxPHqah1i2LdFyT6Uua7AmtJJIohNaShQe2a2tO8Qfuts8ZLfxGuXvbqDSbWJJWYZ9am026inUyW7ByVLbahwuyHBM7yzvIrn/VjP41ayD0PtXmOleJoV1BoZRslDd/Wu3bWoHuI4Y3UsQM/U1lOm0YThZmrKMRuTwKXco4JpJF2wuGbimRj2yvv1rDW+pm1YkckLkU0HIz370hQuCGOF9qcibRjtQIQEGlblRQRjpRTQCZHrS0mV9DQDkVQDHTeCp6Glfrn8KfTXBJGOlIA/gP0pq8oPfmpOO3So1ILMcHI49qEAjA56UHpTmOTSGmAi9fwqKHdtZXBHPFTelHy496AGUUUUAFPQ4FMqSPGOfWrA+aPD1tc6Wsovd3k4O7dUFnpQvFkNnjeWOSe1amvazLqMF7H9nCorcY71B4MKxLLJKxwe1ei0egjqPDWlalBC8Nxc4hC7V9BVPUfDN6l0t0ZPORG3A+ldHok7z2Tsg+X+9W7agGwKOMlxgVm9NjJvU5HUJzeaKUQ5uFYYH061ha9LeDSGnQbZVXaEH8666fQZrNknt28yQHOPT2rG1xJ42kknjwSuMetVHQZxnhyS7utLu1vlZoP4S/BJ9q7LwLoEmo6e6ShRGp+XnBrnPENvcpbWV0mUjUZKrwK6ax0/XtSW21LRZESJEH7vOMnvTk7IG3Y7TRdDTTZXyqlum4dRW4jIxMYI8xRkg9ayNA1S8nPlazbC3uE6N2NUvEpvLG9XUbR1aP+ML6Vy/G3zGL13OlaITI0cvIPIzXmPirwtevemaIb1zwMV3WgeINO1uICG6VJ14ZG659q13eKJP3hyD2NVGfJpYqLZxFt4RE2jxI4EM23JK1x82mTW1xLCrbth6eten32tG2uN0Y3Ivaq1zpdjqc0GowsEkJy4FaKdtZF8zOM8PRz6aZbqQ+WoXketLc+O9WYAwiMRg4Haug1iyjuJTb4CqRx7Vzwt9Jt5WtrhiznjgdKpRUnqXZHX+CfE39tQyfaiBMhx14NdDqWn2+o2Tw3MYkR+MnFedXFlD4f0dprfJaT7p781u+C72/l0ZJLkNuz3PaspRa95ESRWl8HQ2+nXVpHJgSHIH9K41Liy8HXsn2iNppX4CEdK9oWIs0Uh5Xqa57xt4UtvENqrxFIrxBw2OtKFTmdmCn0Oa0vU49Xg3WcK27nrinxi5gupILgmSGQcEdqz30m48HaG15I4nnLYKD0qWw1a4vtE+2W0P7/OCtbpPoaG1a21vZbhbJtLj5sdao+JbZr3Tg1jgSw9QOprGfUbqTTbq6kBV1G0gVn+ENeukvREymZW/h70uRgNtneWRPNO0q2DmtnVVFkILu2dkyQCRWnqPh+Kcl42w+/wAxlHvXNapdzXcjaWkWxUOQaaSk7gaOtWL6japdxSMz4BIqLwZLd2GsKi7lTOG7CtLw3JnT3tPKbz4eGY9KNdsZBaLPazospYfKvapv0A7vUbBLnY5AbI5xWO1kLWOVo88dR2rmfDvi27sboWeoJ5gPC47V263lpext5b7W6EetZWlB6k31OEvL+zuJ/Llj2EHGa0tLsIo5S8UhZeuM0viHw/FJCbiMsZF5AXvUGjRNpli9zeMUDdFrW6a0KN0IpGCKkh/dtgD5e1ZNrqsc33eR61pwy85Heoa6AVvEtibuAS2jbblOV+tYdv4kvrTbBdQMWHBJGa6ZblI3KtxmorlUf5kjV/qKW2gFe/sodatEEykSY4rlrK21DSNW8uKF3QHB29MV2JuQgzJG6sPyp6XO6HeD83XOKd2tkBzmv6BJdEXllHtlPJXvmszSbTVre8aaUsOf4j/Kuytb8TPIu9CQeF75qoWkeYjb0NGr3Qmk9zptJ8U2ptFtb9WFzjAbsfrXSxTRtwpGO1eb3kBkAaQAY6GtG01l1h2S5DoK5pwuzOdNPY7s/h+FJWT4evvtiziSVWIc7dvYYHFa+R16is2rHPJWdhCM0BaXpwevWikSMGHLDptODSYwcUo9u3Bo7570wE5zzg/ShjgVBbxNFLM3mFo5G+UN29cVOTyB61IApyAaABtI9TmgjaCB1FL/AArjnI59jTQDdopdoFLRTAYRg0lSYz1ph6mgBo+XmjrzS0UANHWnAEdKMUqjIqwPn2+i0+xiELXWZm65Gaa9o0VsZAykAZ2oMbq5u50m8e8lSYS+cHAA9q7fTdLuY7aL7Qp8vHJINejI7nJIreHtYuLaQoFJi7L6V21hryTxEfZ2DL3rzHWtYXRtTaC2QlfUiug8OarFqhKKGSYDJHtWUoXYmkzU17xOof7OriObOc55rX8NM97YeXeiOTJyGY8kVwPjOyt7+dHtMeYow5B5+tP8Ny3smoQRrKVjUYIz2FOUUo6EuGmh6tqOj2Nzp7W8tuhjPSuRnudQ8MXEbWJDaXu27PSu4hdTaph84AzmsLxcxfS1jsgjTSvhuOnPWsovoQibVvFsAtLeS2t/tG8c5H3TWF4TsL7XdUnvdSkkWy5VYR0NZ/xCSfSdPsre3lBLKMlR0OKyvAnijVrLUBZSAzwSNjntWluWPul8qsdxcfD+zj1Iahpl1LDIjbvL7GsLUPFd4NT/ALPmHk7Wxlu9ehSanbQQJIxCtuGQO9cB4ptI9W1AXEEEYbOd2cE1NP3tyYpm7eG0Hh6ZkDm5dflJ7n1rm/hjqWoS6nc2l/G7RqMjjoa2obnT7dbW11KcJIgGF9a66yt4/wB39jtVRJf+WmMcUpNRVrFPTcpqbJrpklKq54yT0qnrmmeHrC2a4vyoAwwYHmuW8axT2XixYIpxIZMbdrZxWl4i8KXutW1qsjsgQYYMM5oStq2Gi1JIL/StZhR7XzHijwAjdq2TG0cSPFIqQryQfSqWheFLfRIHdXzIRjb2rmtU8QzLJLCoBjyVwae+wLXY9AsdUtpgEjmQ4OOD3rTbBXjnvXkVxJGfD8s2nO63avk7TyKZ4O8WaiL4i8meSBU+YkdKiVPS4uTqepajp1tqNq0N4m6M9BWQNHtLKxEFouwg8+9WW1yG4svPtnDI1Zj6m1w3lA4J4z604JpDSMvxFapbOqQRgxMPnB7mqGg2tutw0llZusncqOK66S2juoxBMVO4dQeRVjSrrTtJQw/aIgRxg4zVubtyoZwV2+p2OrLcSsWSVx8uOlWfEt5BbuksEeJnXDHHSuvuhbanKXQRnaeACKyfFOkyXlh5VtGnn9gTzTVS9kVc46DULqHSGFqd9zJkNjqBVWK4vLCzRH3cjLEjvVjTvCes214srDywTyM8YpfEz3mnOLaRQ8bd8ZNVuPcLG5jngkmiiQ3KfePc0unS3Q1KNG3L5hzz3FLp0lrp+iz3jZErrtAao9A1C4uLWd8iSRTiOnuOx6TDfWksiWLgCXA6965/xdYS+U0Sgsu7IA71yXhzUby58Tj7aGV4ueOnFerxzWt8nnkjfjkNWDXI7oV2tjyR1vIWVY0ZQDzxXceHmkFkZboH5R3rdaytJ4mk8pSB6Csq5T5DAPkQ8cU51L6BfuAu7G5cjcuR708IY33QuCPQVxd5pN1ZzySRMxBORz1q7od/epcLFdj91jOfSnyW2KbOwnK+TumwB796qRxQMrG34U8YrMmMN/dFEu1CjoM1qWtqIYAu45HWkScjqtvc6ZqJuYCShPateC9fULLzbY7ZUHzL3NbcsEU8PlyID6GqlnpcWnCQ2+T5nUGndPcCS2vvNt1FyMMg71XmmijkVcbncgE+lWoreOZH8wED2qP7NbQFZN/v81K4HLate6hoOptJGxNs7ZrtfDfjQXMCRzKCgxz6VRv7e01i28uXb7YNZdl4eWwc+SzYJ70pqMlZicU0euRzRzRJJEQY2HBFGcnjmuIsdSu9PsWgiZZEPcnkUQ6vqax4SVRjnB71g6Rg6R3G5dxGRkdRQSC2B1rD0DX47pmgvo1huSeueMVuMu07gQRnAIrNrlMpR5RDx1oUilZckHtRt9KkkQ0q0o6UAYNNAIRzSU6m0wCmSdRT6a4PFADaKUjFJTQBUsX3T9aiqWL7p4zzVAcL4PFhqF3fXbBHui4C7hk4+lbPiJreHS2NxGqMx2rgd/pXzxaazfWupNLZztEyNjg4zXsWiLJq1nHd3V6HkXDMrHPPaumUXGV7nQ6dnc53U7KyvI5RcRp5mOCRzmqmmaGujaVdX00qoxTCmk8SQXQ1bY6bIM/fHeuog0ldV0E2jPwSP5Vo5WV2Xc830tRLO+JiXYY471ueF7C4t9aXzyCpHb0rp7TwctjbEpy3RmA5NDWf2KZY4IpHnOOaXOmrlKSa3OqsYEEQ6kH1pDpVsSwYsSTn6VPBBOttHsU7scqaqXeofZUaORNs3YVhrfQyi7vQyNT0i3upPJu5QIFySxqHSfDGn2F2JbCZGU+vWm2y6jq08sdnD5gTlie1ZVt/bC388VrEXKZDfnWivbcu6Wh0d/dWyzyhFBXGQD/eryTV7XXzcvcN5qw78rtOABmvSDHKMPPGDN/EpqO9+2altgWELH6etXHRFI52Dw4/iM293DfD7SigOCR1FeraVc3sekrZsIy6L5YkzzxXHQeEb/T2S7DFFHzFR6Vn6/ql3Z69ps9jK+x+JEB4bFTJc+iIk+Y3B4etNH1sajeyGV3bd85yAfQVau/H2nW2sR292cxv0PpTvGLXWo+G45gm2QYkIHYV5XFol14huxCqFSpyZPSkoqa94Ero9V1/xlpdrbFLJS8sg+8eeDXlXmi4vGckgMx4rqbbR9OtJYbC4u/Ou2BG09KuS+Dobeymunkw6glR6VUUoFKy0M3w9HbxSyZIy4xtPQ1i3Om6raawfsR3W0z84HGD2qWxWaa4gEIPm7gKv+LtYlsrvT7eBl80ON6rWjLZ0kCw6PNb28sZeOTqAPumtDUrrSbS3jmumEEeeM9TVXUbu4/sua9kCRSRRjbkc5ryvV7y91y3xdRyuY3yCq8AVnyqW5MT1ay1DSL9Wt7acCZ/uvnpUk3gS3exldpy1w3KknpXnmj+HNVuYrSXT7eTfwc/jXtmlw3kNjFHd43BQGx61nNuHwsUnqeW6V4c1qy1JdxYwhslgTjFXppri38RfvDJsPCnNelSsVPKDZ0Jrz34ga/b2bW8WmwLNOH+Y9xThU5t0JanVW8b3C4kJOagn8PxTT+bKw/4FzXNSeLbnTY7V5IC5lHzL6V1uja1a6jAsibldx8yt2qJc61Q3dHN+KfB4utKnNrKGZBuCYrO8KWemWGmhrsrBeEn7x/SvQ4Z9pZEO5n7V5r8RvDWoTXyXVhE0i4yVXsadOTeg02dNpmnWwunuWhQsy8EEZNUryzkikbyCyqe1cJPqGq6LJaNO0q5UAqT713ksmqyT28sao9rIuSPSrcX1G3Y1dKn8i2EUnI9T1q/JDb3VuyxlQ+M81i3KtGB7jrTIldY/MViSffpUcvUXmR3tvPZSqJw0qN93A4FQz26PFJnCs64FdbY7bm0VZOnTJ7VkX2gzNIXjc4U5BojO71DmPObjQdRtW3Qq+c5BBrtbBbiLToGuc+bjnNTTW81spaTOBVSN5JBuDHYe1ac1xp3NTf+5yBz0qLzefmGaS3+dSPzoGEYlnVR6moaGPkYlQ0a8L96qOs2YvLB1jOGx0BrRQxSDMUoc+1VmVUuGO80Le4HBWwvNLkDHzCq9vWuy0vUvt1mkxBXsRVmVUlQq8a49cVFDDbQ/JEQGznA71crMASSFgY5SQ2cjNXAkbqgjYbh1Gap6hYGXEsHzPHwy+9T2OnmC380sd57elLRrcmWxLc2wZiNoB6gjrmtXRNceCRbfUjmI/Ksh7fWs2Jj5nz8nFJfQq7RgjPes5RTIaUkd6CpAKMCvXIoOOxrjrLVpYZDC7E7RgH2roLO+EycHmsGrGDptGhRSL90ZpaRAU2lJ5pKACgcZ70UUANfpTakxmmN1oAToDSxO2zigDPWl+7wvAqwPnt/CTfaY7iRAls53MRXSOb20eM2m77MqgYA61ojU/sjCxurUkIMjcKkOvacw8iZCgfjCtjFdt7s63K5zd/8QrdZlspLBJlQ7WkPXNax8WW+mJCxTEbYICdh71jeIvhxI4+3aRIbiORt4FUfEui6lDaW/wBotyj4AIz0ocU1YSR6nY+ILHU9OMts5L4wVPr6Gsy/l1CO8huYNqPn5B/erzCx1CTwzBczu7b3xtQ+td/Yarealptje3eItyfLgfzrNxcdA5FEm13xRc6fcxSXbeQ4/hj6H61Ss/EkWpXnmTOZHJ4X0FX/ABPZaZfSWYg/0iTb+9Y+tYmkaXZWF/c3cgPmJjy0b7pp8isXdWskeiwyJHabfDYQPs3Pk8H1rD0nV0tftPnIDcyvlmHTNZUdyI3lnt5PLD/MFB/OlgkWV+V27vmyR71HKJQXU057eTUJJJJWaI7h8o9K0tT0R/LibSpPNaIbzk9/Ss/SfE+lQy3VhfsrT/w4rJXxrcaRcXNvpUKz3TMcK3OBRyy6CZ0Q+ImkwaYU1IOl2v7sxlc8jjNVba202/AuokIjA3xsRjmuK0/TZta1a4bXIPIDkyFiMdfSuoSC4kaOy0tGeCIckdwKpRSZMY2R1mnlbi0Db1dWypFZjaZLA00Vqgj3AgMO+az9PurmxuHSEbNpw0bV09rfpckeYArYyeRWSTiEYtHl1l4RuV8UwTXF0rYfLDPSu88X3UFjpMwLKzOm2MeteXeIZ9RsvG0t3DI32eN88n5SK6Wy1/TdcbzbleYRjaT3rWUXJpmiXUxdFae1sbnUBE26P7ox1NLoulx3ly2t3geWWM7/AC2HU9queJNXuDEn9mxKlovVQOprsPAunzQaU1zf7cSLu2EcVc5pK7CTscvpOla34iv3vr8/ZbAtxGwxkV31lHpdrAIIrSM9mOzr+NT3m+dY0RlVT0UDGBVqK0jhiIjXL7e/rWEp3tczbMqK/tLC6IMqReiE8CuW8W+INWh1SP7E/wC5K/Kw5BzXN+NPDuoyX09zGZWGchQTxXV+B4Wg0N11eIM6/wCqWSqajBXepfKyloHifUlv0iu42mjkPzEDpWzr9hpty7TQoPMHJq3E8UbsY4EAbnpyKSbSRewSSxswlB6dsVCqRb0HyuOpzzX8YkhjvbVJLcEAe1dGklpb3cMUMaRo4GAO9VLTRYpYcXAIK881q3VosqxNGmDCRtNVJp6XJbMr4gve6Xa2uoaXn922ZFA7VpeGddg8QackseBMB+8Xvmp9KvI78y2l8gYgn5DXIXVifDvilfsJbyLk52joKlLmVuo9zrdT0bTr9QbuBSYzlS3rVRbi3sVjiEeEZtuewrj9d8Tz201wI3OUkHB9O9egaNJZaro0E8BSUsOfUNROMoJOTC1jgtR8XQ2mpXFldR7gr4z6D1qzdCdxHNZyCS1YBiFqt448Fxz3smoRS4BGWUZ+bFYPgrX/ALJqQsrvPlklFU9q2VmrxKR10muNpkCvHyO6962tH8S2Oqx7W2xy46E4zXNa3BEz3FxOjpCo/OuMeNtwntAzR7uSp7UvZxa1G7PY9lkW1uEaJyCrcdawJ7L7LJ5UIyg6Vzo8Rtpk8ccqfuFQAt3z613Wj+Tqtn9qgYMrDjPrU8vIidjlNU1T+xvlKbiR0qte3cWoaeJg5Abghe1M8TGSPXI7O8td8cgOyT0NYVzptxpl6HMw2/eEYPB9q1gk1coQw3ccgbTpyVHJ9RXR6NevdxeXeIRKv8R71hafqUb3pDqIpQM/LXSzw7ijRALkZyKJKw0rl7PlqRMwVBzk1yOuwXQ1A3tlJvjHVF5rev7S4ns/IyQzDOc1QsdHu9PuIZM5QgCQE5BFTYdi/wCGtWkubM5+WROua6Kzu0uImSTBasq3sbeGYyRsg3DJUU6bfHIJYh8g6471Ekt0Q1c1BDEh8yQgbOgpsKG5imuydsaHHPesnWLadjDPbOXQ/eA7fWtMhrrw7cxW5xLGN2B61KJtYrmAs25Th2/StOAm1QKTk9c151bazdQMBK+H3Y2nqK9AWVptPhkwCSOcdac4q1iWrnUafOtxEG3A46+1XmOOtch4dmlg1IqoZo36g9q62bgj3rCSsc81aViMnmo8nON4PtmqupStmOJDjPJNZpHO9ZGJXtTUboLG2GVhkHIpQRmqVlcrNACcBhwRVoHvUNNMTVicVGCdxBHC8inqfl4pjNk9KBDwQeM9KcKhDosoVmUO/wB1SeT9PWplGRVgcBrOtaLauiag6mQcYI+YVjR6fo2s3QazuFMnUJV3xj4SGuFbi0dRcIuMkVxKaDreiXcbRRhiepXvXXHbRnRF3R1twdV0XdAJWMOPlxyBVJ3e+kW4vbku44APaum0ma/uIQl/bKCeMGpLjRgkoMUShWOCAKfOh8yR5l48htVubCaX94FIDovSvRIruCO0toDZFrbywF29uK5fXPBNzf3CsHJUvub2rZvJ5fDmnpJMxaGJeVPeibbL5kzWht7Bl2QkW8z/AMMlU9QheztbmIWrSIVOJF5ArjbnxXFr2q2m0mHc2z5adqPja6sJZrKGRpbVeMv1IpJSWoGM5u1VzEs20Nk4BxXp+i6poVz4UH+kIt5HGQ24cg4rL0HxtGPCcl1PpSNGo8sMF65rjX1W0u1uxbWXkqwO9gOlP432Jbb0Znm2YeJLeWCWOeR5Afl5JGa7/QvCN6/jafUrjEUSk4z34ritEu9K0DQ5L+HN1q7kpEp6R89a9T8P629t4Wj1DVpB9pfOSOjU5NxXugXL+wee8ZpiNo4wtZuozXegILuBGWHGGIHarOi67aX1tdXSzxu8YPyHvUHhfX5/Fkk8P2QLboMfN3ArB83xNAYNh4istRu2DOwkc/Nnik1HW7HSrxA1ww3cYzVHX9PSC4uGsYFEkbbWCCufk0m4ur2Ca5gk2NjJNdHJpdmj2Oq8YNZSeGpJ0RpHmIKOnU1keF9DD6FLLDFI0znpjBxXQ3sb20em2emWhmBxuB5Art7uN7bSG+yW6LcLGDhRjBxzWbqcsUu5Ddjz6DQNRksBCdkZ8wNtJ5Ir0y3QjTYYZT90AH0rw3xBrmqLdR3zNJGUYggn5a9K8IeJm8Q6TLFEv+kqhD/lU1YNrbQJJ2TNCHVrWfxAIIZAWQbCvauluSYwxJwa808NeGruLxCt3dMQquSfep/F3irU01Oa3s4tsCjGW6ZqJU1J2ixKNzrdXuFkhiA4YjJI71lEtNjdyB0FUNE1ZdVsUWVSs0HyuexrUjRfLYh8HtUSi4ux0QVkMVRmt3SlMMEkhOBtzzXOXl1DYRCS5kC59aWx8V2l+v2CKFyJFKl/SkoS6omq2asuo2F5IBZXKOynDKOtWNWuBawW6xDcWYZ9a5Xwp4WGm6jcXccpZW6A/WuovWitrtHuMFSuBlsc1coJNJO5gZki22rXk8WmXAh1KEbuCOTXMG71qTVUe/ti0tq+1mI4IrK0rTNbt/FNxqUMZWFmbktkEVv6trN/LaTyoiF1x93qa1SSdi0cXr6nUPFckeQA7YZQOK3vBlhq2h+I47cZawkGc87RWe+riNbe9a03TtIFkYDoa9MuriS60u0lt0AkVNwJFVN2Vhs1dRsTcQMiAFa8k8bJpWg6pC4jMl0h3sBXXaP4su49Qa1v1j3ZwQaj8Y+DYfEUyX6Mwk24IXoRWMW4PXYVzR024s9b8OBpIl2yqMlh04rOsNMs7cPaxtGUJz/9atLS/K0XSks7gARgYLYrjL2+SLX2MDYti2MjsKuLvdDRD4sisZ9YFkGVAuAx7Vr6Nq0WglNOiWRkxw2OKwLubTTd3Goo5kMLbSvqateH9ci124aIwLAyDILDtWj95WZVjtJ7m2vEjku4AwX7jnrzXJeNPD1xLEmp2Tt5YX7qnNTtPBczLbR3SMVO4hTx+FdNpdwCHs5lH2ccLnvUKLhqgPNdLsoo5o7u6OxmXGGHWrOqX017bGDT5THLGc5Peu31bQI7oYTaAPuj0rkNR8LajbuZlZRCPmJXqKpSUgET7ZHpMD3kjNOOpB7VqWtytzaK+/kcEE81U0q9tb2Mwlyxi6k96rf2bMuqsyzqtrjJx3plo3LOeAuIZCRJ2NX0kjKtGHGfSuSgkkGpmB/mHZqt6glzYTLdLmSPofepcbiaOoWYxxkRLlSelWbTyllDwt5U5HKnvXLz6rd2qRzQR5QjIFWYNSj12BoMm3vNuQw6ZqHBk2OmfRdHmnE93aGO4HzEgcNVGeUxXbRwgCFfu4rh59c1rRrh7O7PmoB8rk5JrrdLFxe6QLqNMAAkijlfUlRd9TofDSh7qY7juAyK6SfJXcMZA715v4K8SQJqcousjblWHrW/q+vPOrLYBkVerN0OaynG8tDGUOZl7V5Cjxy9QBg4rOkW688ssg8hhyBU9ndreWP2aZh5hH3h61UC3dopi2eZnoTTirE2sWLAk3RC/drdQ5HNZOk27xr5sowx6r6VeguQ5lb+GIAsPXNTLchl+I4WjFC8qrDowzS1DJGGJDIrsql1+6xHI+npTw2KKUAEc0wMVHMgVD3FZ+swz3Gnyx2jbbgcI1XQwQ5J+6BS5B5XkntWqLPMo/Fd7ab7S9Rnuk6NjpW/oviy0mQLeBknzjPrWtqGkWl1OskkKiUHPTrTH0DTTI080GG7YFav2b6Gt49TSW5jkiMsTA8ZGa4rx7pWqanDGsTRvGRyitip9fuf7HePymPlN2HaszT1vLnUlYXD+QBv+n1qoR5dR8q3Rp+FfDmm6dDG89kzXOOSeVFXtY8MaVeyeabJcvyfpTdC8RRT6kLGTk5IViOtdRalQ8hAzGTzntUym09RSOfsdE/0BrKK3RbTspqO38LW9tbzQi3ULKDuI7V1cvIxbkFuwFY82qX+nSF2iBgJwc9RS9pLowTM+08L2kdgUi0+BV3j5n65rU1nw+mp6ObRnVMYwM9KyvH1rqGpaLBe6HK6FW3SKprg7u41x5Y1hvmPGGG7vT9+etykdT/YFtoVnCkkwMrMeh6is/xLqU2iW0cvh/arD74Xv71tJ4dvNQsdPmmlBniHIzwa5fxi3/CNXkT3MPmCcc7vu1SSlo3ctSSND4b3V5qRvbi7g3wP8wYjkNntXayQxzskJXhu3pWd4H8RW99oYFvBHbRhsBcD5ql1jW7W3uFhjcGQ/e29s1DlLm2IRa1+eDw/oNzLZSKLtl2pzXnGheL9Yjvdl44kVyc7vSrviKxvdU8TW8cZka0AH0rp9R8D288EEsZ8qRFBfH8QFNqKXvDMnx/Yya14d0+TTrdV+f58d65bQv7T8NyNJJGI9zAj1NewwWaTabDDFmNIsFR2/GuU8U6LdXV7HJgsi9gOKITXwjidRpGq2+u2aOrLHKMb+etXZ9Nsr2IjZGT1ODzXnWjfbZNTezs7cxR/xEd66b7De6Qr3Su0kYBZhyaylHXRhZIsHRLeyYrbfKxOT70q2cnJU5I61h6P4907WL9I7hTBIjbRkYz2rcPiWyfUvskAYtnBIHFP3+qBN9DH8RaQk88BuWYt3x1rW0HR7GzYTxKxKjnd61o3F1FLMpihLADqRVCRr79+UVcEfKBT5m9EFrlq41e2guf3i7VPevMviHLfarrJm0+ZngTA8oNgg0+/h1W5u2S6kdHByq+2au/2Vc2esW7FHZZFGcetaQgoa3GrI2fCOnatN4buGuXZMxMqhq5nTLPUPD4aXVGaeFmbauOorq/F9zqVhYRrDK8cbDnjrWZ4ZnudRtZ4r/8AeQAYUt2NEL2uyhfstvrPh+aOwTZM3zhR1Vqx7PXPEdgY4r7bJCi+WoHWtm3f/hFrozQAvHLwQe1Wri1h1eSO+twYSDkp607pasDL1iCK/lgmgnWK9CjKk9frXbeHJ7xbBY7lUwoxmuH1PRoLrURdNK9u+QBg96PEN/rGlS2sccsjwuMZA60pRU0S0eg3i2t84tjhmcY4rlNX8KQ6est0QZIEQkqO9bHgm0neEXd/lXYfKDXThU8oo6hwww27oaw53TdrkJ2PEPDk9lc3F5bJbMI2Us3HSrmlaIsdheT6Q5eSX5Ar/wAP0ruNW8NRxyPcaUqQlgdyAdaz7WzvEtPLsIjDMDk56NW6qLoWpX3Mbwd4Vls5XvL590g+UCuvSGJHVginH96smK91WC5SDUYflZgAUHWugktZAdvy7+y7uTWVSU2O5QvQJlLK7QyDpt6VG9wwiWCU7lcYJq7LAeEmUj8Olc7rSyWlvOsTbnCnaO4pRlzNIY+DRLSzleeDDFgcMPpXA3l7cW96+3JUE4+ldP8AC/U5LuO6sLti0gyQXHQntWtrPhWIO7MvDA8gZ5rVe63cLnHSanPb6ObrT4hJc5+Ye1a3hvXU8S28lpIqxTgfMKsWOlxaTE0k+0xc5Dd64vW4zpt09/pJbEoIbZ0qrcxT1NvxjfXdi0dtp6boIlAZuxIqDS/EdvBax3VzCVkDYOzpWRa2GqX/AIeDl3bEhZw3oav6Zpos9Hk+2wrJHI4we46UKKFY7aSK28V6YpYBJT91j6Vo6H5+k2LWedyrxj2rF0WSOMRRWUWIgNpNa66gv24woQ5xziokrqwrGNrfhx5mF7pkwWbksg6mrPhZ7l7OWC8B8wHHIrXKEHdE2zvx3pi3LefmXH/ARU819AMS41oaffeUw4U9TW3p/iJJFISRWz/ePNY2vaLHqbq8Z2kHOaqWfhmeOZGkuflz0C4zVWTQWOwfUpn4Q7SR1qGx1Ga1Z0umyjNkmoCI7ZQm75hwealQRGMtMMjpUSgiORHYQ3du1vE3mKobgDNWVII4NcbpBiiuljk/exZ3LuP3TXYqVZQUPFYzVmc048rAc/MevpSr0qNECl2Ylnbue1SL0pkHPsAMqRkHH8qlKBcBeDjqKV1Y/PGFaNgCGXoeKYHC8kYHpVmiF2bwT/F6mojHMA2Hzz0NWAQ/3RgUNFgFqaY9jOutNhvgv2uJTt9Kli0+CGBkjiCqwxkdauRh24IytSlTgAgEfyp87Qrs56w8M2ltqAvkBJXoDitVo/mIj3BSc1eWNBgq2PSngL3AIqXO479yGCJMYMmz1FR6tZrcWXlGUBTxk1YkZYwGQDOenrVe/QzWjeXwx6UJ66DRgaVdzaRHJa3sby25OAy9MGlh8MaRNdeehILHdgniss6nd2dxsuV3Q7sc12NhPbXNsCAOR6VrO8di27EyxxWwEUY/dKMAA1T1nRrLxDp7W93ArAHIz2qaMvbXGxow8JHBNTQTwvIyRMdxPSsuZxehDOFv/DNzYzQnSQvkRYHlr3qhqvh+8n1JXhgZXkOSW6V6kCy8FQPeowygnc2DnIqvbSLTOX8L77R/Ku4yWAxuI5rrP9ZBIynKlSMGsW41ixTWEtAA0jLkjFV7HXGk1z7GYsRk8VM77jZsafMn2YxSAq68HFQ31yRIFVGZSOeK0BbqZ3ZQOTyap3LywmRQFK46moTAh0tI4LgvGoDN3xzW08cclsVlJKNwQemK4CLxXb2epfZrwJy2Aw9a7OO/t/LUvMqhhkL3qpKSd2NnDeL/AAXp9rPFqVi6wJG2ZAO9Yvhy+VNZmyFcdd+O1eia6LTUrBoTJtVuPxrhtS0hdCsJLrP76U7E9xW1OTcWnuOL0O4iMRjVoSvNSnKkENzXCWV7fraoSpTP3QO9XLfUtXMgQRFgehNLkY7HRXMcLXH2ibb8nc96u3N9YW6xzzuuAMKK5LUftkcSveyqoJ+6Kwb/AFYlTsQMo4Gafs29wsdl4v17RobWAX9wrl+Qg7Cs3Tb3Rnn8qynVFYZAzXFXOnQa9erLeTmJgNp+lVNe0K40+5H9mMZI1UbWqlTSja5S1O6+2WepW97Dje8ALD8O4rP8CeI7WW6lt5o5FC521U06ex0KG0ub4v586GN1HQZq1pXhiLSJ7jWbiVGtSpkjT1yOKdk1ZgUr7xLb3eoz27p5bK+Bjp7Vv2eqE6coutrNGflJGdwry5/O1a7u7mGMISS6geldD4S1do5jBfwOUxyT0xVNWQHolh4osR5cU8wiA6A11MV1Bd22+CVGHbFeWT6d4dvrg3UVwzBOWUVd07xBplveJDBKyIRgCuaVK+sSZJW0PRUYox3jr3HalFvvD9ORxWNLr8VkQt3C5jOMSL0rIvta1ea/3aKqS22M4PaoUJEG+witw3nttVedx5x9K4/XPDV7ftNrGh620kynIiJx+ArP8R6l4jntyTbHyQDu2r1/Gub8D69JpOqyTXFwwgB+eJj710KErXRSOs8N+L9SiYxa/AYwvy+Yw61SvfG+nJq1xHJbvIqkYcDg1Z1OfR/EiyTzXTxRKc7av2nhHSL4W95CWaDaAB/ePc0rQjrLcpuxgSaiJHuLi0RIvMTKgcGofC/jy8tZpo9YO+FBwCMkVf8AHPhB4VF9ppcRRjlM9q5uwgs9T0m7Lq0dz91W9TVaS2KVjt9UMHibQZ7rTnG9RuKj0rkPDULXF20Jj3QouWVuma2Phlpd9pRuF1MFIpUKovZga6C30f7F9oNsAGKc4oTtoCdjHvpoYtNntYWVZCMbay9CsbhoprS5yyMMqD2NT2ehNfTMZJT9pL8VsyxyW7nH38bCfQetU9B3EsYY9Ltvs7zKZn9DXMySXFhra5Yklvve1bcOhLLcefLdh2znBPP0rSudJinuI5SqsUGM+tTe2rBsv28pdYxtwrDqTUd3iGXJ2uCcYHNZPiDTtSukjFlKIEUYODVLSfENnZwQ2FxcCefcVZ+uDUNdUSdMuFTgkZ6CsXXpL17MfZiwcelazLlAc4HVPemQ3W1WFwAO1FragcDFeXgb9+8pdeST3rt9zTeG3KEmTbnj6U+60y3u4CUVR+FWbGNIofIVRtAxj1qm4uwHF6Dr5WQwzsQ/qfrXo2la+scKZG9O57157q3hqR7t5IfkJbII7V1Ol24s7KNJAC2OSe9FWKtcmUVJHd2F6l9GXg52/eXvVpN20EoQTXDWF61jeAo/lJJ94NXcWjCe3SSN1ZSODWHKzCVOx5217c+GtG2mRp+yA9h6Uuj+Jb2/uIy9tGox2rW1CwivIl+0qQnU1asrGztEX7KoL4rVtONwbLgDbN2PnPUUFwVwTzTnO1cjn6UCMbc1BIRcrxUgU+lR52EADrUgG77xpPYA/ix3pI+HbPGacoUMRSN97I5HrUAkLIpZcgZFSptCYKHJFRAnGR09KkEisy84PpQO5z+s6KNQvF3OFRTnFaNrZLaIkcfK9zTr5c3aNkhR6VZiIMjFOc+tW5O1mNsk2c/Odw9KjurKKXy5Y0JaM5yGxUqy7WPHajzjhgRwakQ2KZmXe3A9ac7RtETHGWc96phyGKAHaatW/wAoA61LGZg0SzS+W/lGZTycdRWnDBbCYypEpOP9YeoqQW+VLEEg8GnPar5DICcMMVXO2rNjuYl54n0y3naOWYlhwTVW98V6NeW0kNvdAyP8gwMc1btvCmm7JxPEztIfvN2rH1X4f6dNak6Yhgugchs1UXDRX1KRzFp4FvZ9TN3fzKbJT5gI6tzTfihHdxXttdWMsqxhQi8dBXQ+DI9esL5tL1KN5LZ+Ec9hXZ6paWWxUu4kdB0BrV1bStIpSseMa9qGrXWgaTKkb5hJWRgOW5rurdG13QLJLhSro6nB64Heuuht7M2QhWBRHnOMDFEdvaSNtjYHHA2kVEqqa91Bc8l8X3t8niBbTSI3RI8Ddjg1d36jcqPMmdJEXBx/Ea9An0LF00gwSfUc0+30WGNmd41DE8471XtEgc+xw2h6Be6pJvnZiqHnNdND4PtYrkG6BkgUZZa6aHZCjLEoTjqBU0TusZLtvLAjmsXWb2IcmzmdW0TR9QsJTpZRbmP7oB5H4V53NcPA0kUxwyHvWn4p0DWdI1v+2NGMrR5yyg8fiKh8Qqmp20ep7RE2wBx057100lpq9zWD0KmkWsGr6nbLermENn8qo+I9VmuNfkRWcwQ5jSIfdIHrW14RtVuNQtpZXVYE6kN1qld6xp1t4zuQbdfswJXJHOT3p9SjPtPD2p6peLJp4RAw4UNjFdPpfhG5udLvbW9/dT4wrDuazNQWexg/tKxuGjGcoB3rY8KeMLjWXNpfMqzBchhxuolzNWQGHonhK/s72WC4dFGCAwPWtvQ/AtvHN5t8wc5zisifWWj15vMkbZv2nmu+s7yzJVGukDkgAZ65qZSlYTL0SRSA2/2aNljGAD3p8VsqrsjgSCX/AGe4qtdebaK8o7DJqrp3iO11UiCRwkoOFbvXPaTIabNC7aKzg/fzxxow2/Oaw77wdomoxyOEWJ5Fz5idKPFHhWXWGQvcSBBycHqawdPTUvChY3kjXmmA4I6la1hGSWkhXsV73wdYWVjN9iuTLMP9oECmrNqkPhqOC2QJJG+Qw/irqvD0Ph67ke4sJAzy/MYi3Sq+raLd7JFs3YjGVHvVJ33KTvuUfC+q63dpc2ut26+SI/lBHWsnxFobu8ZsUSK1BywjPNb+nXl2bSW31RVgkC7Y3bjca5yHT9ai1FZtjeSW5wcginFOLbHcz/EetyaXParFIzkKODXZ6FrkWqWSPKVC4wST3qPXfDlpeoJZ492VHK9qxNT0LS9P0xbdbxoJJDuXJxUu0tRp3NabTrmK6+1QvuiJ5xT02M8pcZY8muf8NXWq6ZdLbzgywPjBJzkGu5ubKKaN3jG1yKbbQN2OF/tKKXUmiiARom5atKTVoYblIZZCjsARjvWNq/h+6t7qSSEAmRs8Gm32i3N75Dx4DKuGYmrsmM64y+fA8LNnzVwjmuKtPBUkWtG4kmAh37q6TS7OSwslW6fJDZzmrHmtJNhWBBHFZ3toNK5R8TaqmnS2yRYccciqevy/a9EjuIlIB71R8VWtzIyMI2fHAxV/w1bSmweLUFxEOgParS0HYg8F6tNv+yTuDGOntXSOGS4R42yGPaqMOk2kI821OGPWrCObaH5juYniklZ3E1Yn1bUFs4RNKGK44xVC38QWd00ZjU47560/VIJr+xVQowufxrjjp9zAxwpBBqklbUR1GoaDPqlzJew3boB90etbOkXOoWtikTyyZXjmqWgedFZxrI5DmtJyQ2C7E0nqRuzoCPMUK5B2dQKYIUh+beVBqHTJQ4ZXQrcNgv6dO1X5IYJhiWNj9OlYbGDIYp1CZUFlqxG6uuO9JsCRlYwFHtUSjy39zzTEThWJIAGR0zR7HgjrQsoLAY61LjINJ7ARjg00ncTgjjqBTuhyelNFsqyFo2+/zioGiZFCqT1qRolOHxgjnisvxFdXGm6Q88C73BHFUvDms32pD9/aMi9yelVyvcfK9zcCBsg8getOREJ4yo9KiuWlhe38mFpjLKEfDACNcH5jn8KmVXPO0fUHNK4CqpZmOBkVGysWxjB/SrAJC5BwSaJPmXHekBTNudpGSM9xVi1XEeSOnepCTkDtRIRHlV4HpQBHcXZjIhUZZuR9KkjlZVG5ajVMxmaMfMv86fHdGXCsMMOtKyAdNcDy2KryK5/UvEE1kqn7E7LnJPNdA6sCQEZgfSmKm5ds0a57AijRasLmLDrjXCLdqnltt4RuOa5HVdTvJboy3cmzB4RTmuu8V6P9u0uX7L+7mQEjbxmuC8B2barrNxp2pSMJI1JGe+K6IKHx2No2tdno2hXy6hozCEf6RtAGelZeqxWujOk73LR3R6jPFdBpljbaPbu5dURerGqOq6Pba3OjTZMQ5DL0NZKXveRk3fYx5fF1va6U9xcTHzWyIwe9N8OnV9SuIdQaYGwcZAp3jPwL/bUVjBYyJBFCpzuFdLoelDR9GtrGNtwiXGR3pycEroG10JijOcIPlB5zVuOI8YJKDrxmmRq3rXH/ABR1y607Rki0mYxM8mHkBwRx0rKK53ZAots7VcESRyKpDfwGuJ8a+EZdXs/L05liMZLEHgN7Vl/DHVNZ1Bpp7sGW1jQAOTnLV6Ilwqj5h89W06THdxdkeTeE/A2q2l5519L5EScBQfvV0Op+E4XuN/2VXLEEnFdy96h/dkAluhNVrnUzbxhURfMHXPpT9pN9BqTM610aH7EkM8CMoHCkdKzbrQdCsdShlYx2ss2QrE4qbV/EVxZxGYRhgQR8vQfWuLl0a68aSzSG7AuUGUTP3fpVQ5m7vQtNmRrvhu+h8ax28Yae3mcMJF5GKbqvhvWYNeDrvS2DgrITwK9Itr+18I6RbQavcLcXSDljyR7VOl/Z+MtLuDp5BeJThR1GBWiq91oJS7mdp1+8uLe4cTI67Sw9aoa34ZkgQXemrhkO4gdRWXoF9baH4emnvJC91HPtaNu1eh6VqEGoaMNRibEboSw9AKiblGzWwOXYq+EtZ/tCy+zuxWeP7wbvirWr6d50DtAgLnqh5DVz+ly2uoXFxf6G+TCwDKO/qa6dNSidF81ljbHINZS913RJ5xNe2ujys66W1vcg84zg10nh7xhZ6o4t5VaC47qehrb1KzstUgI+RnHQgVyUWg29le77lZNx6MvQVo+WS1GkdRrOlW9/A5mUHyxvXB6154mu63p+tGIWUk9hnaMA/KM16PaRyPEqrOrIOgPanTIEypVST7VMZJaS1QGWZSuC6MI8Z2msXxP4bj8SwRTW7FGj9TitPXPOi0ueexy92pzsP8QrI0TVbjUrB5rEqXj4lh9DWiT3iUXQ9hpOjRw3TBZ4UwmT1qn4a16O5neOZwGP3QfSuE8Y3V9ruv2sCf6O8Z2hT1auv0jw1aW11DeX0ksZCfNjuRVcqUdWUtTq5rOCXa8jAZ6c1wXxI1CDS0jt7CT94+GwpqW78XQZuYn3GKNiI/U0ml+HLLWGh1C+WRmccBmwBSSa1bGZqazO+kW7yDIPDA5zT21JoVguIwSrcba19e0EWojS2IMQ+7jmsPVLCd7a32xFiucqv86tcr2KR0Gnakl5wVAb+6aZHdG5mltz8vGF96wPD6Sx6gvyMB0Iauilt1F4kin5kOTQM5ebVJ9O1XyZGOwHkGuqLi7gS5iIMYXJFZXiPRPt8gurbl2OGrW02ya00pIActxk+tN7CYrXghiLGTaAMkUtrqNleL8pUt71zniSeEXqwwyEkjDrWHZh7fUEjjYh2cdPShRuSemQuoIGBnGcikuJJTJlFypFRREQWrvIfur1rNtvE8QjIKdDgUhWO9ktxOC0TbJOCDViPzQgEgy3QmoWmjht2uHJCR8H64rGsvFNvPJMhj3P2zWag3scp02Ds6c1E7BeSuSKbFcStHGxiaNnXdtYg7fY4pyqCee/JzUXATlhkDr2qSGbaCp4JoZdoOO3SmBNxz3qAJwwx1pP4s9qjebycBl+X1qRGjljBQ5GRyKdgIpriFx5czLg9icZqaJo4kAC8YrEhvGuNZltfs5CKMh2AxWwkYijLufu0hkFxqkNvNhoyzjoMVNFe/aGVo12IBzmrUcdrcAP8jv3xUN5bRGNgp259Kdh6dEQalqNrYIrXUyRgnjcas6beQXsXm28iug6la4H4m2TXGkx3KhysY28UfBu4mltrmOVX8oLkEjvV+z9zmK5U4noSkBnZh9BVYLLJcqQV2dw1XDGSB6NTo4goJOKybJHkhOFxnpgU3APzHg00/ezTjhhwRUgCkls0oTI3dxUbSJGQrNgmn+ZtGOT9KBXADcwGfl7ise80CAa5Dqll+5uQCHI/iHvW5gcMv40E5IPampOOwzyf4s+J79dVTTbUGK3CgsP7xre8O3mqJ4Q8y4LLKhypPcVv654esdXcPdRKXB4buK0rO0ijshZsN8YGAGHFa80OW1ilK2hH4e1BtS0tZ5UKOOpPelbUfMLKkRyvGauRQRwwCGEBYx2FVzCEYsRlcY2+tYkjTIWh+b5Y8ZJ9a8H1u71DxD4ql0mN/3Ms22Idl969xlYFHUqfLxjFc94G0ix/wCEgvbtbbEqPlGI6VrSly3ZS+E2tC0GLwt4f+xI292O52/2qRYrllEUbYGeT7Vd1uUtKAG+QnmrVooWEBMEnuay5r6klb7ABGAxyap3mmiVSHcgEY4raxiqeo5WLK9T0pc7Gtznm0m3iiaEu0qtnIPasfTLOTSNbRowfKJxnHauqtomll+anaqscMeCSG7cVpGpoavTc8x+JdhM+rySmXbbyLkZ6ZxXX+Ara28KfD+81SIrNM6GRipzg44FXrqztdVgW3vYtwI6+lXdH0K10/RLjTkJMDg7g3I/CtJT5o2IkeLaRrUWv60seswCQXB3Ep1HpXrnhiPTbGzk02AsgIYBX6c1y2n6ZZadqc8S2USzBv3brzgV0OvWf2q0jaEeTcKOHBxVVHe0ehVzn9F8N6loniRpkmjispySwz2zXV6npSXcQQylC38SnOa888RWmu3dosf2pyEPVW5NdB4BmvbHSzFrBZm3fKScnFOSl8VxWZmapoms6XeRtYzu8bHGd1dbpL3osD/aaq8kfp1rXlcSRqbeQMhIJyKnkRhtKoHz1Y9aylNMCnYTLIhK/u2PHNXlRioD9R3qsYAsodF24OcGpxNuY545rJiKl1bbSWkfcCCC3oK4RNCvPD+uJqOnTbrCckTqOgFejyASoUIJBFZP2KQK0YkIQn7jdDWkJ2QJ3MLWrDRdWmWeG5jS852MG5zUthbXK2ctlqbKWdSsT+tY+r+BILgST28ssFwuXX5jgn0qz4c1XfbDTdXA89PlSQ1q17uhRyh8P3EN5L9oiUxxscMa0dI1udr2OykRBEeAR2p3xLe+shElozfZSvzH1NZvhlY/LhuZepz8xNaq01dlo9HgWNk8px5mzkA965zxLfLp18rxoUyOVHSo73VP30ItZQXz8yjritPX9NGq2sZgKtKqjdWUY8o3puYWnXCXRkmVOT1qh9tmjvz+7YoDzW1aXtrpMH2OeAGR+GY1neKLxdL8tYYhiRdwJrR6hc2bKTzVZ0UgEU3e7N97AArJ0nXTNCsWFBIxxVqG7MN2I5RwTwaTQ0cxbWBk14mQ53SZx7V10Wm6eXLRgeavNVDYldT+0KMq2elUvLuLO53lZXiZguEUk8nFVcGdEtiTbzRF8lxgGuLvNJvra4eNAzqDwRXaGYwoVc/N2pFvJAMMkZPqTSWuwjqr+1FzZPbDgMSTism38PWkKj5gko79zW/kE7hwcmmsAXQkCsFNpWORENvHhQuWAHfPWrUULHJ3dPWhYSTgcU24eZFTyUDDOGPpStcGTEbSB1pMenWiQ8DBpsTkNkjIHWpAZcqzw7WHWsiyeXT7swz5McnKkdq6JhG332+XtUbxRSY/drkdD6U07AhqLBuQKAHJ+8etSzxMyvEMfNxmoJrbeuV++OlPU3Cx4lXkDg0X1Awbm3utMmSSNmdNxyK3bbVLO4wCyq56qwqCSQjIlHymqNxaQEGSDBJ54p7lJXLF+oSVY5Buti2SCOMVwz/EK10zxS9jp1sEslk8suo6mvQbB0ubYW9x8xIwWPpXJRfDHTv7ea9affHv3mIVcOVpxkx3toegJOssEb+oyPxoMnYY5qAIhfbAT5ajGKlVDXOIkBHTvTVKMx29R1pu5UcKTlycgUySe1t7lY2lSKaTna3egW5YMSOo3KCR3oEQA6k1kan4m0/Sb1Le6bl+p/u1twsk8KzxNmJ/un1otpcTTQiqV5HI9DTN25m+UipSDnI4phc5K55PFK4IjBy+D0pVYHgdaNmOcZPauM8QeJpdE1IedH+6Pb1q4Qc3ZFpXOyZnzgY/GnI/mqUIwwrlNE8Uf23c7bWFwo6k11kakA7uppNWdmKSsRGMheB82KwNAa7tPEElvOo2SksGA4rp1HQClEC+YGKjI70KVkClpYq3KJO7xbMYPWmWe6JtjkfLxWlKu8ZQYNZNzFJHL50fIz8w9KjyFc0uG5qnfTxorI3YVPC++MMOM1laiu26JcZFFi47iW10Fk5UCtV4obqNXZA2eaxNis3mMcKegrasGUW3y9B0oKqGRqE1vBfQ229BK3UDqBVu2kE1wYST8o5Fef8AiPTdWg8bi5iDPE7DDE9BXeaRE7XrSS8EoATWzVrCbscnr3iDS9C1dB9mMhdgCw7V0V+qXlmk68IVzk9hWR4s8MpfXEmoRgSGIZVSOKlt/EFvpXhpbnUo8rgoYxVSd0mgTucfq3inStMvmtoYnuZ8HJ5xVhvF2lpBbAeYJpcbvQe1c1dw2PivWHk0eJrZyCxDdD70zVtBk0/Srd5iJPLbdhe/1rbkW5r0PWNLd054KyD5c+lW2uZ0usFD5R9K8huPiBfxRR/ZYlUREKFbriuh1Dx9qA0Syv7ezVfMYo7Sfd/CsZ0nfQlo9MDhoyeoPSqdwjKpcHgc1n+Gtah1axhaUiOVlztHQ1pyeWWZCx5Xj2rKzvZklKw1iGd2jjI8xeOaL7zLq2ljjk2z5yGFcfNHLpureYBlC55roIS7TKysQcZq5xUbFqHYbpN7LLctb3mVkU4B7Gpde0mCa0nmhiBuYhuBXuamhMMzAzqDL61eTNuwdPmjx0pc9tUTJWZxeg3yeIrSXTdUtnjaJSGdh/Ks7xJoH2EW8NlIqQxry3Y5r0WWKGS2kkjiRZG5yBjJrz7xdqE01k+majGInbiOQdeOla05OUtNhxepy2pGTTb6ObBZAOWXpXa6Rf4a2uInysoG4GuY8KNJqcMulX0YaTou7uB3q3Mp8NwCK/4DMSh9q0kjVWludbcaRFc3b3bYlJ7HoKp6xoaanZ+ZK+0ouF9BV/w9dxzWaTRtmOTjNXNQQrb/ALv8qzu0zPqeaW2mTW12AEbIPBzxXQTLmCNpFUspAOOuaz/EMs8btJEpAA6Cq3hq7kvPMMxKyKfu+ore11ctqx0zXSwxKcHAGTWbpWufaL5owQvzEAirF1f2cREF4ApcYz7Vzs+j3VrcC4sf3kWdwNSlcRteNZX07QnuY3JmY4UjtXGaNqLvZ5uJZDJuOTXc3tuuo6ZEl6hKyJll/un1qnpnhywhttoldgSTk1UFoB6awK7y3Azii3KPEWDZA60XDBVfewAJPJ7VX05lWCYlgV9jXKldXORosPbgi4EblDPjLBicYGOh4H4U6wtmsbVYjKZQOSTTk+aPevSpTny8mjYCORQSGHAJpU701HBXBHQ5p2dyZXjHY1IEpUGMGjyxsx71EFkB9R7VKN4wSCQaAJCCkPyck8Gng4twDwaidh5eQ34VBK8a43vigCUKrPh/umq8tk0CeZbD5e6VLA8TH924J9Kt7JCRgYHfNNFXscLd65dWGpH7RGoUHPFaNp4p0yW4AaUJI/XBrX1bRrfVQxkAEgGARXmXiXwZdaaTcwxtIg5JXPArSMYz0ZcWmtT1yCNXQSQEOh5yDVgEqBXjPhbxhdaNOLaVi0JPzK/JFeoaVr9nq7hYGEUpHKtxWdSm4bkuDWrNA4N2rFOQME1y/izw1dapqcV1azqqgYOe1dfHHlzuHQYPNOEIBJXpUxlyu5Ox574z8IX99ex3GmGOfbGEYSNjcQK67wfY3Wl+HoLe9fdOOoz0rROQMjgU1raSRVdiV2c0Sm2rDd2WS0cSFn6npVZzHIQ+33BrAtdbup9fktplAj7LW/H1ORn0AqXHlYrCsRsHpXlvj2+l/tKB5IFaNDgEivUSVcFUI9PpWfqelWl5F5MsYbP8WK0pSUZalJ2OA8Na+8B229nHbw5yzjvXpunSR3tsJ4yDn0ry3xjZy6XHFHbRDY52/jXf+F9Pl0jTIft11GJZEGEZsYBFaVkrJoqok0mjcQI/CuM9PpUqxMBycr1FZlxNHaWkstv++YcYHQtXnepXvjPUNVAsy8MCjHHTFYxpuepnbueqtuU4A+U96hmj3g7sDPHWvPYNR8Q6JZXF5qjCVQcAPWZb/FWaK7iF9ZR/ZyeWAodGfQpQ6noCTm3ufLb7p7Vp7UlIzyMdK5G+1bTbu/tL2O4xGMHA75rVvr5oWWWz+dGxwKJQcR2NOa0RmBAwKyvFHiaw8L6diVt9w33UDVLPquxC7ZViv3TXnGqT6Zd60o1S3kfLfxg80Qgn8Q+ljsPDPiseKLOb/RmRoup9q6vzLa00eS6kYKkaZbPeqFlp0FpCItNt0iWVQcKO1J4qu9N0fQpIdSdd0sZAXPJqZWbSiTe5R0nxTpd+hgV8JJxz0pninRbPU/D76bHhVzuEnYGvMNN0+K/kzpdwRtOSCcYr07QdKuWt0a7kYKuBtJ+9W0oqGzLceVHM+BPCCaBPcXt7dCSIArgD9a3bbUNG1uOW3HGThVYbd3vV7xDd2Om2qxXDCOOUleO1ctZwWz3qfZoUeJyAkidR9arm53zBFXVzR1LwNo9zpc0MSCO5bpJXOapoEsOjWmnRZuIoxhinOKs6x43jtr9tHgUFWBR5u6nNcvokuv6HrvloZpbeQ/xcqw9RVQcluOxe0m5nh1mLT4UZxFhVIHSu2s/EFk+qnTrksLhe56Zqzo1tENWF81skZYck96z/ABP4dtm1CPVhuGw7vl74qZ2k7BzdDd1Cwt7knKbiMEAVTuUXGUXGABj0qLw/4v0/UWaIskTIduWPWta9tzJErcf7LDoayknezCLcXqYSMY3ZjxzxV9bssArcVSuEMUoikBDU3kPjOR61DN0k9TStrkR5Z2Cx57np707U9P0/V7BlmjWQdQ47H2rJkjjnZ4pG6jpWTaT3+i3yxq5kt2bgGtE01dGTg1qZ3iDQb2IQzaRIUvIO5/jAqG31Kz8SaclnrwMN7GxUv2z613+pwmQo6YUsuTXDt4HGoauspuGWIklwOK1hNP4hGnpehw6dbGGyunkU/MFzwTWjY30gfypVII6g1jxaXeeH72QWjPcWp/hfmtC21m31GYWl0ot7zptPf6Upd0BavIYLl2iZMq/3T71yU/h9Yb7esjxANnav8jXSXD3FnK6KMsPu57VatJotQtylwAJUPUd6qMmtCkrHlXipJ0vpJdpMfAFaWgahJFodzOrYZOFB7muz1HT4Zo5BGitt5IPWuX1myX+yAbWMqQdxA71aatYZf0XUH1iyfDATxrz70y1tLjyzufnNZvguG4W7kkdGRSuMEV1JgnLt5UTMmeCO9U3y6IDr9TtRd291CvJJJU+hrn/C0FyguIbgFUUkDPeukMyrcSKxx83FPZByw5U1yxdlZnKyVFyiqpG1ew71Vv8AU7PT8C7uUBzjaOtLBJ5DIrb/AN6wQFRkjNcxrPhyze6N7f37hSc8cZ9qqKi3qEdWdVFJFcxCW0cSK/PXtVZkuJWbDIm3tnrXITazb6fazW+hLJLcHAX0FXfCFjq9yzT6q7qrHIBPWiULaltI7KMTwxhmKnIqNZpUjIONxNTgopRSxNMdcTgsMhulZmbGx5lOAVVvepf3Afyp0DMRgEVnajbTMjm1Yq49KwotfnhuvLuIzIV+XB61XK3qNRe5q6rp1zF/pFkWbB+6DXD6j4s1tLgwJ5qBTjbtOa7fU726SzF1pw8wKMsvda5yy8U2guXGoQoM/wARXn3rWEU1e1y4trYw7XXPEdyWWOOZsn0rqbDWdatEijvreSWOTghhkV02g3+m3qf6AFJx6frWjOkUx8twMj2qHViulhSlrqjkLvRNC1hvNaD7NP8AxFKtaV4Us9Pl8+3nMjernGK130W3aTfu2t7Uq6WFSRUkZiwwMnoaXO5aNlcyeg0W94SRE5aP1Bq9B9ptoMvhvY1ytlqNxp980bMzgNgqTxXV2Wp216vBxIv8NZyViWie1uUu0bYMOvVD1rnb+41RL8vAxEeeVNa97DKsy3MA+ZfvKO4qwkqSkuI1MmDkelCtHcSPN9Q8S2NjrU00CNJcDAZQe9db4V1+PWoWKDypU6qTzXlFr4Z1G68ZXyOGVGdm39sVp+CNOuLDxikD3SlQxB56jtXRUguW6LSR6Za6fdxaqZvNBgJzgmtl1+YMo6GsrWL8WdrczROriLqF7VU8KeJYdaikjPEq9B61zyjzLmRHK2T+INMGpwtt++h3r9a8I8Sarqlxrtyt7LOJo2CRocgYHpX0jGAB05rD8QeF9P1UBpk8qcHd5qDmrhUilaQ07bnIfDrV9Qaa3sbld8DrkEjJH1r0aRCImA4JxjFUNF0vT9GC+VulkZcB27VqsyNjPGelRVlFv3QbuZ+r6XDqtuIZ+YscjNczrnw7067toxZFUkQYPOQa7JU2s3zZU0RzxZJDfKhwT6VMako7Mak9jzW+0qy03SY7Kd2edDlWUc49K1NY1mLRPD1ldJbvMCwUj8K27y0S51VZ2RfsiglpCK8+8deKrKa2uNIs08yANww65rdN1LFJXNa68daZ9igvTbuWzggdqh8TeL7S90e3ubTRzd3DvtXan3T+Fcx4X8KNrPh2bzZtqB8qB/DXqnhfSV0rRYLGCNZfLbfvK5OcVU4xhq2Kasil8OoPEE73d9rP7lJQPJhY/dFM8eeGBrc8Uguh5yjBUnIFcTrPiHX4vFt4txdukSHaqY2jFP0XxHdQ6lvluRJFuyVY5qVGalz2HGDsdl4X8HW2lwGTzfMkHLMeAa6Z5hbxh0UGIdgc1jX+ojVbZLWMPArDiRTis/XtctfCnh4SSbpZGHlqueT61ElKbuxyT2ZW8cRWviCGEROQY25FZukCLwvpDpNfLLOzZVRyVFUtK8Z2mo6c6GxMDjocfzrNvdX0q1mKG3kmd1JLHotbQ6J7DiW7XwdB4ou5LyzvlS4Ztzpt5Iz2qLWrnV3ufsMKSLFbfud4Xk471Z8FWKadq9nq0l1IIpsqqIeTXoguoPtjtGF/eHpih1OV2ZL3OP0fULiCxjtpS0twh5UjnFcbL411ObX5LW6DC1LmPygDwK9pm0q1klecEC4ccNjmuFXw9Bb+InlvLNnAbImA4/GiMozd0tRpo5PUvCF9ZauDaEhJ8OuD0J5ruNEu5dFht7PWrvdNIcc9BW3I8ZuGwm5VPDf3aw9atbLVMm4nBlhO/KdRUylfdDeu5v6xEZ7ZZI9rPt+VvWucsNTjkna0uQYZx0BHWlsvEkVvPbWb/vIE4Ln1rTvU07WoCbeTbeL8y4HPFRy2+IabWxEVUbiykMeMimtGJ3XfztIK1aCtLpkTD5Zhw1NtkHmBgPrWW2xqp3iaTs8yx7VHAxWLqs13pqpLZwtNvbDKO3vWrYzEyFUOMHtVmUAHIAOOcGmmupz9SnPC91bDyyVYqCV9DXI3vh6fVLd3t2WPUrZ8h+hYV20cUokaRHXnlt38qyfEen3pVL7RpNlzHy8ZP3x6VpTnrZBc4XxF4lvbQQW13bCO+jx5mc/MPWt+0vI9QsUurGN1+XLAnmqWo2r+LLu1mvtPe2nhYeb6MB6VT8TQ6noN6t3pUJlsyPmj9BW1kWmbXhuO7k1edpgfs4G0596brsZsI5pBGXiXooqTQPElrdaf5kUoViQJUbqDXSXUKXCFwFdX5OBwaiUknYGzzrw/4qhu9Sa2YeWCcAYwTXZRu6LgMQPSsAeCrKPUv7QQyCTOdo6LW5KrbvlkQDHfrWja7gp3JPFodpYtu5BjadvrWUviGXTAsMshfjPPXFdN4jdYoUdsYDHjGSa5nXfC0msxRXVlIyuF+70pQ5ZJJmcXG1mb+l+JNOuSqh9sh6BjT/ESpc2ZEa7nHOBXnul+B9V+1tJM5RUIwcmvVbCzWGzjWTDOowSaiyhK6Jlyp3ic54c+xwBYxD5dwTnce9djjA5HBHBrPms7c3MUyQqpXJ49atRyHAVvwqJu7JbuI8Cv8vmjNTwxFfvtk+tRqVdSV+8KmiJK89al6biHMuBleTXN654fiuplmjG2fOSfWukLYz7DNZet3q2sKzMcD0qoTa2CN0zmLa4vdJud0qs0X3SMdRWoR4fvpF+06eSxGcY710Onywanp+fKVlIycjmrEOkWqoP3eH/lT9pbpYqUr6GbYDSNOiM1pDtfHKYPFatjKtxEZwMb+1PEcMOVVFPbkU0L5fAG0HnFYt31JHFRnBPNPLIoxjJxioTJj396bGS3JB5oAiWwtdxZ40Ynp603+zLcNviUq/bFWyyRg7uSfSjd8oYUXa2GiuBcphJcEdgKkaA43DhxyKkdvMBwCG7Ghc+Wcnn1ov1C5znia1uzZT3mnErcxjLAdxXl2jQ3mpayWt5fLuGPc4Kmvc40Uqc4O7gjtXF+L/BpZzqmhZiu05dU4yK6KNW2jLjK+5ieBrLWLLxRdafq6ySW02dxJyCK7Lw1pui2Wp3R0yTNyCdyg8CqHhDX5roS2upYju1QhSw5PHSuF+H91PF4+uIZGdC7tle5560SUveYpbnsd7dR2CiSbiM8c1aba8YORggGsm+1nSZ5TYXc0bS7tuzNaUQWNEUcRjjiuaStuFmVbi3ZpUAb5Ac5qeZ41CAnHbPrUpCu4CMGFESrJncmB05NIRHsDKYycAjNYVpq2l208mmZKsx6t3JrcEaq+SSQP1qjqOi2bxNLBbqLhxw3pVU7bMCv4pglHh2a3s1Lbhxtrw5dHmjumWdWLE+le76NfwMi2UkrNKBg+oNZOveGJbi882yJ2jkkjFbUpKOjLg0tyr4PstO0HTFbULkKJcZTPQmsvxj40vdLvRDpIVLdRlZD/FWB4iZxC0bjEsZxyetYmp3k9xYQh4wSg7c4rX2Sb5macqlqeu6Pa6d4s8MR3V/BG96ynzdp5zXO2ngS2uHZoXmhVT8oasT4URXc+qqInnSHcS+elevStErPGrcAdawlKVP3UzO7WiOHudR0jw9qlpp95dPdXKryigYBx0Nc7deItP8AF+rHSb+yEVorsY2H3sjtTr/wXd3Hi+bUkmWW2Z9zE9V9q1YfCcektdalbp5k6ZdVHvW0Ut29Qvc4zStTtLzUZNKtrFYkBOCOp+tXNf0bTIrq3immleWQjKoMjFP8K6Xfx6y95eacI1fnefevS9E0q3kvnuJ4Iy68LkZxVyko7jb0PNNXsdQ06+geNmGlwAMjAdK3I9ft4tLj1CVJQ5+7nvXYa4iss8U6Rizbrv4H4V5/4ns765SK3s7cfYcfIE6fiai6n0KidTY+LdPfTlubiYrn1Na1rrVndWDXRkBtlXJfPavOfD2j2Vgjv4gZDAOFRj1NbmupaPooTS0jNn2VT+lT7OKdhNamZ4r8S3mrWf2Xw7AvzA7nzgirPgLQH0XS7u614F5bjA5OdorGhS70TQp9QgjEaIu31qPSvGt9Fo0v26JbiKTnLDpVyi4q0QaOy/4RS2TSRICZCJTKhT0PauDk1+70nWGmW3YbG27cY3CvSfBPiWDXNKPlAI0RwyLV27tLK6lLTWaO3ZiKjna92aJu1oM0y7j1HT4rqJRHI6glD3qG+v1skdp4imBjKd6Wa0a3k821Xaq4wo6AelTwXNnqavbyIjyEYKnqKzSuPbVnIw60theGaCQNbO2GHpmu3UQ3dopZN8ci5OO9cL4k8IS2oa40n54ictHnkVt+E7qZNPFvdBlZem6qmk4+6F09joJ9zJ8rYPrXOa1rr6VqNlaBdqTMMsemPWumRf3Zzz3zWB4o0CPXoYonYRujZV/QVnTtsxGzLbDzS4IKkdQfyqnMgEDxn5w3BHoKq6Lpd1pT+RJdtPbgDaGzkVrtEGVvXFU3Z+6NHl2p+HH07UZpNOyLeYZdR65q3pWuXWm3K2lzLmMDC59O1dkYB5h8zBrLv9Jt9RYtPGmUOFZeMfWtlOMtJIZo6dKtxZK4OQwOD61QLFWIPGD3q3pditjN5JmZo1G5VPerM1tDNIZGBBb0qbiNWRUlP7xQeuPzpEQopCDBPenMpJUjoM5/OnBwXwowayTsrGIqq6QqWOHPUClEoHyjv1p0gG7OOagERBJouBMcFh6CnNH5n3TjANRKGXdkk5qjqepWemQq93ciM579T9KdgDSZZBezJIPkz1roY1G35etc/oOtaVq5c6a+Xj/1ntWuJXUb4vmXpSleTuFhxXaSe54rJ8RWgutJm2gMydq19+/n9KBbhQ3yg7+o9aI6DTsYfgneukkSZXkrXTQXHBR87hwD/jWIoksGit0jHku+d1ai4Vy5O5RxRLUT1dx3yC4lUSB2GCcdqSRwBuc+2BSFo4tzkAF+9QMyyEsvI6VAE0KPOckbE/nVmY+S4XAIPpTQTtA7UpznJ60hCxRCXPFQRo6swccjpV6AFRuJ61Hcq2d4J54ouCdyNSF69aUr8pAPWojknGfm9aeHOw7R81MZACw4HUdKf9oZR82SR/nFAIUB5eD0+tSnaIy2M8ZpOwIp3Gk2d7ItwkYjlHO5eDVB/D9rBdy6hbxql+U27x/OtiLCL8ox3okIY7gKpVGlYdzwrUbG6sr+4mvYZHl3F/MHb0Nb3grxjqRvYbW5PnI77R7V1vjqyvZ9HvTYLmSRMAgZIFeY/DrTr6fXDJdRsq2w3MzLgcV1RlGcfeNXqe6fabc3htVcLcgbiAanaIPFtkzkeleS6jrV5/wmaTWyeWshEYY/xCvWzII4oEuJVMzqDgVzVabhr3M3oMChY1QZwtStIjRgITgcGkC8kNTRGqgooAJ54rIDJvNGV70XtliOcdSK0YZJ5bf/AEhvnHGRxUU90sJdF/1oQ4HqazPDerTajLNBOmGj71Vm1caVxmq+GLLUFJRAJSeSTXj2t2lzpviWRIFYIp5TGQa9/aNQw4HWuU8YQOlzHLbQI2Vw7Y71tRqNu0hqVkaOimLTdEtbjaiSSJ91RjmqJnuzOPKfIk7DtUnh+0kuoE/tA4ZTlRntV7U7J9Nsrq708eZcKhZUPQmlJrmsxpk2nRXa2zpc4JPcDFYev65badZytMkj7PeuQ8N/EHxBPr8VnfJG8MjiJhswQT3ru/Ffhe31iCWEhlPQstCjZrmFsc3qXig6tDYx6fEUiYjPtXb2QVIYcMSzKC2fWua8O+C4dLiAlcyhTlPVfrXRS3NrA6xu6xhRyx7UVFFO0dQ30OP+J1lf6vAkNkSYoQWdQcZrC0XWZdL8OR2M9yrXOSFQ8kCtbxP4gXU9NvotIjaR4fleROOK4TwZ4fu9W1xMrIIo3DyO56j0ranFpal3sjcvtF1jxPY28cFuw2yZJbiu88M+EItL03ydQJZu4ByAa6wslsixw8IFAGKz76+t7NPMnlGCOEHWsZVJS0XQz5m9jP8A7E09YZLaY+fFIeIj0rP1HwhaTeVDbxRR24HzR9xU114qtrWznuhbM8qDp61yvh7xbd3+o3N3cW/lQqvyqT+FOLqblWl0N3SPCo0F5DY5w5y1a73qhSpiIYDrio7HV2dMEfM3QVfWS3nhdCB5x4I9DScnLVhZrc4nXdVun0u7NvujZHyePwrn/A91cyX8LpvMhfDsQcYrv5LOBi0d0jjccY7Gs2+i/s50g06IRFz97HStE0lZFbmvPfQRSTMskZCDL4PQ1nyeKvD4mSOS4jEhHUVxWqxtp2j3Utrei7unk3TIp5C56VkWvg3+2lj1O0cJDIfnVuqml7H3bNiaS2O88T+PNO0RoEt/9KEv3ip+6K6LTr+31fT0urKTcjDrjGDXztrlmf8AhI2twGWOFtvPevXfh1q8AsW06eN0EXKt60nT5UDVjtEIk6uN/oetOidSdv4VytjqUuoeKDJaLmyTKsfXFPGqy2mqyWl4CUYko59KjkcdxG3Om8yLjbj3rIukljbqVTGD71R8VT32nwrf6XmRP4lzxj1q1pmqp4j0N5AdjqNrD0NaWsrjTNGOKO6tYpreYOyrg4PNXLV0WEBmwRXm2jajdaBryQMC1tO4U57Zr0aSBGctGBtPIoqLksJ6MfcXm2RtgIXPekj1ER/Mw5q28MZZ/l3EHgDvTRbK0qhoV8ocnPWoVupkJHqcE0gTI3noDxVneey471l6zo4ulD2x2Tr0x3rhNX8R63o2+3u42AU8Nt7VSg5fCUlc9TjO5dy84rjfFngv+15TLBcskrfwsePwql4E8UNrOqGGWTCqgwD3Nd/KAQN0YbH3WJ6Uczg7NCascbZeFX8PeGbuCzk3X138rSDqo9qf4P0DV9PmHn3bvbt1R2JArqLu8S1iUsNxP3V7mrFrcNPbLISwLdj2puo3pYLmSuvWTa0dPG8S5xn3rbgn2ztASAw5AJrFm8OWb6lHfqWE6HP1q3qGnpeXa3BZ0cehqbKwrovXTjzwzDIqC8uzDhQMRnrTkL/dbBIwKy/E2tJpKCa5tDJbouWZRmlGPM7AjVknVlQqFdSOFNSW++SPa8Qi56jpXJ+FvHejarcGLBt2PCh8AZ9K6q81SxhkjhuLqGMuMrlsZqGrO1gszQjGUOOQKa1x5bAlc4qp5kAaPbeQqHGVBcc1OxYDAXdzjIqb3Botx3kcigsOQM1BJdFnIRPl7mq4CAEkEPnkVKidccUWElYFeObKx/K46ilKMM4HI60jRbMyL95envSLqVo7iF5BFP8A3X4z+NAxwXI/ecDtTwQA2ac6bjtU5xyaSMb2J7DqKHsA5MFetEifIT2FLt4OOPSmRls7WOR3qQGQmN4TL94Y4rhPF3j200Kc6dYWAMsgxJKR0rvVh2ZOQR2ArivHXg06zOt5ZLibI3Ct6ai5ascN9Svp9jN4k8PLcSCNJVkEqt7CuH1TVNQGv/bzeSuLeUDb2wPSu90rVG0m4/sq7hVBFDy397iodE0jRtaM94ZCsEchLoe5FbqVr8xrodha6zbDRYb68cRpIMgv61lHxvon2tYBOzZOMquK848ZvqHiK6lh05HbTrVfkRAQBisnw7FZ6hDKt4v2T7Iu5pO5I7VP1dPW4uVHvN5ax3sW6Fgp2na1cFpuoXmias8Eiqcsfmx1rb8JeMtK1Xy7K1Lq0ahQWHBqXxXppe6huFVc57Cs4aPlkTF7o3LKZLuMSAbX/u1FqTp5LQYIkdc9M4zwD+dYtlfSWdygZTsY9a6f/W4ZQo3AAkdSKxmmndCehkmyaOOGSIfvU+9g9apPrnmTtbLIrMh2AA/nXRRWiRho42+/wAfU15V4Y0R5PiHf2r3G5LZzJjJ5rSHvJt9Bx1VzoP8AhFYZddi1OA+W6sGKL0OK7eaXc+QOcc1GipFuRFwBzk1DPeQW80cUzgSScKKhyc1qJXk7I5zVtf8AslybaHeZic8fyrHm0ubWILjzrgxS43bQeRXQa9BY2cU1/L81wvCYHBPauFsBqV39qMMhW4mUrjPBFdFKPVbmq2NHRJ9O0O1lt9OmW4upeJM1P8PRLPrV491lQx+QDpXKeCPDt6fEQW5jeJISWlY9+a9g0+zt7V5JItoHqBTqtRVr6siTKXiPW7TRj5l2TuXIAB6Vwtjr1rqV+FmDlZGyCeldT4p8Mt4jQjzjFJ1RsZrE8N/Dm5stQSfUbneidh3qYRSje400kbM2kqRi2AdCOV9awdV8Gatd4S3eOGAnlU616VHbRW5PlD5T608tzUKtJIn2jOWXRb7TLSyitDFKUGJCw5zUmoRx6fbedczmNnOd3YH0royx3ZrhfijZ3t5YJ9nJZV5KLSi3NgpNvU3Yr7Tv7Ph+0XEWZPusT1qhevFDG0h/extwGHSvOLfSLnV9HS2AIuYnzGpbBPtXf+ErfbpLaZqMqtcRqdyE8r7Vr7Ll1bLtY82sdJvbbxLEIEZ7eWUsSBxg16fHeadp6fZ4YOUOWUcA+tU9FEul381tMPkJzFkZxWV4qntZdQD27Msyfe9CapPndg3OP8V6Q83iGTU7IMVkbcUUdDXUeBIb+41GcX1osNoke0ylcYrU0m4itNOn1B7Pz5I/ug55NclrnxF1G+jurFbZIFP3scECqcm1yJDbvoelaDp0Om2svkzLIrOSNpzis/xDZwz2rOVyVPOPSvOPBfimTSJd94zmEnHJzXqdheWut2gms2EkbDkGsZc0XqS9DM0DUNOezFuzZw23Yx61Q1bS7jRJ5L7RlUwPzJC3f3rYfwxYpcrcRDy5QckDoav72LCA7WyOhpqSvdE3PNdWjuvEgs59Gx58bAyqeor0nTIp0sYVvtpuAoDcVwHiyxk0TUBqehzCKTOZIATzWnpvxI024tEe9iliuOjqAetVNNrQp6nbEkXQIJB4q9j5wMnGSKKKwZmCkhNw6imz20F9H5V3EkqsOdwoop03aREzgfE/hnTtL1BLrTlkt5f9hsCtzwzezzWI81y+DgZoorqr7IuOxpSqJbgFxnb09qu2J3B14AU4GKKK5XsOxYX5WGD19assgEe7vRRUIhrUYyBcMOpqrqsaz2TxyKGRxhlI4NFFXF6otHmWoeGtMtL6KWGEh2Oc56fSqnj2wguI7WZwwkjQAFWxRRXZu9TRGd8PdPXUNaX7VcXLrERtXfxXvUfyx7V4C8CiisK2hmxygHBKjOKcjYcKAMGiiuYQ/qwz2BNZus2Nvf2sgnQZVSysvBBHNFFNAY/w+1W6uZp7K5cSxw8I7fex9a6u6URXCqnAPJooqZfEA3q6DsTS4H3u9FFICNztAx64p0Zzk9CDjiiipkBl6ho9ldaglxNEDL0yO4rGv9JtdPtrxbVWRW+YjPeiiuym3ZFo4ew1W602SaO2YbJDhgwzXVeJtKsovD8E0VuiPOvmSbR1NFFW37xZifDSCOH+1nVFJTBXI6V6DYsb/Sy1wckZwR2oorGp8ZHUositZNuAJU8Gt2w6qvbaKKKnoJjtRJhs7qZCQ6Rll9jXi/wlvJ7n4iXEk0jM0xbf780UU6ezHHY9wliXc55rkvF0Spe28wzvUcZ7UUVnEuj8RyXiW/uG0aSNn3LuyM9sVRlnkg0uK/iYrOsYIx060UV1LYvud34GvJNX0aSa8CGT7pKjGR71u6hGsVgxQYwKKK45fEYy3Ob8KalczX00Uj5jDYArsmjGAcn86KKctxMYyADqaDEvllsnIoooJGbBvUZOCM0k8CMjqwyMd6KKQ47niPi+WWy8SStbSuhjb5cHGK1/B4N5qazzsxllPztnrRRXVL4TZ7HoOu2sKJEwX5lAAPeua1fS7X7fpx2H982H96KKim9RIkM7LrkmnIqraoRhQK474oabbQXaXUUYWV+DjpRRW9N+8BhG2i/4ROW52AyhgAT2q18N724t750SQlCNxU9M0UVrUEz1iCZrmwSZwA5PO2sTxbM+nW8d7asVnAxk9KKK40SSzaPaatp0Vxdo3mum4lTitLRfC2j/AGBN1nGxzyW5JoorZN8pR//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hematoxylin and eosin, 164x. Note the complex pathosis with infiltration of multiple inflammatory cell types into the substantia propria of the conjunctiva, and a \"microangiopathy\", with clustering of lymphocytes and plasma cells around the vasculature.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13972=[""].join("\n");
var outline_f13_41_13972=null;
var title_f13_41_13973="Rivaroxaban: Patient drug information";
var content_f13_41_13973=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Rivaroxaban: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=see_link\">",
"     see \"Rivaroxaban: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13107816\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xarelto&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F6724104\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Xarelto&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017257\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700437",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       People who have had recent spinal anesthesia, epidurals, or spinal taps are more likely to have bleeding problems when started on this drug. This bleeding rarely happens, but can be very bad. Tell your doctor if you have had any spinal care. Do not take any other blood-thinner drugs including nonsteroidal anti-inflammatory drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3560789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have atrial fibrillation and are taking this drug to keep you from getting a stroke,",
"       <b>",
"        do not stop taking this drug without talking to your doctor.",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to thin the blood so that clots will not form.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691756",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat blood clots.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702884",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to rivaroxaban or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703718",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701034",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to milk, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017263\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bleeding problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698653",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fall or crash when you hit your head. Talk with your doctor even if you feel fine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3854133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking less than 15 mg a day, take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3854134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking 15 mg or more a day, take with food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose, brand, or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s4031444",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         15 mg twice daily dosing:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4031442",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take missed dose right away to make sure you get 30 mg in one day. You may take 2 tablets at the same time. Then go back to your normal times the next day.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12198 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-FB51BAF4EE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13973=[""].join("\n");
var outline_f13_41_13973=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13107816\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6724104\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017257\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017259\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017258\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017263\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017264\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017266\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017261\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017262\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017267\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017268\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?5/16/5384?source=related_link\">",
"      Rivaroxaban: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_41_13974="Nonsustained VT in the absence of apparent structural heart disease";
var content_f13_41_13974=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nonsustained VT in the absence of apparent structural heart disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13974/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13974/contributors\">",
"     Robert Phang, MD, FACC, FHRS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13974/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13974/contributors\">",
"     Samuel L&eacute;vy, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13974/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13974/contributors\">",
"     Brian C Downey, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/41/13974/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonsustained ventricular tachycardia (NSVT), defined as three or more consecutive ventricular beats at a rate of greater than 100",
"    <span class=\"nowrap\">",
"     beats/min",
"    </span>",
"    with a duration of less than 30 seconds (",
"    <a class=\"graphic graphic_waveform graphicRef73299 \" href=\"UTD.htm?1/3/1080\">",
"     waveform 1",
"    </a>",
"    ), is a relatively common clinical problem [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/1\">",
"     1",
"    </a>",
"    ]. It is often asymptomatic and typically diagnosed during cardiac monitoring (eg, ambulatory monitoring or inpatient telemetry) or an exercise test performed for other reasons.",
"   </p>",
"   <p>",
"    The major challenge to the clinician is to determine if the NSVT is relatively benign or indicative of an increased risk of sudden cardiac death. A major determinant of prognosis in patients with NSVT is the presence or absence of underlying structural heart disease as diagnosed using other modalities (eg, echocardiography, exercise stress testing, cardiac computed tomography or magnetic resonance imaging).",
"   </p>",
"   <p>",
"    This topic will discuss NSVT in patients without apparent structural heart disease. NSVT occurring in patients with different forms of heart disease, as well as sustained VT in patients without apparent structural heart disease, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39702?source=see_link\">",
"     \"Prognosis of nonsustained VT in the presence of structural heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=see_link\">",
"     \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of NSVT in the general population varies between 0 and 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/2\">",
"     2",
"    </a>",
"    ]. It is more common with increasing age and occurs equally among men and women. These incidence figures are drawn from studies using prolonged recordings in relatively small numbers of normal subjects. It is likely, however, that a single 24-hour recording significantly underestimates the true frequency of this often asymptomatic and intermittent arrhythmia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1048006\">",
"    <span class=\"h1\">",
"     SYNDROMES WITH FREQUENT NSVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several syndromes associated with frequent episodes of NSVT in the absence of structural heart disease, including repetitive monomorphic VT, idiopathic left ventricular tachycardia, and nonsustained polymorphic VT. These conditions are discussed in detail elsewhere but will be briefly reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1048013\">",
"    <span class=\"h2\">",
"     Repetitive monomorphic ventricular tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients have frequent and repetitive episodes of nonsustained and occasionally sustained VT. The arrhythmias are usually monomorphic, most arise from the right ventricular outflow tract (RVOT), and their frequency and duration can be affected by both exercise and autonomic manipulation. Sixty to 80 percent of patients with idiopathic VT have VT originating from the RVOT [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/3\">",
"     3",
"    </a>",
"    ]. The prognosis of repetitive monomorphic VT is almost uniformly good, although sudden death can rarely occur. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link&amp;anchor=H9#H9\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\", section on 'Repetitive monomorphic VT'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1048020\">",
"    <span class=\"h2\">",
"     Idiopathic left ventricular tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other patients who have idiopathic VT originating from the left ventricle that is sensitive to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    are said to have idiopathic left ventricular tachycardia (also known as Belhassen VT or verapamil-responsive VT). This VT is less frequently associated with exercise and also rarely results in sudden cardiac death, although tachycardia-induced cardiomyopathy has been reported in persons with frequent or sustained episodes of VT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=see_link&amp;anchor=H22#H22\">",
"     \"Monomorphic ventricular tachycardia in the absence of apparent structural heart disease\", section on 'Idiopathic left ventricular tachycardia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1048027\">",
"    <span class=\"h2\">",
"     Nonsustained polymorphic ventricular tachycardia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymorphic VT in the absence of structural heart disease occurs in two settings: with a prolonged QT interval in acquired or inherited long QT syndrome in which torsades de pointes, a form of polymorphic VT, is seen; and with a normal QT interval in usually familial disease, which is also called catecholaminergic polymorphic VT. In comparison with the generally good prognosis associated with idiopathic monomorphic VT, polymorphic VT is associated with an increased risk of sudden death. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=see_link\">",
"     \"Prognosis and management of congenital long QT syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=see_link\">",
"     \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3791470\">",
"    <span class=\"h2\">",
"     Arrhythmogenic right ventricular cardiomyopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular arrhythmias, including NSVT, are common in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). While many patients with ARVC have structural cardiac abnormalities that are evident on cardiac imaging, it is possible to diagnose ARVC with the apparent absence of structural heart disease by means of genetic testing or endomyocardial biopsy. The clinical manifestations and approach to diagnosing ARVC are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3791500\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms related to NSVT, as with any tachyarrhythmia, are dependent on the ventricular rate and duration of the arrhythmia as well as the presence or absence of other comorbid conditions (ie, heart failure, obstructive coronary heart disease, cerebrovascular disease). By definition, NSVT is self-limiting, lasting less than 30 seconds. As such, patients with NSVT are less likely to develop symptoms than those with sustained VT, and most patients with NSVT are asymptomatic. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43144?source=see_link&amp;anchor=H3#H3\">",
"     \"Sustained monomorphic ventricular tachycardia: Diagnosis and evaluation\", section on 'Symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, patients with NSVT can develop symptoms of palpitations",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lightheadedness. On rare occasions, syncope may occur if NSVT is very rapid and results in a significant drop in cardiac output. Because of its self-limited duration of less than 30 seconds, NSVT does not usually result in angina or dyspnea, as can sometimes be seen with sustained VT. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20665?source=see_link\">",
"     \"Overview of palpitations in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=see_link&amp;anchor=H5#H5\">",
"     \"Pathogenesis and etiology of syncope\", section on 'Cardiac arrhythmias'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1047907\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;NSVT is typically diagnosed during cardiac monitoring (eg, ambulatory monitoring or inpatient telemetry) or an exercise test performed for other reasons. Once NSVT has been identified, it is important to determine the presence or absence of any associated structural heart disease. In asymptomatic patients, the evaluation for prognostically significant structural heart disease should include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thorough history, including pertinent family history, and physical examination",
"     </li>",
"     <li>",
"      12-lead electrocardiogram",
"     </li>",
"     <li>",
"      Transthoracic echocardiography",
"     </li>",
"     <li>",
"      Exercise stress testing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients who present with syncope felt to be related to ventricular arrhythmia, or those with a strongly positive family history suggesting an inherited cardiomyopathy (eg, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), there may be a role for additional testing. This testing may include genetic testing for specific mutations as well as advanced non-invasive imaging with cardiac computed tomography or magnetic resonance imaging. The diagnostic approach in such patients is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=see_link\">",
"     \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=see_link\">",
"     \"Clinical utility of cardiovascular magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prolonged palpitations, syncope, or presyncope suggest that there may be a coexistent sustained ventricular arrhythmia. Ambulatory event recorders are valuable in this setting. In addition, electrophysiologic studies can be used to provoke sustained arrhythmias that may produce symptoms mimicking the spontaneous arrhythmia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36361?source=see_link\">",
"     \"Ambulatory monitoring in the assessment of cardiac arrhythmias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3097?source=see_link\">",
"     \"Invasive cardiac electrophysiology studies: Tachyarrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1048092\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with NSVT who are asymptomatic and have no evidence of structural heart disease, we suggest no specific medical therapy. However, drug therapy may be required in patients with disabling symptoms. We generally begin with a &szlig;-blocker unless there is a contraindication (eg, uncontrolled asthma), in which case we will try a calcium channel blocker, usually",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"     verapamil",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"     diltiazem",
"    </a>",
"    . If the arrhythmia persists despite treatment with these drugs, the therapeutic options include more potent antiarrhythmic medications or to perform catheter-based ablative therapy. The management of NSVT, including antiarrhythmic drugs and catheter ablation, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22952?source=see_link\">",
"     \"Management of nonsustained ventricular tachycardia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13129?source=see_link\">",
"     \"Catheter ablation for ventricular arrhythmias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with nonsustained polymorphic VT may have a worse prognosis, and management can be quite complex. Such patients should be referred to an electrophysiologist or cardiologist with experience and expertise in treating this specific arrhythmia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=see_link\">",
"     \"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis of NSVT is dependent upon the presence or absence of structural heart disease, with a generally benign prognosis in those without apparent structural heart disease. The prognostic significance of NSVT in the absence of apparent heart disease has been studied by many investigators [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/2,4-6\">",
"     2,4-6",
"    </a>",
"    ]. The results obtained have varied with the rigor with which underlying heart disease was excluded.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The large, long-term Busselton and Framingham community studies suggested that complex ventricular ectopy and NSVT were associated with an approximately threefold increase in risk of subsequently developing heart disease including angina pectoris, myocardial infarction, and congestive heart failure, but neither study used exercise stress testing to evaluate for coronary artery disease [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/5,6\">",
"       5,6",
"      </a>",
"      ]. A similar limitation was present in the large Multiple Risk Factor Intervention Trial (MRFIT) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The results were different in two smaller studies in which exercise testing, echocardiography and, when indicated, coronary arteriography were used to exclude significant structural heart disease [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/4,8\">",
"       4,8",
"      </a>",
"      ]. These studies followed 118 patients for an average of four years. Only two (1.7 percent) cardiac events were observed, an event rate",
"      <strong>",
"       lower",
"      </strong>",
"      than that in an age-matched population in the United States. The Baltimore Longitudinal Study of Aging, in which patients aged 60 to 85 were screened for cardiovascular disease and followed for 10 years, found that NSVT did not predict a coronary event in this population [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings suggest that a thorough search for organic heart disease is important and that NSVT in the absence of structural heart disease is generally benign. The prognosis of NSVT in persons with underlying structural heart disease is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39702?source=see_link\">",
"     \"Prognosis of nonsustained VT in the presence of structural heart disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Exercise-induced NSVT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 1 to 1.5 percent of subjects without obvious evidence of heart disease develop NSVT during exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/10-13\">",
"     10-13",
"    </a>",
"    ]. The prognostic significance of exercise-induced NSVT was investigated in 1390 asymptomatic airmen who underwent exercise treadmill testing to screen for latent coronary artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/12\">",
"     12",
"    </a>",
"    ]. NSVT, defined as three or more consecutive premature ventricular complexes, was found in 1.2 percent. In the absence of ischemic ST-segment changes, exercise-induced NSVT was not associated with an increased incidence of angina pectoris, myocardial infarction, or sudden death over more than six years of follow-up.",
"   </p>",
"   <p>",
"    Similar findings have been noted in other studies of patients referred for clinically-indicated stress testing (rather than screening), suggesting that the occurrence of NSVT during exercise in patients without apparent heart disease does not affect prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13974/abstract/11,13,14\">",
"     11,13,14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nonsustained ventricular tachycardia (NSVT), defined as three or more consecutive ventricular beats at a rate of greater than 100",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      with a duration of less than 30 seconds (",
"      <a class=\"graphic graphic_waveform graphicRef73299 \" href=\"UTD.htm?1/3/1080\">",
"       waveform 1",
"      </a>",
"      ), is a relatively common clinical problem that occurs in up to 4 percent of the population. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      NSVT is typically diagnosed during cardiac monitoring (eg, ambulatory monitoring or inpatient telemetry) or during exercise stress testing. (See",
"      <a class=\"local\" href=\"#H1047907\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once NSVT has been diagnosed, it is important to determine the presence or absence of any associated structural heart disease. A thorough history and physical examination, 12-lead electrocardiogram, transthoracic echocardiography, and exercise stress testing is generally sufficient to exclude prognostically significant structural heart disease in asymptomatic patients. (See",
"      <a class=\"local\" href=\"#H1047907\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients who present with syncope felt to be related to NSVT, or those with a strongly positive family history suggesting an inherited cardiomyopathy (eg, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy), there may be a role for additional testing, including genetic testing for specific mutations as well as advanced non-invasive imaging with cardiac computed tomography or magnetic resonance imaging. (See",
"      <a class=\"local\" href=\"#H1047907\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with NSVT who are asymptomatic and have no evidence of structural heart disease, we suggest no specific medical therapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). However, for patients with disabling symptoms, we generally use a &szlig;-blocker unless there is a contraindication (eg, uncontrolled asthma), in which case we will try a calcium channel blocker, usually",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/18/9514?source=see_link\">",
"       verapamil",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/16/12554?source=see_link\">",
"       diltiazem",
"      </a>",
"      . If the arrhythmia persists despite treatment with these drugs, the therapeutic options include more potent antiarrhythmic medications or to perform catheter-based ablative therapy. (See",
"      <a class=\"local\" href=\"#H1048092\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22952?source=see_link&amp;anchor=H16#H16\">",
"       \"Management of nonsustained ventricular tachycardia\", section on 'Summary and Recommendations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In contrast to persons with underlying structural heart disease, the prognosis of NSVT is generally benign in those without apparent structural heart disease. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Prognosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39702?source=see_link\">",
"       \"Prognosis of nonsustained VT in the presence of structural heart disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/1\">",
"      American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology), Buxton AE, Calkins H, et al. ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). Circulation 2006; 114:2534.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/2\">",
"      Kinder C, Tamburro P, Kopp D, et al. The clinical significance of nonsustained ventricular tachycardia: current perspectives. Pacing Clin Electrophysiol 1994; 17:637.",
"     </a>",
"    </li>",
"    <li>",
"     Lerman B, Stein, K, Markowitz S, et al. Ventricular tachycardia in patients with structurally normal hearts. In: Cardiac Electrophysiology: From Cell to Bedside, 4th ed, 2004. p.668.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/4\">",
"      Kennedy HL, Whitlock JA, Sprague MK, et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985; 312:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/5\">",
"      Cullen K, Stenhouse NS, Wearne KL, Cumpston GN. Electrocardiograms and 13 year cardiovascular mortality in Busselton study. Br Heart J 1982; 47:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/6\">",
"      Bikkina M, Larson MG, Levy D. Prognostic implications of asymptomatic ventricular arrhythmias: the Framingham Heart Study. Ann Intern Med 1992; 117:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/7\">",
"      Abdalla IS, Prineas RJ, Neaton JD, et al. Relation between ventricular premature complexes and sudden cardiac death in apparently healthy men. Am J Cardiol 1987; 60:1036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/8\">",
"      Montague TJ, McPherson DD, MacKenzie BR, et al. Frequent ventricular ectopic activity without underlying cardiac disease: analysis of 45 subjects. Am J Cardiol 1983; 52:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/9\">",
"      Fleg JL, Kennedy HL. Long-term prognostic significance of ambulatory electrocardiographic findings in apparently healthy subjects greater than or equal to 60 years of age. Am J Cardiol 1992; 70:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/10\">",
"      McHenry PL, Fisch C, Jordan JW, Corya BR. Cardiac arrhythmias observed during maximal treadmill exercise testing in clinically normal men. Am J Cardiol 1972; 29:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/11\">",
"      Fleg JL, Lakatta EG. Prevalence and prognosis of exercise-induced nonsustained ventricular tachycardia in apparently healthy volunteers. Am J Cardiol 1984; 54:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/12\">",
"      Froelicher VF Jr, Thomas MM, Pillow C, Lancaster MC. Epidemiologic study of asymptomatic men screened by maximal treadmill testing for latent coronary artery disease. Am J Cardiol 1974; 34:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/13\">",
"      Yang JC, Wesley RC Jr, Froelicher VF. Ventricular tachycardia during routine treadmill testing. Risk and prognosis. Arch Intern Med 1991; 151:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13974/abstract/14\">",
"      Lin D, Callans DJ. Nonsustained VT during exercise testing: causes and work-up. Am Coll Cardiol Curr J Rev 2003; Nov-Dec:57.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 933 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-6A12EA632A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13974=[""].join("\n");
var outline_f13_41_13974=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1048006\">",
"      SYNDROMES WITH FREQUENT NSVT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1048013\">",
"      Repetitive monomorphic ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1048020\">",
"      Idiopathic left ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1048027\">",
"      Nonsustained polymorphic ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3791470\">",
"      Arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3791500\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1047907\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1048092\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Exercise-induced NSVT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/933\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/933|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?1/3/1080\" title=\"waveform 1\">",
"      ECG nonsustained ventricular tachycardia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/32/36361?source=related_link\">",
"      Ambulatory monitoring in the assessment of cardiac arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/48/37641?source=related_link\">",
"      Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/52/13129?source=related_link\">",
"      Catheter ablation for ventricular arrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=related_link\">",
"      Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/3/34874?source=related_link\">",
"      Clinical utility of cardiovascular magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/1/3097?source=related_link\">",
"      Invasive cardiac electrophysiology studies: Tachyarrhythmias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/26/22952?source=related_link\">",
"      Management of nonsustained ventricular tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/14/26858?source=related_link\">",
"      Monomorphic ventricular tachycardia in the absence of apparent structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20665?source=related_link\">",
"      Overview of palpitations in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/9/5272?source=related_link\">",
"      Pathogenesis and etiology of syncope",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/3/26682?source=related_link\">",
"      Prognosis and management of congenital long QT syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39702?source=related_link\">",
"      Prognosis of nonsustained VT in the presence of structural heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/8/43144?source=related_link\">",
"      Sustained monomorphic ventricular tachycardia: Diagnosis and evaluation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_41_13975="Diagnosis and management of chronic radiation enteritis";
var content_f13_41_13975=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnosis and management of chronic radiation enteritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13975/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13975/contributors\">",
"     Ingram Roberts, MD, MBA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13975/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13975/contributors\">",
"     J Thomas LaMont, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13975/contributors\">",
"     Christopher G Willett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13975/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13975/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/41/13975/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to the intestines can occur following radiation therapy for cancer. It can affect both the large and small intestine, is often progressive, and may lead to a variety of clinical consequences (such as diarrhea, nausea, weight loss, abdominal pain, intestinal obstruction, and perforation) depending upon the extent of the injury. It usually develops six or more months after radiation therapy. This contrasts with the timing of acute radiation enteritis (characterized by diarrhea and abdominal pain), which develops during or shortly after radiation therapy and resolves within two to six weeks after completion of treatment.",
"   </p>",
"   <p>",
"    Chronic radiation enteritis is due to an obliterative arteritis that leads to intestinal ischemia, which can result in stricture, ulceration, fibrosis, and occasionally fistula formation. The physiologic consequences can include altered intestinal transit, reduced bile acid absorption, increased intestinal permeability, bacterial overgrowth and lactose malabsorption. Clinical manifestations may include nausea, vomiting, lactose intolerance, obstructive symptoms, diarrhea, weight loss, malnutrition, and bleeding (usually in patients with colonic involvement).",
"   </p>",
"   <p>",
"    This topic review will focus on the diagnosis and management of chronic radiation injury to the small intestines and proximal colon. The pathogenesis, clinical manifestations, and risk factors associated with radiation enteritis, along with the prevention and treatment of chronic radiation proctitis, are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=see_link&amp;anchor=H14#H14\">",
"     \"Gastrointestinal toxicity of radiation therapy\", section on 'Radiation enteritis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25049?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of radiation proctitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis is usually established by suggestive radiologic findings in patients with compatible clinical features who have a history of prior radiation exposure. The patient's previous radiation treatment record should be reviewed to determine the total dose and distribution of the radiation field. This may help to determine which intestinal segments may have received excessive radiation exposure, information that can be correlated with the radiologic findings and the clinical presentation.",
"   </p>",
"   <p>",
"    We usually obtain an abdominal CT scan followed by an upper gastrointestinal series with small bowel follow through in patients with suspected small bowel disease. Additional imaging is reserved for patients in whom the diagnosis remains unclear. We generally perform a colonoscopy in patients with suspected colonic involvement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Upper gastrointestinal series",
"    </span>",
"    &nbsp;&mdash;&nbsp;An upper gastrointestinal series with small bowel follow-through is a useful initial test for evaluating the extent of disease although it is not as sensitive as enteroclysis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Enteroclysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteroclysis involves the instillation of contrast material (usually administered through a nasoenteric tube) into the small bowel using a pump (making it considerably less comfortable than a standard small bowel follow-through). It provides more detailed visualization of the small bowel compared with a standard upper gastrointestinal series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Suggestive findings include submucosal thickening, single or multiple stenoses, adhesions, and sinus or fistula formation. Its sensitivity and specificity for radiation enteritis have not been well-defined.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Computed tomography may show thickening of bowel segments, but the findings are nonspecific. CT may be helpful in narrowing the differential diagnosis, particularly in distinguishing strictures due to radiation enteritis from those arising from abdominal metastases or a local recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/4-7\">",
"     4-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT enteroclysis (in which a CT is performed after instilling contrast into the intestine using a nasoenteric tube) produces superior bowel opacification compared with conventional CT, and may therefore be useful for identifying low-grade or intermittent obstruction (reported sensitivity and specificity of approximately 88 and 82 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. However, the technique is still used only in a few specialized centers. Similarly, other improvements in CT imaging of the small bowel (such as three-dimensional imaging) will likely also have a role in diagnosis of radiation enteritis but are not yet widely available [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Magnetic resonance enteroclysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance enteroclysis permits visualization of the small bowel using similar principles as described above for CT enteroclysis. Initial studies suggest the results are comparable to (and possibly more sensitive than) CT enteroclysis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/11\">",
"     11",
"    </a>",
"    ]. However, only small numbers of patients have been studied and the technique is not yet widely available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Enteroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteroscopy (peroral endoscopy of the small bowel using specialized endoscopes) has a limited role in the diagnosis of radiation enteritis although it may help to narrow the differential diagnosis. Enteroclysis can be performed following enteroscopy by leaving a tube inserted in the intestine upon withdrawal of the enteroscope [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Capsule endoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is little published experience with capsule endoscopy specifically for diagnosing radiation enteritis, although there is some clinical experience (",
"    <a class=\"graphic graphic_picture graphicRef75475 \" href=\"UTD.htm?27/32/28174\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef53206 \" href=\"UTD.htm?38/30/39406\">",
"     picture 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/13\">",
"     13",
"    </a>",
"    ]. However, it should probably not be performed in patients in whom there is a strong clinical suspicion for radiation enteritis because the capsule may become lodged in a strictured segment, requiring surgical removal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17178?source=see_link\">",
"     \"Wireless video capsule endoscopy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Colonoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colonoscopy is helpful in evaluating colonic involvement and can also visualize the terminal ileum. Mucosal features consistent with radiation injury include pallor with friability and telangiectasias, which can be multiple, large, and serpiginous; these changes tend to be continuous. Although mucosal biopsies are not diagnostic, they can help to exclude other causes of proctitis such as infection or inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of chronic radiation enteritis is broad. Other diagnostic possibilities include post-surgical adhesions, malabsorption syndromes, abdominal metastases, lymphoma, Crohn's disease, infectious, ischemic or ulcerative colitis, and intestinal pseudo-obstruction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     MEDICAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention is the key to avoiding chronic radiation enteritis. Once established, treatment should be as conservative as possible focusing on relief of symptoms. Experience with specific medical treatments has been derived largely from small clinical trials and case series. Approaches used to treat small bowel disease will be summarized below while specific treatments aimed at radiation proctitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25049?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of radiation proctitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Dietary recommendations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There does not appear to be a clear-cut diet that reliably alleviates symptoms. A high fiber diet should probably not be recommended specifically since it may worsen diarrhea and urgency [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/15\">",
"     15",
"    </a>",
"    ]. Some patients develop lactose intolerance, which may be due to bacterial overgrowth, and may improve following antibiotic treatment (see below). Others may require avoidance of lactose. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/32/5641?source=see_link\">",
"     \"Lactose intolerance\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Antidiarrheal agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Judicious use of antidiarrheal agents (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"     loperamide",
"    </a>",
"    ) can help improve diarrhea, although it should not be used in patients with suspected small or large bowel obstruction. The efficacy of loperamide was evaluated in a crossover trial involving 18 patients with diarrhea due to radiation enteritis who were randomly assigned to loperamide or placebo for 14 days separated by a 14 day washout period [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/16\">",
"     16",
"    </a>",
"    ]. Loperamide was associated with a significant reduction in the frequency of bowel movements, slower intestinal transit, and improvement in the absorption of bile acids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics may reduce symptoms in patients in whom bacterial overgrowth has developed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=see_link\">",
"     \"Clinical manifestations and diagnosis of small intestinal bacterial overgrowth\"",
"    </a>",
"    .) Specific testing for bacterial overgrowth is preferable to empiric therapy. A major drawback to empiric therapy is that treatment may require more than one antibiotic, and repeated and sometimes cyclic treatment. Because antibiotics may be associated with adverse effects, some of which may mimic symptoms of bacterial overgrowth (such as diarrhea and abdominal discomfort), establishing a firm diagnosis is important. This can usually be accomplished with a breath test. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=see_link\">",
"     \"Treatment of small intestinal bacterial overgrowth\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     5-ASA drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A case report (published nearly three decades ago) suggested a possible benefit from",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    with or without oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/17\">",
"     17",
"    </a>",
"    ]. There is no large published experience with either of these drugs. Discordant results have been obtained from controlled clinical trials evaluating mesalazine or sulfasalazine in the prevention of acute radiation enteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Hyperbaric oxygen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperbaric oxygen (HBO) has been used for treatment of refractory foot ulcers in diabetes and in other conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/21\">",
"     21",
"    </a>",
"    ]. The theoretical benefit of hyperbaric oxygen therapy (HBO) may be via inhibition of bacterial growth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/22\">",
"     22",
"    </a>",
"    ], preservation of marginally perfused tissue, and inhibition of toxin production [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A benefit in chronic radiation enteritis was suggested in a case report of a patient in whom 20 treatments over a one month period brought about objective improvements in symptoms and absorption of D-xylose [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/24\">",
"     24",
"    </a>",
"    ]. However, this anecdote did not give the results of long-term follow-up. HBO was noted to be useful in treating an additional patient with severe hypomagnesemia secondary to radiation enteritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/25\">",
"     25",
"    </a>",
"    ]. Other reports have also suggested a benefit for patients with chronic radiation proctitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25049?source=see_link\">",
"     \"Clinical features, diagnosis, and treatment of radiation proctitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The equipment needed for hyperbaric oxygen treatment is expensive and not widely available. Thus, at the present time, it is not a practical means of treating chronic radiation enteritis outside of centers specializing in this approach, particularly since its effectiveness has not been well-studied. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=see_link\">",
"     \"Hyperbaric oxygen therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Parenteral nutrition",
"    </span>",
"    &nbsp;&mdash;&nbsp;A mainstay of the medical therapy of severe chronic radiation enteritis has been",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    (TPN), the success of which is similar for other intestinal disorders requiring TPN [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. One of the largest series included 54 patients who required home TPN mostly because of intestinal obstruction (27 patients), short bowel syndrome (17 patients), malabsorption (five patients), fistula formation (three patients), and dysmotility (two patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/27\">",
"     27",
"    </a>",
"    ]. TPN was initiated a median of 20 months after radiation therapy and was administered for a median of 20 months. Cumulative 5-year survival was 64 percent. Most early deaths were due to recurrent cancer. Similar survival estimates were reached in other series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/30\">",
"     30",
"    </a>",
"    ]. In another study, 30 patients with radiation enteritis were initially treated by either surgery (17 patients) or home TPN (13 patients). Nutritional autonomy and five-year survival were 100 and 90 percent, respectively, in the home TPN group versus 59 and 68 percent, respectively, in the surgically treated group [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery for radiation enteritis should be avoided if possible because of several inherent difficulties in operating on patients with chronic radiation injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diffuse fibrosis and adhesions between bowel loops can make resection technically challenging.",
"     </li>",
"     <li>",
"      The risk of a leak is high when creating an anastomosis between irradiated tissues [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/32\">",
"       32",
"      </a>",
"      ]. Furthermore, it can be difficult to distinguish healthy tissue for irradiated tissue by gross inspection alone; intraoperative endoscopy may be helpful in this setting, but experienced is limited [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Extensive resection may be required, potentially leading to short bowel syndrome.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Primary intestinal strictures and colorectal anastomotic strictures have a higher chance of successful treatment with surgery as opposed to patients with diffuse severe radiation enteritis, which necessitates permanent diversion ostomy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite attempts at conservative management, approximately one-third of patients progress to the point where surgery is required [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/35\">",
"     35",
"    </a>",
"    ]. Most surgical series of patients treated for radiation enteritis are small; the most common indications for surgery have been persistent ileus, intestinal fistulization, and massive adhesions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/32,36\">",
"     32,36",
"    </a>",
"    ]. Surgical mortality rates are as high as 10 to 22 percent and many patients require more than one laparotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/32,35-37\">",
"     32,35-37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An illustrative series focused on 109 patients who underwent surgery during a 10 year period [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/35\">",
"     35",
"    </a>",
"    ]. Five patients died postoperatively (all of whom had undergone resection) while 33 (30 percent) had postoperative complications. Complications were more likely in patients who underwent emergency surgery. Repeat surgery was required in 40 percent of patients during a 40 month follow-up period. Overall survival in patients without a cancer recurrence was 85 percent at year one, and 69 percent at year five.",
"   </p>",
"   <p>",
"    Strictureplasty may offer a less invasive approach to the management of strictures, but experience is limited [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/38\">",
"     38",
"    </a>",
"    ]. The role of small bowel transplantation in this setting is still being determined; its role, if any, will probably be only in children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/39\">",
"     39",
"    </a>",
"    ]. The American Gastroenterological Association (AGA) guideline for short bowel syndrome and intestinal transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13975/abstract/40\">",
"     40",
"    </a>",
"    ], as well as other AGA guidelines, can be accessed through the AGA web site at",
"    <a class=\"external\" href=\"file://www.gastro.org/practice/medical-position-statements\">",
"     www.gastro.org/practice/medical-position-statements",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21488992\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prognosis is variable since the disease is progressive. Early mortality is usually due to cancer recurrence. Five-year survival is approximately 70 percent in those without cancer recurrence, although many patients continue to have troubling digestive symptoms for the remainder of their lives.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Chronic radiation enteritis may lead to a variety of clinical consequences (such as diarrhea, nausea, weight loss, abdominal pain, intestinal obstruction and perforation) depending upon the extent of the injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=see_link&amp;anchor=H14#H14\">",
"       \"Gastrointestinal toxicity of radiation therapy\", section on 'Radiation enteritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The diagnosis is usually established by suggestive radiologic findings in patients with compatible clinical features who have a history of prior radiation exposure. The patient's previous radiation treatment record should be reviewed to determine the total dose and distribution of the radiation field. This may help to determine which intestinal segments may have received excessive radiation exposure, information that can be correlated with the radiologic findings and the clinical presentation. We usually obtain an abdominal CT scan and an upper gastrointestinal series with small bowel follow-through. Further testing with an enteroclysis (standard, CT, or MRI depending upon local expertise) can be performed if the above is unrevealing and clinical suspicion remains.",
"     </li>",
"     <li>",
"      Management should be conservative, addressing the predominant symptoms. Patients with diarrhea, abdominal pain, nausea or bloating should undergo breath testing for bacterial overgrowth and treated with antibiotics if bacterial overgrowth is confirmed. Avoidance of lactose may benefit other patients while antidiarrheal agents (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/53/16214?source=see_link\">",
"       loperamide",
"      </a>",
"      ) may also be helpful. Loperamide should be avoided in patients with obstructive symptoms.",
"      <br/>",
"      <br/>",
"      Patients with intermittent obstructive symptoms may benefit from a low residue diet, although dietary tolerance is variable. A low residue diet is low in fiber. Patients should be instructed to avoid foods that are high in fiber, such as fruits, vegetables, and whole grains (",
"      <a class=\"graphic graphic_table graphicRef51448 \" href=\"UTD.htm?17/2/17453\">",
"       table 1",
"      </a>",
"      ). Radiologic evaluation may help to identify the strictured segment, information which may be critical should strictureplasty or surgery be ultimately required. The narrowed segment may not always be visible with an upper gastrointestinal series, particularly in patients with intermittent symptoms. Such patients may require enteroclysis as described above. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/38/8807?source=see_link\">",
"       \"Small bowel obstruction: Clinical manifestations and diagnosis\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14058?source=see_link\">",
"       \"Small bowel obstruction: Causes and management\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Despite conservative measures, surgery will be required in approximately 30 percent of patients. This is usually due to persistent ileus, intestinal fistulization, and massive adhesions. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prognosis is variable since the disease is progressive. Early mortality is usually due to cancer recurrence. Five-year survival is approximately 70 percent in those without cancer recurrence, although many patients continue to have troubling digestive symptoms for the remainder of their lives. (See",
"      <a class=\"local\" href=\"#H21488992\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intensive, ongoing research on mechanisms related to fibrogenesis may eventually produce effective means to prevent or reverse disease progression once it has been established. However, at the present time, prevention during radiation therapy is central to reducing the risk of developing chronic radiation enteritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=see_link&amp;anchor=H23#H23\">",
"       \"Gastrointestinal toxicity of radiation therapy\", section on 'Prevention'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/1\">",
"      Nolan DJ. The true yield of the small-intestinal barium study. Endoscopy 1997; 29:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/2\">",
"      Dixon PM, Roulston ME, Nolan DJ. The small bowel enema: a ten year review. Clin Radiol 1993; 47:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/3\">",
"      Willis JR, Chokshi HR, Zuckerman GR, Aliperti G. Enteroscopy-enteroclysis: experience with a combined endoscopic-radiographic technique. Gastrointest Endosc 1997; 45:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/4\">",
"      Horton KM, Corl FM, Fishman EK. CT of nonneoplastic diseases of the small bowel: spectrum of disease. J Comput Assist Tomogr 1999; 23:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/5\">",
"      Wagholikar GD, Gupta RK, Kapoor VK. Polyvisceral gangrene due to radiation enteritis. Trop Gastroenterol 2002; 23:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/6\">",
"      Yoshimura K, Hirata I, Maemura K, et al. Radiation enteritis: a rare complication of the transverse colon in uterine cancer. Intern Med 2000; 39:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/7\">",
"      Macheta M, Chopra R, Morgenstern G, Chang J. Chemotherapy for leukaemia following previous pelvic radiotherapy is associated with severe enteritis and haemorrhagic cystitis. Ann Hematol 2001; 80:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/8\">",
"      Bender GN, Timmons JH, Williard WC, Carter J. Computed tomographic enteroclysis: one methodology. Invest Radiol 1996; 31:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/9\">",
"      Maglinte DD, Bender GN, Heitkamp DE, et al. Multidetector-row helical CT enteroclysis. Radiol Clin North Am 2003; 41:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/10\">",
"      Horton KM, Fishman EK. The current status of multidetector row CT and three-dimensional imaging of the small bowel. Radiol Clin North Am 2003; 41:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/11\">",
"      Schmidt S, Lepori D, Meuwly JY, et al. Prospective comparison of MR enteroclysis with multidetector spiral-CT enteroclysis: interobserver agreement and sensitivity by means of \"sign-by-sign\" correlation. Eur Radiol 2003; 13:1303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/12\">",
"      Mendelson RM, Nolan DJ. The radiological features of chronic radiation enteritis. Clin Radiol 1985; 36:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/13\">",
"      Kopelman Y, Groissman G, Fireman Z. Radiation enteritis diagnosed by capsule endoscopy. Gastrointest Endosc 2007; 66:599; discussion 599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/14\">",
"      Shepherd NA. Pathological mimics of chronic inflammatory bowel disease. J Clin Pathol 1991; 44:726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/15\">",
"      Sekhon S. Chronic radiation enteritis: women's food tolerances after radiation treatment for gynecologic cancer. J Am Diet Assoc 2000; 100:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/16\">",
"      Yeoh EK, Horowitz M, Russo A, et al. Gastrointestinal function in chronic radiation enteritis--effects of loperamide-N-oxide. Gut 1993; 34:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/17\">",
"      Goldstein F, Khoury J, Thornton JJ. Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroids. A pilot study. Am J Gastroenterol 1976; 65:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/18\">",
"      Resbeut M, Marteau P, Cowen D, et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol 1997; 44:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/19\">",
"      Baughan CA, Canney PA, Buchanan RB, Pickering RM. A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin Oncol (R Coll Radiol) 1993; 5:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/20\">",
"      Kili&ccedil; D, Egehan I, Ozenirler S, Dursun A. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol 2000; 57:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/21\">",
"      Feldmeier JJ, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med 2002; 29:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/22\">",
"      Hill GB, Osterhout S. Experimental effects of hyperbaric oxgen on selected clostridial species. I. In-vitro studies. J Infect Dis 1972; 125:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/23\">",
"      . INHIBITION OF TOXIN PRODUCTION IN CLOSTRIDIUM PERFRINGENS IN VITRO BY HYPERBARIC OXYGEN. Antonie Van Leeuwenhoek 1965; 31:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/24\">",
"      Neurath MF, Branbrink A, Meyer zum B&uuml;schenfelde KH, Lohse AW. A new treatment for severe malabsorption due to radiation enteritis. Lancet 1996; 347:1302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/25\">",
"      Huddy JE, Patel P, Johnson MW, et al. Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowel. Eur J Gastroenterol Hepatol 2006; 18:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/26\">",
"      Jain G, Scolapio J, Wasserman E, Floch MH. Chronic radiation enteritis: a ten-year follow-up. J Clin Gastroenterol 2002; 35:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/27\">",
"      Scolapio JS, Ukleja A, Burnes JU, Kelly DG. Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am J Gastroenterol 2002; 97:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/28\">",
"      Scolapio JS, Fleming CR, Kelly DG, et al. Survival of home parenteral nutrition-treated patients: 20 years of experience at the Mayo Clinic. Mayo Clin Proc 1999; 74:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/29\">",
"      Gavazzi C, Bhoori S, Lovullo S, et al. Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol 2006; 101:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/30\">",
"      Thompson JS. Inflammatory disease and outcome of short bowel syndrome. Am J Surg 2000; 180:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/31\">",
"      Galland RB, Spencer J. Surgical management of radiation enteritis. Surgery 1986; 99:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/32\">",
"      Girvent M, Carlson GL, Anderson I, et al. Intestinal failure after surgery for complicated radiation enteritis. Ann R Coll Surg Engl 2000; 82:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/33\">",
"      Kuroki F, Iida M, Matsui T, et al. Intraoperative endoscopy for small intestinal damage in radiation enteritis. Gastrointest Endosc 1992; 38:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/34\">",
"      Turina M, Mulhall AM, Mahid SS, et al. Frequency and surgical management of chronic complications related to pelvic radiation. Arch Surg 2008; 143:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/35\">",
"      Regimbeau JM, Panis Y, Gouzi JL, et al. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg 2001; 182:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/36\">",
"      Nakashima H, Ueo H, Shibuta K, et al. Surgical management of patients with radiation enteritis. Int Surg 1996; 81:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/37\">",
"      Libotte F, Autier P, Delmelle M, et al. Survival of patients with radiation enteritis of the small and the large intestine. Acta Chir Belg 1995; 95:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/38\">",
"      Dietz DW, Remzi FH, Fazio VW. Strictureplasty for obstructing small-bowel lesions in diffuse radiation enteritis--successful outcome in five patients. Dis Colon Rectum 2001; 44:1772.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/39\">",
"      Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg 1998; 186:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13975/abstract/40\">",
"      American Gastroenterological Association. American Gastroenterological Association medical position statement: short bowel syndrome and intestinal transplantation. Gastroenterology 2003; 124:1105.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4057 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.131.240.2-593C6D74E4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13975=[""].join("\n");
var outline_f13_41_13975=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Upper gastrointestinal series",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Enteroclysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CT scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Magnetic resonance enteroclysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Enteroscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Capsule endoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Colonoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      MEDICAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Dietary recommendations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Antidiarrheal agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      5-ASA drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Hyperbaric oxygen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Parenteral nutrition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21488992\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/4057\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4057|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/32/28174\" title=\"picture 1\">",
"      Radiation enteritis capsule",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/30/39406\" title=\"picture 2\">",
"      Jejunal stricture capsule",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/4057|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/2/17453\" title=\"table 1\">",
"      Dietary fiber in foods",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/29/25049?source=related_link\">",
"      Clinical features, diagnosis, and treatment of radiation proctitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/45/11990?source=related_link\">",
"      Clinical manifestations and diagnosis of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/42/20137?source=related_link\">",
"      Gastrointestinal toxicity of radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5448?source=related_link\">",
"      Hyperbaric oxygen therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/32/5641?source=related_link\">",
"      Lactose intolerance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/46/14058?source=related_link\">",
"      Small bowel obstruction: Causes and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/38/8807?source=related_link\">",
"      Small bowel obstruction: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/50/28454?source=related_link\">",
"      Treatment of small intestinal bacterial overgrowth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17178?source=related_link\">",
"      Wireless video capsule endoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_41_13976="ERCP in pregnancy";
var content_f13_41_13976=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   ERCP in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Suku George, MD, MPH, FACP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Marc F Catalano, MD, FACP, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13976/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/41/13976/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy is associated with an increased risk of gallstone formation. Fortunately, complications due to cholelithiasis, such as cholecystitis, choledocholithiasis, and pancreatitis, are relatively uncommon, and in many cases can be managed conservatively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28201?source=see_link\">",
"     \"Gallstone disease in pregnant women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"     \"Intercurrent hepatobiliary disease during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=see_link\">",
"     \"Epidemiology of and risk factors for gallstones\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, occasionally, patients develop complications related to gallstones that require intervention during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Although there are no precise estimates of the incidence, several reports have found that biliary tract disease (most commonly cholecystitis) represented one of the most frequent indications for non-obstetrical surgery during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/4-6\">",
"     4-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subset of patients requires (endoscopic retrograde cholangiopancreatography) ERCP, most commonly for choledocholithiasis or presumed gallstone pancreatitis. Opinions regarding the safety of ERCP during pregnancy differ in various reports, reflecting the relatively limited data [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7-13\">",
"     7-13",
"    </a>",
"    ]. Major concerns surround issues related to radiation exposure to the fetus and the risk of the procedure on pregnancy outcome.",
"   </p>",
"   <p>",
"    A general principle in the care of women with an acute biliary tract disorder during pregnancy is to provide the most conservative management possible with the hope of delaying intervention until after pregnancy or until the second trimester, when surgical intervention is relatively safest. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=see_link\">",
"     \"Management of pregnant women undergoing nonobstetric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few ERCP-related complications to the mother or fetus have been reported. A literature review described complications that were reported during a total of 64 ERCPs performed during pregnancy (mostly described in case series of one to four patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/11,14-36\">",
"     11,14-36",
"    </a>",
"    ]. Of these procedures, 14 were done in the first trimester, 23 in the second, 19 in the third, and 8 unspecified. Therapeutic procedures included 56 sphincterotomies.",
"   </p>",
"   <p>",
"    Of 47 pregnancies that were followed to term, there were two premature births. Conservative treatment of a type I choledochal cyst resulted in cyst rupture at 18 weeks of gestation with subsequent peritonitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/37\">",
"     37",
"    </a>",
"    ]. Spontaneous abortion of the fetus occurred after surgery. A patient with a pancreatic pseudocyst who underwent diagnostic ERCP before EUS-guided cyst-gastrostomy has also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39705?source=see_link\">",
"     \"Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following illustrate the range of findings in the largest individual reports.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The largest series included 65 patients; the most common indications for ERCP during pregnancy were recurrent biliary colic, abnormal liver function tests, and a dilated bile duct on ultrasound [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/39\">",
"       39",
"      </a>",
"      ]. The median fluoroscopy time was 1.45 minutes. Almost all patients underwent a therapeutic procedure. Post-ERCP pancreatitis developed in 11 patients (16 percent), none of whom had a severe course. Most patients achieved a term pregnancy (89 percent).",
"     </li>",
"     <li>",
"      Another series of 23 patients included 20 of who underwent a therapeutic ERCP while three underwent a diagnostic ERCP only [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"       7",
"      </a>",
"      ]. One patient developed post ERCP pancreatitis (after each of her three ERCPs). There was one spontaneous abortion (three weeks after ERCP) and one neonatal death 26 hours after delivery. The neonatal death and post-ERCP pancreatitis were in the same patient who had undergone three ERCPs (twice during the first and once during the third trimesters) with pancreatic duct stenting for stenosis of pancreatic orifice after a previous surgical sphincteroplasty. She was also not known to be pregnant at the time of the first ERCP.",
"     </li>",
"     <li>",
"      Another series described long-term follow-up of 18 pregnant women who underwent biliary sphincterotomy for CBD stones during pregnancy (first trimester 4, second 6, third 8) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/40\">",
"       40",
"      </a>",
"      ]. Despite short-term complications (one with postsphincterotomy bleed, one with mild post-ERCP pancreatitis and preterm labor), no long-term complications were seen after a median of six years (range 1 to 11) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a series of 15 patients, the incidence of complications (7 percent) was no different than the rate of complications observed in nonpregnant patients [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/10\">",
"       10",
"      </a>",
"      ]. There were no serious adverse outcomes to the fetus or mother.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     STRATEGIES TO MINIMIZE RADIATION RISK TO THE FETUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The perceived risk of radiation exposure is much greater than the actual risk, but a full explanation of these risks to the woman and her family is more credible if given prior to the exposure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .) The following represent approaches to minimize the radiation risk to the fetus in women in whom ERCP is being considered",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Preprocedure interventions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H148340539\">",
"    <span class=\"h3\">",
"     Avoid ERCP for weak indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;ERCP should be avoided for weak indications such as preoperative cholangiography in patients with a low probability of having choledocholithiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/41\">",
"     41",
"    </a>",
"    ]. Intraoperative cholangiography during laparoscopic cholecystectomy can be done in patients thought to have an intermediate probability of a retained bile duct stone. Postoperative ERCP can be performed if definite filling defects are seen, thereby avoiding unnecessary preoperative ERCP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Inquire about pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women of childbearing age should be asked about the possibility of pregnancy and a pregnancy test should be ordered based upon clinical history. Three out of 23 patients in the largest series were not known to be pregnant at the time of ERCP [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Consider other imaging tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other methods of diagnosis that do not involve radiation should be considered. Magnetic resonance cholangiopancreatography (MRCP) can provide diagnostic information for a variety of hepatobiliary conditions while endoscopic ultrasonography (EUS) is highly sensitive and specific for choledocholithiasis. MRCP for the detection of CBD stone and subsequent stone extraction without using fluoroscopy has been reported in a pregnant patient in the third trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .) In most reports, the sensitivity of EUS ranged from 88 to 97 percent with a specificity of 96 to 100 percent, which is comparable to ERCP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/34/43557?source=see_link\">",
"     \"Endoscopic ultrasound in patients with suspected choledocholithiasis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While they may provide an alternative to ERCP, the safety of EUS and MRCP in pregnancy has not been evaluated formally.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Fully inform patient and document",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be fully informed, and discussion documented, regarding the issues surrounding radiation risk to the fetus, other potential procedure-related complications and alternatives. Background population risks for miscarriage, congenital anomalies, genetic disease, and growth restriction are approximately 20, 4, 10, and 10 percent, respectively. Potential radiation exposure risks to the fetus can be divided into four categories: intrauterine fetal death, malformations, and disturbances of growth and development, mutagenic and carcinogenic effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .) A discussion of strategies that might be used to minimize radiation exposure is also imperative.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Choose a highly-experienced endoscopist",
"    </span>",
"    &nbsp;&mdash;&nbsp;Highly experienced biliary endoscopists should ideally perform the procedure for two reasons. The greatest risk to the fetus is probably severe maternal pancreatitis, the risk of which can be reduced when ERCP is performed by a highly skilled endoscopist. Even in tertiary centers, endoscopists deal with pregnant women and their biliary and pancreatic disorders infrequently [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/42\">",
"     42",
"    </a>",
"    ]. Endoscopists who perform a low volume of ERCPs should consider referring these patients to higher volume centers unless the clinical urgency would preclude such a transfer (such as in patient's cholangitis or obstructive jaundice). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Avoid fluoroscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even though the fetus can be shielded, efforts should be made to avoid performing ERCP during the first trimester [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/43\">",
"     43",
"    </a>",
"    ]. While harmful effects of radiation exposure are unlikely to develop below a certain threshold of radiation dose, the threshold associated with a risk of childhood cancers such as leukemia is not known precisely. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ERCP without fluoroscopy has been reported but its safety is not established. The largest series to describe this approach used the following approach in 21 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/44\">",
"     44",
"    </a>",
"    ]. Endoscopist-controlled wire-guided cannulation was first attempted; the cannula was not advanced into the duct unless the endoscopist was confident that the bile duct had been cannulated, as assessed by the presence of bile flowing around the wire from the papillary orifice. Once biliary cannulation was confirmed, a standard wire-guided biliary sphincterotomy was performed using the papillotome.",
"   </p>",
"   <p>",
"    When bile was not seen flowing around the guidewire, instead of advancing the catheter to aspirate fluid, a 5F 2 cm stent was inserted over the wire and the drainage from the stent was observed. The color of draining fluid was used to assess whether the stent was in the bile duct (yellow) or the pancreatic duct (clear). If the stent revealed bile flow, a stent-guided biliary sphincterotomy using a needle-knife was performed. Cannulation was then attempted using a guidewire, which had been previously inserted into the needle-knife. The stent was removed after extending the biliary sphincterotomy. There was one case of mild post-ERCP pancreatitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Intraprocedural interventions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Medicines used in ERCP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications that may be used during ERCP, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    (Category D),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"     meperidine",
"    </a>",
"    (Category B),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/52/38730?source=see_link\">",
"     fentanyl",
"    </a>",
"    (Category C),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    (Category B) and glucagon (Category B), are thought to be generally safe in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/45\">",
"     45",
"    </a>",
"    ]. Medication dosages needed may be on the high side. In the largest series, the mean dose of meperidine was 115 mg (range 50 to 325 mg) and the mean dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    was 25 mg (range 8 to 70 mg) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ]. A guideline issued by the American Society for Gastrointestinal Endoscopy on endoscopy in pregnant and lactating women includes the following recommendations [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/46\">",
"     46",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      For procedural sedation during pregnancy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/44/11976?source=see_link\">",
"       meperidine",
"      </a>",
"      alone is preferred, followed by small doses of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"       midazolam",
"      </a>",
"      as needed.",
"     </li>",
"     <li>",
"      If deep sedation is needed, it should be administered by an anesthesia professional.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Proper shielding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lead shielding should be used to minimize radiation exposure to the uterus. The lead apron shield must be placed underneath the patient and not draped over the abdomen since the radiation source is underneath the patient when using the standard fluoroscopy C-arm [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/18\">",
"     18",
"    </a>",
"    ]. External shielding cannot, however, eliminate fetal exposure due to internally scattered radiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Consider patient positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the later part of pregnancy, prone positioning is impossible. Thus, the left lateral decubitus position is required [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ]. Proper supporting cushions or pillows should be available and lead shielding should be adjusted appropriately.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Minimize procedure time",
"    </span>",
"    &nbsp;&mdash;&nbsp;Procedure time should be minimized. All equipment anticipated to be needed should be readily available. Inexperienced or trainee endoscopists should preferably have only an observational role.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Consider involvement of an anesthesiologist",
"    </span>",
"    &nbsp;&mdash;&nbsp;It may be reasonable to involve an anesthesiologist, particularly in patients in whom conscious sedation may be difficult such as those with a history of difficulty with conscious sedation, prescribed or illicit benzodiazepine or opiates use, or heavy alcohol use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=see_link\">",
"     \"Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy\"",
"    </a>",
"    .) The procedure should be aborted if the patient is not tolerating conscious sedation. General anesthesia can be used to minimize the risk of hypoxia and aspiration [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Request obstetrical consultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;An obstetrician (ideally one specializing in high risk pregnancies) should be consulted for consideration of fetal monitoring during the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Minimize fluoroscopy time",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroscopy time should be minimized to the shortest period needed to assess the anatomy and confirm positions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spot x-ray films should be avoided since they emit from 25 to 2000 mrem of exposure per procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/17\">",
"       17",
"      </a>",
"      ]. One group described using videotapes to capture fluoroscopic images and thereby minimizing the need for additional fluoroscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/17\">",
"       17",
"      </a>",
"      ]. If stones are extracted, endoscopic photographs can be taken for documentation instead of roentgenographic films. Sphincterotomy and stone retrieval using balloon catheters can be performed without the use of spot radiographs. Use of ultrasound to confirm position of the papillotome in the bile duct prior to sphincterotomy and subsequent avoidance of fluoroscopy has also been described [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/28,40\">",
"       28,40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      It may be possible to identify successful bile duct cannulation using bile aspiration in place of fluoroscopy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/30\">",
"       30",
"      </a>",
"      ]. Two variations of the technique include guidewire cannulation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/12\">",
"       12",
"      </a>",
"      ] and direct cannulation with the sphincterotome with or without fluoroscopy along with bile aspiration to identify the correct duct [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7,11\">",
"       7,11",
"      </a>",
"      ]. One group described successful cholangiography in six pregnant women by initial cannulation with a guidewire under video endoscopic views and subsequent advancement of the catheter into the bile duct for bile aspiration to confirm the position [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/12\">",
"       12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Magnification of the fluoroscopic image should be avoided since it results in increased radiation dose.",
"     </li>",
"     <li>",
"      Digital radiography may minimize the radiation exposure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Use fetal radiation exposure monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal radiation exposure should be monitored directly since fluoroscopy time and fetal radiation exposure do not always correlate well. The fetal dose of concern for teratogenesis is considered over 5 rad, although harm first becomes apparent at 10 to 20 rad. It is possible that smaller doses could cause childhood cancers such as leukemia. Fetal radiation exposure is generally much lower than 5 rad in various reports: 30 to 50 mrem [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/11\">",
"     11",
"    </a>",
"    ], 59 mrem [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/47\">",
"     47",
"    </a>",
"    ], 2 mrem [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ], and 310 mrad [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=see_link\">",
"     \"Biology and clinical features of radiation injury in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=see_link\">",
"     \"Diagnostic imaging procedures during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The largest study to evaluate fetal radiation exposure during ERCP included 17 women who were exposed to fluoroscopy for a mean of 14 seconds (range 1 to 48 seconds) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/11\">",
"     11",
"    </a>",
"    ]. While there was a significant relationship between fluoroscopy time and estimated fetal radiation exposure, there was as much as a threefold difference in estimated exposure for a given fluoroscopy time. Furthermore, nearly 50 percent of the estimated exposures were between 30 and 50 mrem, while the corresponding fluoroscopy times ranged from 6 to 30 seconds. The authors hypothesized that the variation might be due to differences in the patients' body habitus",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the accuracy of the thermoluminescent devices used to monitor radiation exposure.",
"   </p>",
"   <p>",
"    The following protocol was used in their study. Patients were placed supine on the fluoroscopy table, and the lower abdomen and pelvis shielded with a 0.5- to 1.0-mm thickness of lead or its equivalent. The uterus was positioned outside the primary x-ray beam.",
"   </p>",
"   <p>",
"    Four pairs of thermoluminescent dosimeters (TLD) were taped to the skin: one pair on the abdomen over the uterus shielded by lead, one pair on the upper abdomen in the primary beam, one pair on the lower back beneath the uterus shielded by lead, and one pair on the upper back in the primary beam. Fluoroscopy was performed at 75 kVp. The TLDs were calibrated at 75 kVp. A TLD reader (Harshaw-3000; Filtrol, Solon, Ohio) was used to read the TLDs; readings were converted into milliRad of dose received at the skin surface by using a calibration curve.",
"   </p>",
"   <p>",
"    The TLDs on the upper back in the primary beam recorded the highest dose; 10 percent of this dose was estimated to be the fetal dose. The fetus was considered to be 10 cm from the posterior surface, and percentage depth dose at 10 cm was taken as approximately 10 percent. The depth dose will vary with both body habitus and gestational age, and, thus, the dose estimate is an approximation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Generous sphincterotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If indicated, a generous sphincterotomy is reasonable to avoid the possibility of an impacted stone especially if minimum fluoroscopy is used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Avoid pancreatic endotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic endotherapy generally requires relatively lengthy fluoroscopy time, can be technically challenging, and may be associated with increased risk. As a result, it should preferentially be avoided unless absolutely indicated. A case series described two patients with pancreatic disease who underwent pancreatic endotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ]. One patient with pancreas divisum underwent minor papilla sphincterotomy and stent placement. The other underwent three ERCPs with pancreatic duct stenting, complicated by mild post ERCP pancreatitis. Neonatal death occurred with the infant dying 26 hours after delivery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Precut papillotomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Precut papillotomy using a needle knife approach has been performed during pregnancy, allowing for removal of an impacted common bile duct stone without the need for fluoroscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/12,20,30\">",
"     12,20,30",
"    </a>",
"    ] or for cutting of a minor papillotomy over a stent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ]. Despite the potential benefit on reducing fluoroscopy time, the indications for a precut papillotomy during pregnancy should probably be the same as in nonpregnant patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/10/25767?source=see_link\">",
"     \"Precut (access) papillotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Stenting or sphincterotomy or both",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some authorities have suggested that performance of biliary sphincterotomy to facilitate stone passage is preferable to leaving a stent without sphincterotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/42\">",
"     42",
"    </a>",
"    ]. Stent occlusion or migration can easily precipitate cholangitis and in addition a second procedure is needed to remove the stent. However, sphincterotomy alone may not be sufficient to maintain biliary decompression, especially in patients in whom cholecystectomy will be delayed until after the post partum period [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/17,48\">",
"     17,48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By contrast, others have demonstrated that marked reductions in fluoroscopy time (0.1 min to confirm guidewire position) can be achieved by foregoing precise diagnostic information and performing a palliative therapeutic procedure such as placement of a stent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/29,40\">",
"     29,40",
"    </a>",
"    ]. This is especially important when informed consent discussions with the patient sometimes place the highest priority on the minimization of fetal radiation exposure based upon patient preference. One group described a two-stage approach in pregnant patients with choledocholithiasis in which a sphincterotomy and stent were placed during pregnancy without fluoroscopy followed by ERCP with stone extraction after pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Placement of stents (biliary or pancreatic) have been reported for management of two patients with PSC, one patient with bile leak and two patients with pancreatic duct strictures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Use of peroral choledoscopy to confirm ductal clearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Spyglass Direct Visualization System (Boston Scientific) was used in a report of five patients to confirm stone clearance without use of fluoroscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/44\">",
"     44",
"    </a>",
"    ]. The 0.77 mm optical probe (SpyGlass) was introduced through the guidewire port of the needle-knife, which had previously been inserted over a guidewire.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     ACUTE BILIARY PANCREATITIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute biliary pancreatitis is uncommon during pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"     \"Intercurrent hepatobiliary disease during pregnancy\"",
"    </a>",
"    .) When it does occur, up to 70 percent of patients will have an intrapartum recurrence if the initial the event is managed conservatively (ie, without endoscopic intervention or cholecystectomy) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. Biliary pancreatitis during pregnancy has been associated with substantial maternal and fetal mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/53\">",
"     53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several questions commonly arise when biliary pancreatitis occurs during pregnancy:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Is endoscopic sphincterotomy (ES) alone sufficient treatment?",
"     </li>",
"     <li>",
"      Is ES needed in patients without evidence of choledocholithiasis?",
"     </li>",
"     <li>",
"      Is cholecystectomy required after delivery?",
"     </li>",
"     <li>",
"      Is there a role for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"       ursodeoxycholic acid",
"      </a>",
"      ?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Is endoscopic sphincterotomy sufficient?",
"    </span>",
"    &nbsp;&mdash;&nbsp;A traditional approach following an episode of biliary pancreatitis has been to perform cholecystectomy in the second trimester, or immediately postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/52,54\">",
"     52,54",
"    </a>",
"    ]. However, some authorities have proposed that endoscopic sphincterotomy may be sufficient to prevent recurrence during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/18\">",
"     18",
"    </a>",
"    ], an approach that has also been described in nonpregnant patients in whom cholecystectomy was deferred. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=see_link\">",
"     \"Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whether sphincterotomy will be fully protective against a recurrent attack of pancreatitis or other gallstone-related complication during pregnancy without cholecystectomy is uncertain. Studies demonstrating the safety of this approach during pregnancy have been based upon small numbers of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/18\">",
"     18",
"    </a>",
"    ]. In the nonpregnant setting (where greater numbers of patients have been evaluated) expectant management following sphincterotomy has been associated with up to a 50 percent risk of a recurrent gallstone-related complication within two years. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=see_link\">",
"     \"Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To further complicate matters, recurrent gallstone complications are not always severe. Thus, whether the benefit of a relatively conservative approach (ie, sphincterotomy without cholecystectomy) is justified by a sufficiently low risk of recurrence (and particularly a severe recurrence) of gallstone related complications is not straightforward.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Is sphincterotomy needed in patients without choledocholithiasis?",
"    </span>",
"    &nbsp;&mdash;&nbsp;A similar controversy surrounds whether endoscopic sphincterotomy is warranted in patients with gallstone pancreatitis who do not have choledocholithiasis at ERCP [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/10,14,18\">",
"     10,14,18",
"    </a>",
"    ]. The main risks of this approach are related to the sphincterotomy itself as well as a theoretical risk of long-term complications due to bacterobilia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/42,55,56\">",
"     42,55,56",
"    </a>",
"    ]. The risk is probably justified since microlithiasis may be responsible for pancreatitis, especially if cholecystectomy will be deferred until after pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Is cholecystectomy needed after delivery?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with an episode of gallstone pancreatitis who complete pregnancy without a cholecystectomy should probably undergo a cholecystectomy following delivery. It must be acknowledged, however, that the benefit of this approach is uncertain since gallstones and sludge frequently resolve following pregnancy. The benefit would appear to be most clear cut in women who desire additional pregnancies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=see_link\">",
"     \"Intercurrent hepatobiliary disease during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Is there a role for ursodeoxycholic acid?",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no published data regarding the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/5/12373?source=see_link\">",
"     ursodeoxycholic acid",
"    </a>",
"    (UDCA) during pregnancy and in the postpartum period to prevent postpartum gallstone complications, although there are anecdotal reports of its use [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13976/abstract/10\">",
"     10",
"    </a>",
"    ]. Selection of candidates for such treatment has been best described in the nonpregnant setting, where treatment may reduce symptoms even in patients in whom complete dissolution cannot be achieved. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6408?source=see_link\">",
"     \"Dissolution therapy for the treatment of gallstones\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A concern with UDCA therapy is that bile acids can cross the placenta, which might lead to fetal toxicity. UDCA has been used in pregnancy for treatment of intrahepatic cholestasis of pregnancy without fetal adverse effects. However, such treatment is generally begun late in the third trimester; thus, it is not clear if these data can be extrapolated to earlier use of the drug. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=see_link\">",
"     \"Intrahepatic cholestasis of pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy can be done safely and successfully.",
"     </li>",
"     <li>",
"      Careful institution of pre- and intra-procedural risk reduction strategies is helpful in achieving a good outcome. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Strategies to minimize radiation risk to the fetus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A multidisciplinary team consisting of obstetricians, surgeons, and biliary endoscopists should coordinate the management of pancreaticobiliary disease in pregnancy, particularly those requiring early intervention.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/1\">",
"      Hill LM, Johnson CE, Lee RA. Cholecystectomy in pregnancy. Obstet Gynecol 1975; 46:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/2\">",
"      Glenn F, McSherry CK. Gallstones and pregnancy among 300 young women treated by cholecystectomy. Surg Gynecol Obstet 1968; 127:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/3\">",
"      Printen KJ, Ott RA. Cholecystectomy during pregnancy. Am Surg 1978; 44:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/4\">",
"      Amos JD, Schorr SJ, Norman PF, et al. Laparoscopic surgery during pregnancy. Am J Surg 1996; 171:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/5\">",
"      Curet MJ, Allen D, Josloff RK, et al. Laparoscopy during pregnancy. Arch Surg 1996; 131:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/6\">",
"      Graham G, Baxi L, Tharakan T. Laparoscopic cholecystectomy during pregnancy: a case series and review of the literature. Obstet Gynecol Surv 1998; 53:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/7\">",
"      Jamidar PA, Beck GJ, Hoffman BJ, et al. Endoscopic retrograde cholangiopancreatography in pregnancy. Am J Gastroenterol 1995; 90:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/8\">",
"      Sungler P, Heinerman PM, Steiner H, et al. Laparoscopic cholecystectomy and interventional endoscopy for gallstone complications during pregnancy. Surg Endosc 2000; 14:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/9\">",
"      Farca A, Aguilar ME, Rodriguez G, et al. Biliary stents as temporary treatment for choledocholithiasis in pregnant patients. Gastrointest Endosc 1997; 46:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/10\">",
"      Tham TC, Vandervoort J, Wong RC, et al. Safety of ERCP during pregnancy. Am J Gastroenterol 2003; 98:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/11\">",
"      Kahaleh M, Hartwell GD, Arseneau KO, et al. Safety and efficacy of ERCP in pregnancy. Gastrointest Endosc 2004; 60:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/12\">",
"      Simmons DC, Tarnasky PR, Rivera-Alsina ME, et al. Endoscopic retrograde cholangiopancreatography (ERCP) in pregnancy without the use of radiation. Am J Obstet Gynecol 2004; 190:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/13\">",
"      Howden JK, Baillie J. Preoperative versus postoperative endoscopic retrograde cholangiopancreatography in mild to moderate pancreatitis: a prospective randomized trial. Gastrointest Endosc 2001; 53:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/14\">",
"      Baillie J, Cairns SR, Putman WS, Cotton PB. Endoscopic management of choledocholithiasis during pregnancy. Surg Gynecol Obstet 1990; 171:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/15\">",
"      Nesbitt TH, Kay HH, McCoy MC, Herbert WN. Endoscopic management of biliary disease during pregnancy. Obstet Gynecol 1996; 87:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/16\">",
"      al Karawi M, Mohamed SA. Therapeutic endoscopic retrograde cholangiopancreatography with ultra-short fluoroscopy: report of two cases. Endoscopy 1997; 29:S31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/17\">",
"      Axelrad AM, Fleischer DE, Strack LL, et al. Performance of ERCP for symptomatic choledocholithiasis during pregnancy: techniques to increase safety and improve patient management. Am J Gastroenterol 1994; 89:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/18\">",
"      Barthel JS, Chowdhury T, Miedema BW. Endoscopic sphincterotomy for the treatment of gallstone pancreatitis during pregnancy. Surg Endosc 1998; 12:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/19\">",
"      Berger Z. Endoscopic papillotomy without fluoroscopy in pregnancy. Endoscopy 1998; 30:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/20\">",
"      Binmoeller KF, Katon RM. Needle knife papillotomy for an impacted common bile duct stone during pregnancy. Gastrointest Endosc 1990; 36:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/21\">",
"      Eichenberg BJ, Vanderlinden J, Miguel C, et al. Laparoscopic cholecystectomy in the third trimester of pregnancy. Am Surg 1996; 62:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/22\">",
"      Freist&uuml;hler M, Braess A, Petrides AS. [Ultrasound-controlled endoscopic papillotomy in pregnancy in severe biliary pancreatitis]. Z Gastroenterol 1999; 37:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/23\">",
"      Friedman RL, Friedman IH. Acute cholecystitis with calculous biliary duct obstruction in the gravid patient. Management by ERCP, papillotomy, stone extraction, and laparoscopic cholecystectomy. Surg Endosc 1995; 9:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/24\">",
"      Goldschmiedt M, Wolf L, Shires T. Treatment of symptomatic choledocholithiasis during pregnancy. Gastrointest Endosc 1993; 39:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/25\">",
"      Kim SY, Wong DKH. ERCP in the management of pancreaticobiliary disease during pregnancy. Gastrointest Endosc 1996; 43:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/26\">",
"      Llach J, Bordas JM, Gin&egrave;s A, et al. Endoscopic sphincterotomy in pregnancy. Endoscopy 1997; 29:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/27\">",
"      Martins L, Rodrigues R, Meirinho M. [Acute pancreatitis and pregnancy]. Acta Med Port 1997; 10:715.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/28\">",
"      Parada AA, Gon&ccedil;alves MO, Tafner E, et al. Endoscopic papillotomy under ultra-sonographic control. Int Surg 1991; 76:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/29\">",
"      Rahmin MG, Hitscherich R, Jacobson IM. ERCP for symptomatic choledocholithiasis in pregnancy. Am J Gastroenterol 1994; 89:1601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/30\">",
"      Uomo G, Manes G, Picciotto FP, Rabitti PG. Endoscopic treatment of acute biliary pancreatitis in pregnancy. J Clin Gastroenterol 1994; 18:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/31\">",
"      Z&aacute;goni T, Tulassay Z. Endoscopic sphincterotomy without fluoroscopic control in pregnancy. Am J Gastroenterol 1995; 90:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/32\">",
"      Bagci S, Tuzun A, Erdil A, et al. Treatment of choledocholithiasis in pregnancy: a case report. Arch Gynecol Obstet 2003; 267:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/33\">",
"      Andreoli M, Sayegh SK, Hoefer R, et al. Laparoscopic cholecystectomy for recurrent gallstone pancreatitis during pregnancy. South Med J 1996; 89:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/34\">",
"      Gamberdella FR. Pancreatic carcinoma in pregnancy: a case report. Am J Obstet Gynecol 1984; 149:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/35\">",
"      Comitalo JB, Lynch D. Laparoscopic cholecystectomy in the pregnant patient. Surg Laparosc Endosc 1994; 4:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/36\">",
"      Wishner JD, Zolfaghari D, Wohlgemuth SD, et al. Laparoscopic cholecystectomy in pregnancy. A report of 6 cases and review of the literature. Surg Endosc 1996; 10:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/37\">",
"      Hewitt PM, Krige JE, Bornman PC, Terblanche J. Choledochal cyst in pregnancy: a therapeutic dilemma. J Am Coll Surg 1995; 181:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/38\">",
"      Ryan ME. Endoscopic management of a pancreatic pseudocyst during pregnancy. Gastrointest Endosc 1992; 38:605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/39\">",
"      Tang SJ, Mayo MJ, Rodriguez-Frias E, et al. Safety and utility of ERCP during pregnancy. Gastrointest Endosc 2009; 69:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/40\">",
"      Gupta R, Tandan M, Lakhtakia S, et al. Safety of therapeutic ERCP in pregnancy - an Indian experience. Indian J Gastroenterol 2005; 24:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/41\">",
"      Basso L, McCollum PT, Darling MR, et al. A study of cholelithiasis during pregnancy and its relationship with age, parity, menarche, breast-feeding, dysmenorrhea, oral contraception and a maternal history of cholelithiasis. Surg Gynecol Obstet 1992; 175:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/42\">",
"      Baillie J. ERCP during pregnancy. Am J Gastroenterol 2003; 98:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/43\">",
"      Siegel JH, Cohen SA. ERCP in a pregnant patient. Am J Gastroenterol 1994; 89:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/44\">",
"      Shelton J, Linder JD, Rivera-Alsina ME, Tarnasky PR. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc 2008; 67:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/45\">",
"      Cappell MS. The fetal safety and clinical efficacy of gastrointestinal endoscopy during pregnancy. Gastroenterol Clin North Am 2003; 32:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/46\">",
"      ASGE Standard of Practice Committee, Shergill AK, Ben-Menachem T, et al. Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2012; 76:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/47\">",
"      Hoffman BJ, Cunningham JT. Radiation exposure to the pregnant patient during ERCP (abstract). Gastrointest Endosc 1992; 38:A109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/48\">",
"      Axelrad AM, Fleischer D. ERCP in a pregnant patient. Response to Drs. Siegel and CohenD. (Letter). Am J Gastroenterol 1994; 89:1596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/49\">",
"      Sharma SS, Maharshi S. Two stage endoscopic approach for management of choledocholithiasis during pregnancy. J Gastrointestin Liver Dis 2008; 17:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/50\">",
"      Chen CP, Wang KG, Su TH, Yang YC. Acute pancreatitis in pregnancy. Acta Obstet Gynecol Scand 1995; 74:607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/51\">",
"      Ramin KD, Ramin SM, Richey SD, Cunningham FG. Acute pancreatitis in pregnancy. Am J Obstet Gynecol 1995; 173:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/52\">",
"      Swisher SG, Hunt KK, Schmit PJ, et al. Management of pancreatitis complicating pregnancy. Am Surg 1994; 60:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/53\">",
"      Wilkinson EJ. Acute pancreatitis in pregnancy: a review of 98 cases and a report of 8 new cases. Obstet Gynecol Surv 1973; 28:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/54\">",
"      Block P, Kelly TR. Management of gallstone pancreatitis during pregnancy and the postpartum period. Surg Gynecol Obstet 1989; 168:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/55\">",
"      Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13976/abstract/56\">",
"      Tranter SE, Thompson MH. Comparison of endoscopic sphincterotomy and laparoscopic exploration of the common bile duct. Br J Surg 2002; 89:1495.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 653 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13976=[""].join("\n");
var outline_f13_41_13976=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H29\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      STRATEGIES TO MINIMIZE RADIATION RISK TO THE FETUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Preprocedure interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H148340539\">",
"      - Avoid ERCP for weak indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Inquire about pregnancy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Consider other imaging tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Fully inform patient and document",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Choose a highly-experienced endoscopist",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Avoid fluoroscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Intraprocedural interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Medicines used in ERCP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Proper shielding",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Consider patient positioning",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Minimize procedure time",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Consider involvement of an anesthesiologist",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Request obstetrical consultation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Minimize fluoroscopy time",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Use fetal radiation exposure monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Generous sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Avoid pancreatic endotherapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Precut papillotomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Stenting or sphincterotomy or both",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Use of peroral choledoscopy to confirm ductal clearance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      ACUTE BILIARY PANCREATITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Is endoscopic sphincterotomy sufficient?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Is sphincterotomy needed in patients without choledocholithiasis?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Is cholecystectomy needed after delivery?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Is there a role for ursodeoxycholic acid?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43049?source=related_link\">",
"      Alternatives and adjuncts to moderate procedural sedation for gastrointestinal endoscopy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4106?source=related_link\">",
"      Biology and clinical features of radiation injury in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28120?source=related_link\">",
"      Diagnostic imaging procedures during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/16/6408?source=related_link\">",
"      Dissolution therapy for the treatment of gallstones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/23/22905?source=related_link\">",
"      Endoscopic management of bile duct stones: Standard techniques and mechanical lithotripsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/34/43557?source=related_link\">",
"      Endoscopic ultrasound in patients with suspected choledocholithiasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/24/4489?source=related_link\">",
"      Epidemiology of and risk factors for gallstones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/34/28201?source=related_link\">",
"      Gallstone disease in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/24/14726?source=related_link\">",
"      Intercurrent hepatobiliary disease during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/32/4617?source=related_link\">",
"      Intrahepatic cholestasis of pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15482?source=related_link\">",
"      Management of pregnant women undergoing nonobstetric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39705?source=related_link\">",
"      Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/10/25767?source=related_link\">",
"      Precut (access) papillotomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_41_13977="Efficacy of cardiac rehabilitation in patients with coronary heart disease";
var content_f13_41_13977=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Efficacy of cardiac rehabilitation in patients with coronary heart disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13977/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13977/contributors\">",
"     Nanette K Wenger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13977/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13977/contributors\">",
"     Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/41/13977/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/41/13977/contributors\">",
"     Gordon M Saperia, MD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/41/13977/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lack of physical activity is among the risk factors that are considered to have adverse effects on the progression of coronary atherosclerosis. Numerous observational studies in both men and women have demonstrated that both regular exercise and physical fitness are associated with a reduced risk of coronary events and coronary death (",
"    <a class=\"graphic graphic_figure graphicRef56864 \" href=\"UTD.htm?4/18/4398\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef60770 \" href=\"UTD.htm?8/13/8414\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon these observations and the demonstrated benefit of risk factor reduction, cardiac rehabilitation programs have been developed to provide exercise training and counseling on risk factor modification for the secondary prevention of coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=see_link\">",
"     \"Secondary prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiac rehabilitation includes provision of comprehensive long-term services involving the following core components (",
"    <a class=\"graphic graphic_table graphicRef60257 graphicRef73513 \" href=\"UTD.htm?3/62/4067\">",
"     table 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medical evaluation",
"     </li>",
"     <li>",
"      Prescribed exercise",
"     </li>",
"     <li>",
"      Coronary risk factor",
"      <span class=\"nowrap\">",
"       reduction/secondary",
"      </span>",
"      prevention",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    It may also include educational, counseling, and behavioral interventions that are designed to optimize cardiovascular risk reduction, to limit the adverse physiologic and psychologic effects of coronary illness and adherence to preventive medications, to reduce the risk of sudden death or reinfarction, to control coronary symptoms, to stabilize or reverse the progression of atherosclerosis, to reduce cardiovascular disability, and to enhance the patient's psychosocial and vocational status [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Comprehensive risk factor intervention'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16250?source=see_link\">",
"     \"Psychosocial and other social factors in acute myocardial infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/15/23800?source=see_link\">",
"     \"Psychosocial factors in sudden cardiac arrest\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Many studies presented in this topic focus on the efficacy of cardiac rehabilitation in patients with recent myocardial infarction (MI). However, there has been wide acceptance of the benefits of supervised exercise programs for most patients with coronary heart disease. Rehabilitation services for patients with coronary artery revascularization procedures using either percutaneous coronary intervention or coronary bypass surgery and for patients with stable angina are now covered by Medicare and many third party payers in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. Referral for cardiac rehabilitation is recommended in most contemporary clinical practice guidelines, including those for ST segment elevation MI, unstable",
"    <span class=\"nowrap\">",
"     angina/non-ST",
"    </span>",
"    segment elevation MI, chronic stable angina, percutaneous coronary intervention, and coronary artery bypass graft surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/11-15\">",
"     11-15",
"    </a>",
"    ]. As of March 2006, the US Center for Medicare and Medicaid Services concluded that cardiac rehabilitation is reasonable and necessary for these indications.",
"   </p>",
"   <p>",
"    The efficacy of cardiac rehabilitation programs will be reviewed here. The details of these programs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=see_link\">",
"     \"Components of cardiac rehabilitation and exercise prescription\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite the benefits of cardiac rehabilitation described below, only 10 to 20 percent of eligible patients following myocardial infarction are referred to and participated in formal structured cardiac rehabilitation in the United States (US) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/16-19\">",
"     16-19",
"    </a>",
"    ]. Fewer than 30 percent of eligible US patients currently participate in supervised exercise rehabilitation following a cardiovascular event [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/20\">",
"     20",
"    </a>",
"    ]. Cardiac rehabilitation is equally underutilized in the United Kingdom [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with depression have a fivefold increased risk of failure to complete cardiac rehabilitation and require enhanced attention and support [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/22\">",
"     22",
"    </a>",
"    ]. Women have a two-fold increased risk of noncompletion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EFFICACY OF CARDIAC REHABILITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed below, cardiac rehabilitation improves outcomes (including survival). Thus, both referral by a physician and enrollment and completion by the patient are necessary for benefits to accrue.",
"   </p>",
"   <p>",
"    Women, non-whites, and patients over age 65 (and particularly older than 75) were conspicuously underrepresented [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/17,18,23\">",
"     17,18,23",
"    </a>",
"    ]. Patients with comorbidities, less medical insurance coverage, and with geographic limitations to accessibility to program sites were less likely to be referred and to participate [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/18/17705?source=see_link&amp;anchor=H1#H1\">",
"     \"Cardiac rehabilitation: Exercise training and secondary prevention of coronary heart disease in older adults\", section on 'Introduction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For example, in a study of 2096 acute myocardial infarction patients (2003 to 2004), predictors of non-participation were women, the uninsured, and patients with hypertension, peripheral arterial disease, lower physical function, and prior percutaneous coronary intervention at one month, and non-whites, older individuals, smokers, and individuals with economic burden at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Exercise training",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise training has beneficial hemodynamic effects in patients following MI (lower heart rate and blood pressure for a given level of exertion), with an improvement in aerobic capacity averaging 20 percent. Resistance (strength) training, when superimposed on aerobic training, improves skeletal muscle strength and endurance. More important are reductions in both mortality and recurrent MI.",
"   </p>",
"   <p>",
"    Abnormal heart rate recovery predicts mortality. In a study of 544 patients with abnormal baseline heart rate recovery before a Phase II Cardiac Rehabilitation Program, heart rate recovery improved in 41 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/26\">",
"     26",
"    </a>",
"    ]. There was a strong association of abnormal heart rate recovery at program exit with all-cause mortality; however, patients with an abnormal heart rate recovery at baseline who normalized their heart rate recovery with exercise training had mortality similar to that of individuals with baseline normal heart recovery.",
"   </p>",
"   <p>",
"    Several meta-analyses have evaluated exercise rehabilitation alone or as a component of multifactorial rehabilitation with risk-factor education and counseling [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The patient populations varied. In one meta-analysis of 63 randomized trials, 35 trials had excluded elderly patients and 19 had excluded women [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Results from individual randomized cardiac rehabilitation trials using exercise as the sole intervention have shown favorable but not significant improvements in morbidity and mortality, probably due to the small sample sizes studied.",
"   </p>",
"   <p>",
"    The limitation of small study size was addressed in a 2005 meta-analysis that encompassed 63 randomized trials and included 21,295 patients with coronary disease (most but not all post-MI). Benefits did not differ in programs incorporating risk-reduction strategies and supervised exercise, those with solely an exercise program, and those with risk-reduction education and counseling but no supervised exercise. Recurrent MI was reduced by 17 percent at one year, with mortality benefit apparent with longer follow-up, 47 percent at two years and 15 percent overall. Benefit was similar in recently published trials to those of over two decades ago, before the widespread use of contemporary medical and revascularization therapies, emphasizing a similar magnitude of benefit of cardiac rehabilitation in the contemporary therapeutic environment. The authors concluded that secondary prevention programs improved processes of care, coronary risk factor profiles, functional status, and quality of life [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27\">",
"     27",
"    </a>",
"    ]. These findings were substantiated in a 2011 meta-analysis of 34 randomized trials including 6111 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A 2004 systematic review and meta-analysis included patients following myocardial revascularization procedures, the majority of whom had a recent acute coronary syndrome (ACS); approximately 20 percent of patients were women and there was a sizable number of patients older than 65 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/28\">",
"     28",
"    </a>",
"    ]. Exercise-based rehabilitation was associated with lower total and cardiac mortality rates with favorable but insignificant trends for nonfatal MI and the need for myocardial revascularization. The benefits of exercise were independent of the dose of exercise intervention or the coronary heart disease subset. Additional benefits included greater reductions compared to the control group in total cholesterol (14.3",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [0.37",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    triglycerides (20.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [0.23",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    systolic blood pressure (3.2 mmHg), and self-reported smoking (odds ratio 0.64). There were no significant differences in LDL or HDL cholesterol [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exercise also appears beneficial in patients with stable coronary disease. This was illustrated in a trial of 101 men age &le;70 with class I to III angina and angiographic evidence of coronary disease who were randomly assigned to an exercise training program (20 minutes of bicycle ergometry per day) or percutaneous coronary intervention with stenting [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/30\">",
"     30",
"    </a>",
"    ]. At one year, survival free of cardiac events (cardiac death, cardiac arrest, MI, stroke, revascularization, or hospitalization for worsening angina) was significantly higher with exercise training (88 versus 70 percent). The distance walked on a six-minute walk test predicted cardiovascular events in patients with stable coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Depressive symptoms were assessed by questionnaire and mortality was evaluated at 40 months in over 500 consecutive coronary patients completing vs not completing rehabilitation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/32\">",
"     32",
"    </a>",
"    ]. Depressed patients had an over fourfold increase in mortality, 22 versus 5 percent, than nondepressed patients; depressed patients completing rehabilitation had a substantially lower mortality, 8 versus 30 percent. Decreased depressive symptoms and decreased mortality were associated with improved fitness, with only modest improvement in fitness levels needed to produce these benefits. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Psychosocial intervention'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Exercise training after MI also may improve left ventricular function and attenuate remodeling. These benefits were demonstrated in the Exercise in Left Ventricular Dysfunction (ELVD) trial in which the efficacy of exercise was evaluated in patients with a first Q wave MI and a left ventricular ejection fraction below 40 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/33\">",
"     33",
"    </a>",
"    ]. A six month exercise training program increased both exercise capacity and the left ventricular ejection fraction (from 34 to 38 percent), while left ventricular end systolic and diastolic volumes were unchanged compared to increased volumes in the control group. In 2011 systematic review, a beneficial effect of exercise training on left ventricular remodeling was shown in clinically stable patients following myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/34\">",
"     34",
"    </a>",
"    ]. The greatest benefit occurred when training started earlier following MI (from one week) and lasted longer than three months.",
"   </p>",
"   <p>",
"    In a national sample of United States Medicare beneficiaries, there was a strong dose response relationship between the number of cardiac rehabilitation sessions attended in an exercise-based cardiac rehabilitation program and the long-term outcomes. Attendance at all 36 sessions was associated with a significantly lower risk of death and myocardial infarction at four years, compared with attendance at fewer sessions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study of postacute, inpatient cardiac rehabilitation showed equal benefit for patients younger than 65 years of age, those 65 to 74, and those older than 75 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/36\">",
"     36",
"    </a>",
"    ]. Another study compared improvements in physiologic outcomes in women completing a 12-week gender-specific versus a traditional cardiac rehabilitation program. Exercise capacity improved significantly among women in both programs. Modifiable factors associated with the improvement in exercise capacity included reduced waist circumference and improved physical functioning [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The issue of whether cardiac rehabilitation is of benefit in patients with coronary artery disease who undergo percutaneous coronary intervention has been addressed in a few studies, which have included patients with and without ACS. The following are two representative examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an observational study of over 600,000 older Medicare patients with coronary artery disease, three separate statistical analyses of those who had undergone PCI showed significantly lower 1 to 5 year mortality rates (approximately 30 percent) in users compared to non-users [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective analysis of data from an Olmsted county registry of nearly 2400 patients who underwent PCI (the majority of whom had recent ACS), there was a significant reduction (nearly 50 percent) in five-year all-cause mortality of those who underwent cardiac rehabilitation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Exercise rehabilitation may have benefits in addition to reductions in recurrent MI",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. Improvement in functional capacity, including an increase in the activity threshold before the onset of ischemia, and a reduction in symptoms can enable return to work as well as to leisure and recreational activities. For elderly patients, moderate increases in functional capacity can help maintain independent living [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Mechanisms of benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of factors may contribute to the benefit of exercise rehabilitation. Well described effects include improvement in the lipid profile, a reduction in blood pressure, treatment and prevention of type 2 diabetes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=see_link\">",
"     \"Exercise and fitness in the prevention of cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a randomized trial of 74 overweight patients with coronary artery disease, high-calorie expenditure exercise (3000 to 3500",
"    <span class=\"nowrap\">",
"     kcal/week)",
"    </span>",
"    compared with standard cardiac rehabilitation exercise (700 to 800",
"    <span class=\"nowrap\">",
"     kcal/week),",
"    </span>",
"    was associated with a significantly greater weight loss and a more favorable cardiometabolic risk profile with the high-calorie expenditure approach [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other factors also may contribute. These include a reduction in inflammation, as manifested by a decrease in serum C-reactive protein concentration that is independent of weight loss and other medical therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/42\">",
"     42",
"    </a>",
"    ], and possibly ischemic preconditioning. Exercise is also associated with improved endothelial function and a more favorable fibrinolytic balance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39529?source=see_link\">",
"     \"Clinical implications of ischemic preconditioning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Psychosocial intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The possible benefit of reducing emotional distress and depression as part of cardiac rehabilitation is discussed in detail elsewhere, but two trials are reviewed briefly here. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16250?source=see_link&amp;anchor=H16#H16\">",
"     \"Psychosocial and other social factors in acute myocardial infarction\", section on 'Depression and psychosocial stress post MI'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25528?source=see_link&amp;anchor=H14#H14\">",
"     \"Psychosocial factors in coronary and cerebral vascular disease\", section on 'Interventions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the randomized ENRICHD trial of psychosocial interventions in 2481 patients after MI, patients receiving psychosocial intervention had less depression and better levels of perceived social support, but there was no reduction in mortality (24 percent in both groups at a mean follow-up of 29 months) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a randomized trial of 134 patients with stable coronary heart disease (57 percent with a prior MI) and exercise-induced ischemia, the patients were assigned to usual medical care alone, with exercise training for 35 minutes three times per week, or with 1.5 hours of stress management training for 16 weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/44\">",
"       44",
"      </a>",
"      ]. Compared to usual care, exercise and stress management were associated with significant reductions in general distress and depressive symptoms (without between-group differences in hostility or anxiety measures), and with significant improvements in markers of cardiovascular risk, such as a smaller reduction in left ventricular ejection fraction during mental stress testing and a lower mean wall motion abnormality score in patients with significant stress-induced wall motion abnormalities at baseline.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H519015287\">",
"    <span class=\"h2\">",
"     Role of program completion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benefits of cardiac rehabilitation obviously occur only if the patient attends and completes an appropriate program. This issue was addressed in a prospective cohort study of 5886 patients following coronary angiography (70 percent after an acute coronary syndrome) subsequently referred for cardiac rehabilitation between 1996 and 2009 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/45\">",
"     45",
"    </a>",
"    ]. Of these, 2432 did not start, 554 started but did not complete, and 2900 completed a program. The median length of follow-up was 5.4 years and the median time to enrollment (among those who participated) was 84 days.",
"   </p>",
"   <p>",
"    The patients who completed cardiac rehabilitation, compared to the combination of non-completers and non-enrollers, had a lower risk of death (adjusted hazard ratio [HR] 0.59, 95% CI 0.49-0.84) and all-cause hospitalization (adjusted HR 0.77, 95% CI 0.71-0.84). The rate of survival was similar between non-enrollers and non-completers. In a propensity matched analysis, survival was lower in completers compared to non-completers (HR 0.67, 95% CI 0.54-0.81).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Long-term impact",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of participation in a cardiac rehabilitation as described above may decline with time [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. Whether continued intervention leads to preservation or further improvement in the benefits seen in patients who completed cardiac rehabilitation programs was evaluated in the ELMI trial.",
"   </p>",
"   <p>",
"    In ELMI, 322 patients were randomly assigned to usual care or ongoing intervention (exercise sessions, telephone follow up, counseling sessions, and reports to the participants' family physicians) that required a total of 16 hours of direct participant contact [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/48\">",
"     48",
"    </a>",
"    ]. At four years, the Framingham risk score, total and LDL-cholesterols were significantly lower compared to baseline in the intervention group but not in the usual care group. The blood pressure fell significantly in the intervention group, and rose in the usual care group.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMPREHENSIVE RISK FACTOR INTERVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comprehensive risk factor intervention refers to the sustained use by the patient of all evidence based therapies (including medications, exercise, diet, smoking cessation, and counseling). However, many cardiac rehabilitation programs support the patient for one or two of these, such as exercise and medications, and many do not offer long term care.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Magnitude of benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;The magnitude of benefit when all major aspects of secondary prevention are followed derives from the finding's observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/49-53\">",
"     49-53",
"    </a>",
"    ], of which the following two epidemiologic studies are representative.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The magnitude and causes of the reduction in CHD mortality was evaluated in adults between the ages 25 and 84 in the United States from 1980 to 2000 [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/52\">",
"       52",
"      </a>",
"      ]. The age-adjusted death rate for CHD in men and women fell from 543 to 267 and from 263 to 134 per 100,000 population, respectively. Approximately one-half of this effect was due to improvements in therapy including secondary preventive measures or revascularization after myocardial infarction.",
"     </li>",
"     <li>",
"      Temporal trends in mortality after hospitalization for acute MI were evaluated in over 21,000 elderly patients (average age 80 years) between 1995 and 2004 who survived at least 30 days [",
"      <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/53\">",
"       53",
"      </a>",
"      ]. Mortality decreased significantly over time by about 3 percent per year and was entirely explained by the combined use of statins, beta blockers, ACE inhibitors or ARBs, and antiplatelet drugs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Short-term comprehensive intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Direct evidence of benefit from short term comprehensive rehabilitation programs comes from the EUROACTION trial, which randomly assigned twelve hospitals to deliver either a comprehensive risk factor intervention program or usual care (no cardiac rehabilitation) to over 1800 patients with established coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/54\">",
"     54",
"    </a>",
"    ]. The intervention patients and their partners received at least eight sessions of a hospital-based, nurse-coordinated, multidisciplinary program in which dietary instruction, exercise training, smoking cessation support, and monitoring of the use of cardioprotective drugs and risk factors were performed.",
"   </p>",
"   <p>",
"    Compared to patients who received usual care, patients in the intervention programs who either smoked or had hypertension at baseline had significantly higher rates of smoking cessation (58 versus 47 percent) or achievement of the blood pressure target of",
"    <span class=\"nowrap\">",
"     &lt;140/90",
"    </span>",
"    mmHg (65 versus 55 percent) at one year. Significant improvements in multiple recommended dietary components were also seen in patients in the intervention groups, but there was no significant difference in other end points such as achievement of lipid or body mass index goals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Long-term comprehensive intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;The effect on prognosis of a long-term intensive rehabilitation strategy was evaluated in the Italian GOSPEL trial in which 3241 patients with a recent MI were randomly assigned to either a three year intensive, multifactorial, continuous educational and behavioral program or to usual care [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/55\">",
"     55",
"    </a>",
"    ]. All patients received standard post-MI, one-month cardiac rehabilitation.",
"   </p>",
"   <p>",
"    The primary combined endpoint (cardiovascular mortality, nonfatal MI, nonfatal stroke, or hospitalization for angina pectoris) was not significantly improved by intensive intervention (16.1 versus 18.2 percent for usual care). However, intensive intervention significantly decreased several secondary endpoints including the combination of cardiovascular mortality plus nonfatal MI and stroke (3.2 versus 4.8 percent) and cardiac death plus nonfatal MI (2.5 versus 4.0 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Temporal trends in risk factor modification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The EUROASPIRE I (1995-1996), II (1999-2000), and III (2006-2007) surveys were used to evaluate temporal trends in the frequency of cardiovascular risk factors in patients in eight European regions with either recent revascularization or hospitalization for an acute coronary syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/56\">",
"     56",
"    </a>",
"    ]. With the exception raised total cholesterol, the proportion of patients with the following risk factors remained the same or increased over the three time periods (results are earliest to latest in percent):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Smoking: 20.3 versus 21.2 versus 18.2",
"     </li>",
"     <li>",
"      Obesity: 25.0 versus 32.6 versus 38.0",
"     </li>",
"     <li>",
"      Raised blood pressure",
"      <span class=\"nowrap\">",
"       (&ge;140/90",
"      </span>",
"      mmHg in patients without and",
"      <span class=\"nowrap\">",
"       &ge;130/90",
"      </span>",
"      mmHg in patients with diabetes): 58.1 versus 58.3 versus 60.9",
"     </li>",
"     <li>",
"      Self reported diabetes: 17.4 versus 20.1 versus 28.0",
"     </li>",
"     <li>",
"      Raised total cholesterol (&ge;4.5",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      [&ge;174",
"      <span class=\"nowrap\">",
"       mg/dl]):",
"      </span>",
"      94.5 versus 76.7 versus 46.2.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Wide variation in the use of cardioprotective therapies such as statins was demonstrated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have documented the safety of cardiac rehabilitation in supervised programs; many antedated current beneficial medical and revascularization therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/6,57-59\">",
"     6,57-59",
"    </a>",
"    ]. In a more contemporary study of over 25,000 patients enrolled in 65 cardiac rehabilitation centers in 2003, there was one cardiac event for every 8484 exercise tests performed, one cardiac event for every 50,000 patient hours of exercise training, and 1.3 cardiac arrests for every million patient hours of exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2007 American Heart Association scientific statement on exercise and acute cardiovascular events estimated that the risk of any major cardiovascular complication (cardiac arrest, death or MI) is one event in 60,000 to 80,000 hours of supervised exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/6/37987?source=see_link\">",
"       \"Patient information: Heart attack recovery (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/52/12100?source=see_link\">",
"       \"Patient information: Heart attack recovery (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?23/16/23813?source=see_link\">",
"       \"Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac rehabilitation improves outcomes after MI. The magnitude of this effect has been demonstrated in the meta-analyses cited above of trials in patients with coronary disease (most post-MI) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The following findings were highlighted in the 2005 meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27\">",
"     27",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Exercise rehabilitation alone produced a significant reduction in all-cause mortality (6.2 versus 9.0 percent, summary risk ratio 0.72, 95% CI 0.54-0.95) and an almost significant reduction in recurrent MI (summary risk ratio 0.76, 95% CI 0.57-1.01).",
"     </li>",
"     <li>",
"      A combined program of exercise rehabilitation and risk factor education produced an almost significant reduction in all-cause mortality (9.3 versus 10.8 percent, summary risk ratio 0.88, 95% CI 0.74-1.04) and a significant reduction in recurrent MI (summary risk ratio 0.62, 95% CI 0.44-0.87).",
"     </li>",
"     <li>",
"      Risk-factor education without exercise was also beneficial, being associated with significant reductions in all-cause mortality (summary risk ratio 0.87, 95% CI 0.76-0.99) and an almost significant reduction in recurrent MI (summary risk ratio 0.86, 95% CI 0.72-1.03).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As of March 22, 2006, the Center for Medicare and Medicaid Services (CMS) in the United States concluded that cardiac rehabilitation is reasonable and necessary following acute MI, coronary artery bypass graft surgery, stable angina pectoris, and percutaneous coronary intervention with or without stenting. This recommendation was based upon a report conducted by the Agency for Healthcare Research and Quality (AHRQ), which reviewed 46 randomized trials of secondary prevention in 18,821 patients with coronary heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. It was concluded that secondary prevention programs improved processes of care, enhanced quality of life and functional status, and reduced hospitalization, recurrent MI, and long-term mortality.",
"   </p>",
"   <p>",
"    The summary risk ratio for all-cause mortality was 0.87 (95% CI, 0.79-0.97) in the 29 trials that reported this outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/61\">",
"     61",
"    </a>",
"    ]. This value was similar to the summary risk ratio of 0.85 (95% CI 0.77-0.94) reported in the 2005 meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In 2007, the",
"    <span class=\"nowrap\">",
"     AACVPR/ACC/AHA",
"    </span>",
"    published performance measures for the referral to and delivery of cardiac",
"    <span class=\"nowrap\">",
"     rehabilitation/secondary",
"    </span>",
"    prevention services [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/63\">",
"     63",
"    </a>",
"    ]. These performance measures were created for hospital settings, office practices, and cardiac rehabilitation programs. They are designed to accelerate and expand the adoption of cardiac rehabilitation as an integral component of cardiac care and provide incentive for rehabilitation referral and better standardizing of care. In addition, evidence-based guidelines for cardiovascular disease prevention in women specifically recommend cardiac rehabilitation following a coronary event [",
"    <a class=\"abstract\" href=\"UTD.htm?13/41/13977/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All eligible patients (acute MI, coronary artery bypass graft surgery, stable angina pectoris, and percutaneous coronary intervention with or without stenting) should be referred to a cardiac rehabilitation program. Limited data suggest that participation can be improved when health care providers make early appointments at cardiac rehabilitation programs for appropriate patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=see_link&amp;anchor=H870866319#H870866319\">",
"     \"Components of cardiac rehabilitation and exercise prescription\", section on 'Timing of first visit'",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/1\">",
"      Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med 2001; 345:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/2\">",
"      Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124:2458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/3\">",
"      Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124:2610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/4\">",
"      Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124:2574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/5\">",
"      Kwan G, Balady GJ. Cardiac rehabilitation 2012: advancing the field through emerging science. Circulation 2012; 125:e369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/6\">",
"      Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2007; 115:2675.",
"     </a>",
"    </li>",
"    <li>",
"     Wenger NK, Froelicher ES, Smith LK, et al. Clinical Practice Guideline No. 17. AHCPR Publication No. 96-0672, U.S. Department of Health and Human Services, Agency for Healthcare Policy and Research, and the National Heart, Lung, and Blood Institute, Rockville, MD 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/8\">",
"      Wenger NK. Current status of cardiac rehabilitation. J Am Coll Cardiol 2008; 51:1619.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Medicare and Medicaid Services. Decision memo for cardiac rehabilitation programs (CAG-00089R) www.cms.hhs.gov/mcd/viewdecisionmemo.asp?id-164 (Accessed on October 08, 2007).",
"    </li>",
"    <li>",
"     Wenger, NK. Rehabilitation of the patient with coronary heart disease. In: Hurst's The Heart, 11th ed, Fuster V, Alexander RW, O'Rourke RA, (Eds), McGraw-Hill, New York 2004. p.1517-1527.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/11\">",
"      Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/12\">",
"      Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007; 50:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/13\">",
"      Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 2003; 41:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/14\">",
"      Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/15\">",
"      Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol 2004; 44:e213.",
"     </a>",
"    </li>",
"    <li>",
"     Wenger, NK. Rehabilitation of the patient with coronary heart disease. In: Hurst's The Heart, 11th ed, Fuster, V, Alexander, RW, O'Rourke, RA (Eds), McGraw-Hill, New York 2004. p.1517-1527.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/17\">",
"      Cottin Y, Cambou JP, Casillas JM, et al. Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome. J Cardiopulm Rehabil 2004; 24:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/18\">",
"      Suaya JA, Shepard DS, Normand SL, et al. Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 2007; 116:1653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/19\">",
"      Lavie CJ, Thomas RJ, Squires RW, et al. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc 2009; 84:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/20\">",
"      Cort&eacute;s O, Arthur HM. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: a systematic review. Am Heart J 2006; 151:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/21\">",
"      Bethell H, Lewin R, Dalal H. Cardiac rehabilitation in the United Kingdom. Heart 2009; 95:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/22\">",
"      Caulin-Glaser T, Maciejewski PK, Snow R, et al. Depressive symptoms and sex affect completion rates and clinical outcomes in cardiac rehabilitation. Prev Cardiol 2007; 10:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/23\">",
"      Witt BJ, Jacobsen SJ, Weston SA, et al. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 2004; 44:988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/24\">",
"      Balady GJ, Ades PA, Bittner VA, et al. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. Circulation 2011; 124:2951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/25\">",
"      Parashar S, Spertus JA, Tang F, et al. Predictors of early and late enrollment in cardiac rehabilitation, among those referred, after acute myocardial infarction. Circulation 2012; 126:1587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/26\">",
"      Jolly MA, Brennan DM, Cho L. Impact of exercise on heart rate recovery. Circulation 2011; 124:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/27\">",
"      Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med 2005; 143:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/28\">",
"      Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 2004; 116:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/29\">",
"      Lawler PR, Filion KB, Eisenberg MJ. Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J 2011; 162:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/30\">",
"      Hambrecht R, Walther C, M&ouml;bius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004; 109:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/31\">",
"      Beatty AL, Schiller NB, Whooley MA. Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med 2012; 172:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/32\">",
"      Milani RV, Lavie CJ. Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med 2007; 120:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/33\">",
"      Giannuzzi P, Temporelli PL, Corr&agrave; U, et al. Attenuation of unfavorable remodeling by exercise training in postinfarction patients with left ventricular dysfunction: results of the Exercise in Left Ventricular Dysfunction (ELVD) trial. Circulation 1997; 96:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/34\">",
"      Haykowsky M, Scott J, Esch B, et al. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling. Trials 2011; 12:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/35\">",
"      Hammill BG, Curtis LH, Schulman KA, Whellan DJ. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation 2010; 121:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/36\">",
"      Frengley JD, Sansone GR, Alba A, et al. Influence of age on rehabilitation outcomes and survival in post-acute inpatient cardiac rehabilitation. J Cardiopulm Rehabil Prev 2011; 31:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/37\">",
"      Beckie TM, Beckstead JW, Kip K, Fletcher G. Physiological and exercise capacity improvements in women completing cardiac rehabilitation. J Cardiopulm Rehabil Prev 2013; 33:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/38\">",
"      Suaya JA, Stason WB, Ades PA, et al. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol 2009; 54:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/39\">",
"      Goel K, Lennon RJ, Tilbury RT, et al. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 2011; 123:2344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/40\">",
"      Ades PA, Grunvald MH. Cardiopulmonary exercise testing before and after conditioning in older coronary patients. Am Heart J 1990; 120:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/41\">",
"      Ades PA, Savage PD, Toth MJ, et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation 2009; 119:2671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/42\">",
"      Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 2004; 43:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/43\">",
"      Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003; 289:3106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/44\">",
"      Blumenthal JA, Sherwood A, Babyak MA, et al. Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease: a randomized controlled trial. JAMA 2005; 293:1626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/45\">",
"      Martin BJ, Hauer T, Arena R, et al. Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation 2012; 126:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/46\">",
"      Boesch C, Myers J, Habersaat A, et al. Maintenance of exercise capacity and physical activity patterns 2 years after cardiac rehabilitation. J Cardiopulm Rehabil 2005; 25:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/47\">",
"      Willich SN, M&uuml;ller-Nordhorn J, Kulig M, et al. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort study. Eur Heart J 2001; 22:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/48\">",
"      Lear SA, Spinelli JJ, Linden W, et al. The Extensive Lifestyle Management Intervention (ELMI) after cardiac rehabilitation: a 4-year randomized controlled trial. Am Heart J 2006; 152:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/49\">",
"      Hippisley-Cox J, Coupland C. Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis. BMJ 2005; 330:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/50\">",
"      Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004; 109:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/51\">",
"      Mukherjee D, Fang J, Kline-Rogers E, et al. Impact of combination evidence based medical treatment in patients with acute coronary syndromes in various TIMI risk groups. Heart 2005; 91:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/52\">",
"      Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356:2388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/53\">",
"      Setoguchi S, Glynn RJ, Avorn J, et al. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol 2008; 51:1247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/54\">",
"      Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008; 371:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/55\">",
"      Giannuzzi P, Temporelli PL, Marchioli R, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med 2008; 168:2194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/56\">",
"      Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/57\">",
"      Franklin BA, Bonzheim K, Gordon S, Timmis GC. Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up. Chest 1998; 114:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/58\">",
"      Van Camp SP, Peterson RA. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA 1986; 256:1160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/59\">",
"      Pavy B, Iliou MC, Meurin P, et al. Safety of exercise training for cardiac patients: results of the French registry of complications during cardiac rehabilitation. Arch Intern Med 2006; 166:2329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/60\">",
"      Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology. Circulation 2007; 115:2358.",
"     </a>",
"    </li>",
"    <li>",
"     Agency for Healthcare Research and Quality (AHRQ) Technology Assessment Program. Randomized trials of secondary prevention programs in coronary artery disease: a systematic review, Rockville, Maryland 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/62\">",
"      Jolliffe JA, Rees K, Taylor RS, et al. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001; :CD001800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/63\">",
"      Thomas, RJ, King, M, Lui K, et al. AACVPR/ACC/AHA Performance Measures on Cardiac Rehabilitation for Referral to and Delivery of Cardiac Rehabilitation/Secondary Prevention Services. Endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Assocaition of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons. J Am Coll Cardiol 2007; 50:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/41/13977/abstract/64\">",
"      Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115:1481.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1552 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-4A54400AA2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13977=[""].join("\n");
var outline_f13_41_13977=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EFFICACY OF CARDIAC REHABILITATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Exercise training",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Mechanisms of benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Psychosocial intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H519015287\">",
"      Role of program completion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Long-term impact",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMPREHENSIVE RISK FACTOR INTERVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Magnitude of benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Short-term comprehensive intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Long-term comprehensive intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Temporal trends in risk factor modification",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SAFETY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1552\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1552|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/18/4398\" title=\"figure 1\">",
"      Lifestyle and survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/13/8414\" title=\"figure 2\">",
"      Graded benefit of fitness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1552|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/21/9566\" title=\"table 1A\">",
"      Core components rehab A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/3/57\" title=\"table 1B\">",
"      Core components rehab B",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/18/17705?source=related_link\">",
"      Cardiac rehabilitation: Exercise training and secondary prevention of coronary heart disease in older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39529?source=related_link\">",
"      Clinical implications of ischemic preconditioning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/43/31417?source=related_link\">",
"      Components of cardiac rehabilitation and exercise prescription",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/28/14793?source=related_link\">",
"      Exercise and fitness in the prevention of cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/52/12100?source=related_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/6/37987?source=related_link\">",
"      Patient information: Heart attack recovery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/16/23813?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?20/42/21156?source=related_link\">",
"      Patient information: Recovery after coronary artery bypass graft surgery (CABG) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/55/16250?source=related_link\">",
"      Psychosocial and other social factors in acute myocardial infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/59/25528?source=related_link\">",
"      Psychosocial factors in coronary and cerebral vascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/15/23800?source=related_link\">",
"      Psychosocial factors in sudden cardiac arrest",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40906?source=related_link\">",
"      Secondary prevention of cardiovascular disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_41_13978="Inferior pontine syndrome";
var content_f13_41_13978=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F71587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F71587&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Inferior pontine syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 709px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kistler, JP, et al, Cerebrovascular Diseases, Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill, New York 1994. Copyright 1994 McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13978=[""].join("\n");
var outline_f13_41_13978=null;
var title_f13_41_13979="SGA fetal mortality";
var content_f13_41_13979=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fetal mortality in SGA infants",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Weight",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Rate",
"per 1000",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        37 to 38 weeks",
"       </td>",
"       <td class=\"subtitle2\">",
"        39 to 40 weeks",
"       </td>",
"       <td class=\"subtitle2\">",
"        41 to 42 weeks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        AGA* 2750 to 3999 g",
"       </td>",
"       <td>",
"        3.7",
"       </td>",
"       <td>",
"        2.4",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        SGA&bull;",
"1500 to 2500 g",
"       </td>",
"       <td>",
"        85.3",
"       </td>",
"       <td>",
"        93.5",
"       </td>",
"       <td>",
"        93.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        SGA &lt;1500 g",
"       </td>",
"       <td>",
"        405",
"       </td>",
"       <td>",
"        455",
"       </td>",
"       <td>",
"        375",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Appropriate for gestational age.",
"     <br>",
"      &bull; Small for gestational age.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Williams RL, Creasy RK, Cunningham GC, et al. Obstet Gynecol 1982; 59:624.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13979=[""].join("\n");
var outline_f13_41_13979=null;
var title_f13_41_13980="The hydration debate";
var content_f13_41_13980=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The hydration debate",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Arguments for hydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Provides a basic human need",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Provides comfort and prevents uncomfortable symptoms: confusion, agitation, and neuromuscular irritability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prevents complications (eg, neurotoxicity with high-dose narcotics)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Relieves thirst, recognized as a sign of fluid needs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Does not \"artificially\" prolong life to any meaningful degree",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allows providers to continue their efforts to find ways to improve comfort and life quality, despite the perception of a poor quality of life",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Provides minimum standards of care; not doing so would break a bond with the patient",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Denying hydration may set a precedent to withhold therapies from other patients who are compromised",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Arguments against hydration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Interferes with acceptance of the terminal condition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intravenous therapy is painful and intrusive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prolongs suffering and the dying process",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unnecessary since unconscious patients do not experience uncomfortable symptoms, such as pain or thirst",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less urine output means less need for bed pan, urinal, commode, or catheter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less fluid in the GI tract and less vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Less pulmonary secretions and less cough, choking, and congestion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minimizes edema and ascites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ketones and other metabolic by-products in dehydration act as natural anesthetics for the central nervous system, causing decreased levels of consciousness and decreased suffering",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Bruera E, Dalal S. Dehydration in cancer patients: To treat or not to treat. J Support Oncol 2004; 2:467. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13980=[""].join("\n");
var outline_f13_41_13980=null;
var title_f13_41_13981="Features of Meckels diverticulum on imaging studies";
var content_f13_41_13981=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F87461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F87461&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Features of Meckel's diverticulum on imaging studies",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Modality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Features and caveats",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plain abdominal film",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           May demonstrate nonspecific signs of intestinal obstruction",
"          </span>",
"         </li>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           An enterolith may be seen in the lower abdomen, but cannot be definitively localized to the Meckel's as opposed to the appendix",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ultrasonography",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           An obstructed Meckel&rsquo;s diverticulum may be identified as a fluid-filled pouch off the distal small intestine",
"          </span>",
"         </li>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           Ultrasound findings are nonspecific and are easily confused with appendicitis",
"          </span>",
"         </li>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           Intussusception&nbsp;can be&nbsp;diagnosed with ultrasound, but attributing the lead point to be a Meckel&rsquo;s diverticulum cannot be determined with any certainty",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Computed tomography",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           Asymptomatic or bleeding diverticula are rarely or infrequently identified with computed tomography",
"          </span>",
"         </li>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           A distinction between a Meckel&rsquo;s diverticulum and normal small intestinal loops is virtually impossible in the absence of associated inflammation",
"          </span>",
"         </li>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           Acutely inflamed diverticula can be identified as a blind pouch off the distal small intestine, and is typically with associated bowel wall thickening of the peri-diverticular fat",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Upper gastrointestinal series",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           Small bowel series have demonstrated Meckel&rsquo;s diverticulum, but are unreliable even using enteroclysis in experienced hands",
"          </span>",
"         </li>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           False negative rates are high due to:",
"          </span>",
"         </li>",
"        </ul>",
"        <p>",
"         <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- Rapid emptying of contrast from the diverticulum",
"         </span>",
"        </p>",
"        <p>",
"         <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;Obscured visualization of the diverticulum due to overlying contrast-",
"         </span>",
"         <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"          filled small bowel loops",
"         </span>",
"        </p>",
"        <p>",
"         <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- Poor filling of the diverticulum (occlusion or narrowing of the entrance)",
"         </span>",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mesenteric arteriorgraphy",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           A&nbsp;diagnosis of",
"           <span style=\"font-family: verdana; font-size: 13px;\">",
"            Meckel's",
"           </span>",
"           is&nbsp;based upon the finding of an anomalous superior mesenteric artery branch feeding the diverticulum; a",
"           <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"            ctive contrast extravasation may be seen in patients with ongoing hemorrhage",
"           </span>",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Meckel's scan",
"       </td>",
"       <td>",
"        <ul>",
"         <li>",
"          <span style=\"font-family: verdana,sans-serif; font-size: 10pt;\">",
"           Identifies areas of ectopic gastric mucosa, if present",
"          </span>",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13981=[""].join("\n");
var outline_f13_41_13981=null;
var title_f13_41_13982="Cortisol in the critically ill";
var content_f13_41_13982=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66966&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66966&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 520px\">",
"   <div class=\"ttl\">",
"    Cortisol levels in normal subjects and the critically ill",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 500px; height: 326px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Vermes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995; 80:1238. Copyright &copy; 1995 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13982=[""].join("\n");
var outline_f13_41_13982=null;
var title_f13_41_13983="Congenital lip pits";
var content_f13_41_13983=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50289&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50289&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lip pits in a child with Van der Woude syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the bilateral, paramedian depressions in the lip mucosa. They contain salivary tissue and often secrete mucus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_41_13983=[""].join("\n");
var outline_f13_41_13983=null;
